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1 Introduction 
 
Chronic alcohol abuse is a major social and medical problem in western countries. For the year 
2000, WHO reported that 6 % of the male and 3.8 % of the female adult population of Germany 
was alcohol dependent (WHO Global Status Report on Alcohol, 2004). In 2005, 14.940 German 
people died in consequence of chronic alcohol abuse (Statistisches Bundesamt, 2005).  
Deleterious effects of alcohol use on health have long been described, including symptoms, which 
are associated with a damaged liver and increased illness and death seen in alcohol abusers. One of 
the least appreciated medical complications of alcohol abuse is an altered immune regulation 
leading to immunodeficiency and autoimmunity. Impairment of the immune system, which serves 
as defense against infections and uncontrolled tumor growth, increases a person’s risk for 
developing various illnesses and certain types of cancer (Szabo, 1997). The consequences of the 
immunodeficiency include high susceptibility to bacterial and viral infections (Cook, 1998).  
Alcoholics have long been recognized to be at a greater risk of community-acquired pneumonias 
(Friedman et al., 2003) and are twice as likely to die of pneumonia. The incidence of tuberculosis is 
15- to 200fold higher than in a control population. The increase in both, the frequency and  the 
severity of infections in ethanol-abusing individuals is attributed to immune dysfunction 
(Messingham, 2002). 
In addition, the most destructive complication of alcoholism, liver disease and liver failure result 
from a dysregulated immune response. In this case, chronic alcohol consumption leads to an 
increase in the expression of a number of inflammatory mediators, including cytokines, reactive 
oxygen and nitrogen species, and chemokines (Tilg and Diehl, 2000). One of the primary 
mechanisms causing liver damage in response to ethanol exposure is due to activation of Kupffer 
cells that is causing an increase in TNF-α production and reactive oxygen species, leading to the 
progression of fatty liver, inflammation, and fibrosis (Thurmann, 1998).  
Kupffer cells are critical to the onset of ethanol-induced liver injury because of their function as the 
first site of exposure to gut-derived lipopolysaccharide/endotoxin (LPS). Since alcohol 
consumption is associated with impaired barrier function (Parlesak et al., 2000) and increased serum 
levels of LPS, the increase in TNF-α after alcohol consumption is at least in part due to an increase 
in LPS exposure (Bode et al., 1997). Additionally mechanisms of Kupffer cell activation during 
chronic alcohol exposure may involve the activation of autoimmunity in response to oxidative 
damage to hepatic proteins and phospholipids (Albano, 2002, Vidali et al., 2003). 
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Studies during the last three decades have demonstrated that alcohol has multiple effects on the 
host immune responsiveness. These effects are characterized by depletion of circulating lymphocyte 
populations and altered lymphoid organ architecture and immune functions (Friedman et al., 2003).  
Many of the functions of immunocompetent cells are regulated by a network of cytokines that are 
able of effecting local and systemic immune and inflammatory responses. Cytokines produced by 
lymphocytes such as interleukins and interferons regulate the functions of immune cells as well as 
non-immune cells (e.g. nerve cells, hormone-producing cells). The effect of either chronic or acute 
alcohol use on cytokine production might be the key element to understand immune dysregulation 
seen in alcohol abusers.  
Altered cytokine balance caused by alcohol is leading to a new insight on the regulation of the 
immune system although much remains to be learned of the basic immune disorders of the 
alcoholic (Cook, 1998). 
Since IFN-γ together with IL-12 is crucial for the induction of cell-mediated immune response, 
ethanol-induced changes in the production of those cytokines might be a key factor to 
compromised immunity. Consequently, in the absence of appropriate IFN-γ stimulation a 
preferential induction of the humoral immune response may occur. The accompanying lack of  
cell-mediated response would make the individuals more susceptible to infections that require a  
T cell response. Furthermore, decreased IFN-γ levels are likely to contribute to additional cytokine 
abnormalities and thereby to further impairment of cell-mediated immune response (Szabo, 1997). 
A reason we conducted the current study was to determine the effect of ethanol on Interferon γ 
production and to examine possible mechanisms by which ethanol is modulating intracellular 
signaling leading to a suppression of IFN-γ expression in NK-92 cells. 
Studies that focused on ethanol-mediated changes of IFN-γ expression have already been carried 
out and showed a significant suppression of serum levels of IFN-γ in alcoholics. The inhibitory 
action of ethanol on IFN-γ production is supported by in vivo and in vitro findings (Wagner et al., 
1992, Chen et al., 1993, Laso et al., 1997, Waltenbaugh et al., 1998, Starkenburg et al., 2001, Szabo et 
al., 2001, Dokur et al., 2003). The question remains to be answered on which level ethanol is able to 
interfere with intracellular signaling pathways. 
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1.1 Alcohol – damage to the immune system 
An overwhelming amount of evidence reveals that both acute and chronic alcohol exposure 
suppresses all branches of the immune system, including early responses to infection and the tumor 
surveillance system (Cook, 1998, Diaz et al., 2002, Nelson and Kolls, 2002, Messingham et al., 2002). 
For example, there is a decrease in the ability to recruit and activate germ-killing white blood cells 
(Deaciuc, 1997, Szabo et al., 1999). In addition, epidemiological data have identified chronic alcohol 
consumption as a significant risk factor for upper alimentary tract cancer, including cancer of the 
oropharynx, larynx and the esophagus and of the liver. The increased risk attributable to alcohol 
consumption of cancer in the large intestine and in the breast is much smaller (Pöschl, 2004). 
The association between alcohol exposure and the risk of developing an alcohol-related disease is 
multifactorial and there is a considerable individual variation, with a particular female susceptibility. 
This highly variable individual susceptibility is influenced apart from sex by different factors such as 
age, race, hormones and body mass as well as genetic and environmental factors (Diaz et al., 2002). 
Although more severe alcohol-induced morbidity is generally preceded by high levels of alcohol 
consumption and long duration of drinking, both development and progression of lesions are 
highly variable. Liver cirrhosis and pancreatitis are usually associated with excessive alcohol 
consumption. Conditions that occur include digestive disturbance, fatty infiltration of the liver, 
gastrointestinal bleeding, neuropsychological impairment, nutritional deficiency, peripheral 
neuropathy and skeletal myopathy (Thakker, 1998). 
The two toxicity types of ethanol most readily discussed are hepatoxicity and neurotoxicity, but 
there is a persistent and widespread ambivalence to recognizing ‘intrinsic toxicity of alcohol’. 
Today it is generally accepted that drinking alcohol regularly for years is toxic to almost every tissue 
in the body (Diaz, 2002). 
In the last few years, researchers have become more knowledgeable about the influence of alcohol 
consumption, both in moderate and high amounts, on the immune system.  
A survey of the consequences of ethanol abuse on health status and immune system is the objective 
of the following chapter. 
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1.1.1 Human diseases related to alcohol abuse  
Evidence supports the idea that both acute and chronic exposure to alcohol have negative effects 
on several biologic systems, including the immune system (Díaz et al., 2002 and Nelson and Kolls, 
2002). Chronic exposure to ethanol leads to alcoholic liver damage and increased morbidity and 
mortality due to infectious diseases (Cook, 1998 and Watson, 1994). For example, individuals who 
consume alcohol, compared with those who do not, are twice as likely to die of pneumonia 
(Cortese et al., 1992 and Esposito, 1984). Moreover, the incidence of tuberculosis is significantly 
greater in people who abuse alcohol than in those who consume moderate amounts of alcohol 
(Cook, 1998 and Friedman et al., 1987). Thus, infections in ethanol-consuming individuals who 
consume large amounts of alcohol are both more frequent and more severe (Cook, 1998), in part 
because of ethanol-induced dysregulation of immune responses. In addition to the increased 
incidence of infectious disease in alcoholics, acute (or binge), ethanol exposure has detrimental 
effects on inflammatory and immune responses (Messingham et al., 2002). 
Investigation of the potential relationship between alcohol use and HIV-1 infection is evolving. In 
case of alcohol abuse and HIV infections, two essential questions remain: Does prior or concurrent 
alcohol ingestion increase the susceptibility to infection at the time of exposure, and on the other 
hand, does alcohol abuse by infected individuals increase the rate of progression from HIV 
infection to AIDS and profound immune deficiency. However, further research is needed to 
understand cellular and intracellular mechanisms by which ethanol consumption may modulate the 
biology and clinical course of HIV-1 infection (Szabo, 1999). 
The other viral disease where alcohol consumption has been shown to adversely affect the natural 
course of the disease is Hepatitis C. Recent reports show evidence that alcohol consumption 
promotes clinical progression and liver damage in patients with chronic hepatitis C infection (Wiley 
et al., 1998). Prevalence of HCV is 3-fold to 30-fold higher in alcoholics compared with the general 
population. Patients with HCV infection and alcohol abuse develop more severe fibrosis with 
higher rate of cirrhosis and hepatocellular cancer compared with non-drinkers. Increased oxidative 
stress seems to be the dominant mechanism for this synergism between alcohol and the HCV. 
Additionally, it was shown that response rates to interferon in alcoholics were significantly lower. 
As for HIV infections, the answer whether alcoholism in some way predisposed the individual to 
HCV infections is still to be elucidated (Singal and Anand, 2007).  
Several less common infections are more apparent in the chronic alcoholic: lung abscess, 
emphysema, spontaneous bacterial peritonitis, diphtheria and meningitis (MacGregor et al., 1997). 
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A disastrous medical complication of chronic alcohol abuse is alcoholic liver disease with eventual 
liver failure. In 2005, 10.007 German people died as a consequence of alcohol liver disease 
(Statistisches Bundesamt, 2005). The liver is predominantly damaged by chronic alcohol intake, 
since the liver is the central organ of ethanol metabolism (Messingham et al., 2002).  
It has become commonly accepted that immune mechanisms are partially responsible for the onset 
and/or progression of alcoholic liver disease (ALD). This observation is often overlooked because 
of the many other complications of alcohol abuse such as malnutrition, ingestion of high saturated 
fats, vitamin deficiency, drug abuse, and smoking (Thiele, 2004). 
In alcoholic liver disease, Kupffer cells in the liver are activated by lipopolysaccaride (LPS) caused 
from a breakdown in the intestinal wall permeability. This phenomenon has been called ‘leaky gut’ 
and occurs when alcohol increases gut permeability, causing bacteria from the intestinal tract to 
escape into the blood stream (Keshavarzian et al., 1999). When LPS is present, it activates Kupffer 
cells to release TNF-alpha and superoxides that result in an inflammatory response. Already very 
small amounts of LPS can stimulate Kupffer cells to release these proinflammatory cytokines 
(Duryee, 2004). Once these cytokines are initiated, inflammation and necrosis occurs to hepatocytes 
and other cell types of the liver.  
Alcoholic liver disease has often been associated with circulating antibodies and lymphocytes 
specific to hepatic antigens (Klassen, 1995). Circulating antibodies specific to acetaldehyde adducts 
and hydroxyethyl-free radicals have also been found to correlate with ALD (Clot, 1995). This 
provides a possible mechanism of autoantibody production wherein metabolites of ethanol modify 
hepatic self-antigens and induce an autoimmune response against the liver. 
When metabolites of alcohol are present in the liver, the immune response is tremendously 
increased. Toxicity due to the chemical breakdown of these metabolites and the inflammation of 
immune cells increase the number of hepatocyte damage. Self-proteins from hepatocytes could 
become modified with acetaldehyde, malondialdehdye, or both. These self-proteins could bind to 
and be taken up by macrophage, endothelial cells, or dendritic cells and presented to T cells. If this 
occurs, reactive cytotoxic T cells or the production of antibody could aid in damaging the liver 
(Thiele, 2003). 
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1.1.2 Alterations of the immune system 
Healthy individuals protect themselves against microbes by many different mechanisms including 
innate (non-specific) and acquired (specific) immunity. Elements of innate immunity exist prior to 
exposure to microbes and include phagocytes such as neutrophils and macrophages, natural killer 
(NK) cells, circulating molecules, i.e. complement and macrophage-derived soluble mediators. 
Acquired immunity is triggered by exposure to foreign substances (antigens) and involves an 
integrated system of host defense in which numerous cells and molecules function cooperatively. 
Acquired immunity features humoral and cell-mediated immune responses as a result of a complex 
cross-talk between T and B lymphocytes, antigen presenting cells (monocytes, macrophages, 
dendritic cells, B lymphocytes), and also utilizes specific antibodies and lymphocyte-derived 
cytokines. However, exogenous agents that affect any of these components of the immune system 
can impair this well-orchestrated defense mechanism against pathogens. 
Alcohol has been shown as one of the modulators of host defense. Impaired immunity in patients 
with chronic alcohol use has long been described in the medical literature (Jerrels 1993, Cook 1995, 
MacGregor and Louria, 1997). Chronic and even acute, moderate alcohol use can increase host 
susceptibility to infections caused by bacterial and viral pathogens. Impaired host defense after 
alcohol exposure appears to be linked to a combination of decreased inflammatory response, 
altered cytokine production and abnormal reactive oxygen intermediate generation. Furthermore, 
cellular immunity, particularly antigen-specific immune response, is impaired by both acute and 
chronic alcohol use (Szabo, 1999).  
While malnutrition, vitamin deficiency and advanced liver cirrhosis can contribute to some of the 
immune abnormalities in chronic alcoholics, alcohol itself is a potent modulator of the immune 
system. Increasing evidence from human and animal studies in vivo as well as from experiments 
in vitro suggests that alcohol use can indeed modulate the immune system at various levels  
(Szabo, 1999).  
The unfavorable effects of chronic alcohol abuse include a general decrease in the main cellular 
components of the immune system (Laso et al., 1997) and are reported to be caused by impaired 
cell proliferation (Brodie and Watson), increased apoptosis (Slukvin and Jerrells, 1995), or reduced 
production of particular antibody (Helm et al., 1996). Brodie et al., (1992) suggested a  
Ca2+ membrane channel inhibition and subsequent suppression of c-fos induction as the major 
effects of ethanol on B cell proliferation. For immunoglobulin A (IgA) or immunoglobulin G 
(IgG), the results of clinical studies show an immunoglobulin increase in patients with ethanol-
induced liver cirrhosis (Mühlbauer et al., 2001). The latter report indicates a spontaneously higher  
B lymphocyte secretion rate in alcoholics for IgA and IgG (but not IgM), which is described being 
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due to increased T lymphocyte-derived B cell differentiation factors. Gluud and Tage-Jensen (1983) 
monitored increased IgM, IgA, and IgG concentrations in patients with liver cirrhosis. However, 
ethanol seems to negatively affect the CD19+/CD5+subset of B cells in alcoholic patients with 
alcoholic hepatitis, decreasing their concentration (Laso et al., 1997). 
Immunosuppression associated with chronic alcohol use is characterized by reduced antigen-
specific T cell response and impaired delayed-type hypersensitivity. T lymphocyte activation and 
proliferation are also dependent on the cell surface signals received during cell-cell interactions. 
Although T lymphocyte functions can be directly affected by ethanol, decreased antigen presenting 
cell function appears to be a key element in the ethanol-induced decrease in cell-mediated 
immunity. Chronic alcohol consumption is associated with reduced antigen-specific T cell 
proliferation due to insufficient accessory cell function. (Szabo et al., 2001).  
Additionally, the T cell proliferation-inhibiting effects of ethanol-induced monocyte-derived 
cytokines and mediators (TGF-β, IL-10, PGE2) might be important (Szabo et al., 1993). In 
addition, a preferential induction of Th2 vs. Th1 immune response has been suggested, based on 
the increased immunoglobulin levels seen in chronic alcoholics (Szabo, 1999). 
There have been reports of reduced natural killer (NK) activity in human alcoholics. Cell surface 
markers and fresh NK activity in controls and alcoholics showed abnormalities in both phenotype 
and function (Cook, 1997).  
In contrast to cell types that show a decrease in number and depressed function, other cell types are 
enhanced in their activity. Polymorphonuclear neutrophils (PMNs) are involved primarily in the 
elimination of microbial antigens at sites of infection. However, they are also implicated in the 
initiation of tissue injury in alcoholic liver disease. Migration of PMNs is controlled by a series of 
events triggered by infection, injury, or both. The most prominent factors involved in these 
processes are proinflammatory mediators, such as, reactive oxygen species (ROS), cytokines, 
chemotactic lipids and peptides, and complement products. Additionally circulating IL-8 levels 
correlate with neutrophilic infiltration in patients with severe alcoholic hepatitis (Maltby et al., 1996).  
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1.1.3 Mechanism of alcohol-induced modulation of immune response 
1.1.3.1 Cellular interactions of the immune system 
In the past several years, research in immunology has demonstrated a dramatic degree of interaction 
among the different types of immunocompetent cells. The insights from that work have suggested 
new fields for investigation the immune alterations in alcoholism. 
Among the lymphocytes, T cells play a central role. They can inhibit or stimulate B cells to produce 
antibodies and they are the source of many regulatory cytokines, but also interact with monocytes 
and interact and regulate other T cell subclasses. It is therefore of importance to evaluate their 
interaction and possible alteration after both acute and chronic alcohol exposure (Szabo, 2002). 
Encountered microbes or antigens are internalized and microbial peptides are produced by 
proteolytic cleavage and are bound to MHCII molecules. Both peptide and MHCII are displayed 
on the surface of dendritic cells (DCs) or macrophages. Antigen-presenting cells then interact with 
antigen-specific receptors on CD4+ T helper cells. This interaction is critical in determining the 
subsequent type 1 or type 2 nature of the effector immune response. The different types show 
defined patterns of cytokine secretion (Romagnani, 1994). Type 1 responses lead to cell-mediated 
immune responses such as delayed-type hypersensitivity (Macatonia et al., 1995). Both IL-4 and  
IL-10 are associated with type 2 responses (Mosmann and Sad, 1994) and up-regulate antibody 
production. 
Ethanol consumption diminishes type 1 IL-12/IFN-γ (Mandrekar et al., 2004, Starkenburg, 2001) 
production, but up-regulates type 2-dependent IgE responses in both human and  mice (Gonzalez-
Quintela et al., 2004 and Latif et al., 2002). This is attributed to the effect of ethanol on diminished 
type 1 cytokine secretion and to the influence of APC on CD4+ T cell maturation. 
 
1.1.3.2 Alcohol and cytokine network 
One of the most important developments in immunology in recent years has been the discovery of 
a vast network of regulator molecules called cytokines. Changes in their balance have profound 
effects on the function of immune cells.  
Induction of inflammatory cytokines by pathogens is the initial step in the host’s immune defense. 
Whereas acute alcohol exposure seems to dampen inflammatory cytokine production, which is 
pivotal to innate immune activation after pathogen contact, chronic alcohol abuse is associated with 
inflammatory processes (Crews et al., 2006, Szabo, 1999). Furthermore, the presence of already 
developed diseases, such as alcohol liver diseases affects the cytokine balance as well (Messingham 
et al., 2002).  
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Ethanol-mediated changes in monocytes cytokine production  
Alcohol can adversely affect the innate immune responses: Acute alcohol can inhibit 
proinflammatory cell activation pivotal to innate immune activation. This down-regulation in the 
production of proinflammatory cytokines involves the inhibition of NF-κB-mediated intracellular 
pathways (Mandrekar et al., 2004). Physiological innate immune responses to pathogens involve the 
induction of proinflammatory cytokines followed by induction of antiinflammatory cytokines by 
the same pathogen that provide a mechanism for resolution of inflammation. IL-10 has 
antiinflammatory properties as it inhibits TNF-α production and is also a negative regulator of 
antigen-specific T cell activation through inhibition of IL-12 production by antigen presenting cells 
such as monocytes and dendritic cells (Xia and Kao, 2003). Moderate alcohol consumption 
augments LPS-induced IL-10 production in monocytes. Taking together, these observations 
suggest that acute, moderate alcohol consumption has dual antiinflammatory effects by inhibiting 
proinflammatory and augmenting antiinflammatory cytokines in monocytes (Szabo et al., 2001).  
In contrast, chronic alcohol us in humans is associated with increased proinflammatory cytokine 
activation (Mandrekar et al., 2004). Importantly, in ALD there is activation of monocytes and 
macrophages resulting in massive increases in proinflammatory cytokines including TNF-α, IL-1 
and IL-6 and the chemokine IL-8 (McClain et al., 1999).  
In vitro treatment of human monocytes with 25 mM alcohol for 7 days revealed, that chronic 
alcohol treatment resulted in augmentation of LPS-induced TNF-α production. Consistent with 
this induction of proinflammatory cytokine production, there was an up-regulation of NF-κB 
activation by LPS after chronic alcohol treatment. The activation of monocytes responses can be 
modulated by ethanol at different stages. In this case, the recognition of pathogens by innate 
immune cells with the help Toll-like receptors is important. Toll-like receptor 4 sense bacterial LPS, 
whereas TLR 2 is able to recognize diverse pathogens including Gram-positive bacteria and certain 
viral proteins (Lien et al., 1999).  
Acute alcohol treatment inhibited TLR4 (LPS)-induced TNF-α production at the protein and 
mRNA levels, whereas TLR2-induced TNF-α production was not inhibited by alcohol. Additionally 
acute alcohol augmented TNF-α protein and mRNA levels in the presence of TLR2 and TLR4 
costimulation in human monocytes. Opposite changes in IL-10 production in TLR4 and TLR4 plus 
TLR2-stimulated cells were obtained, when cells were treated with ethanol. In this case, acute 
alcohol augmented IL-10 in TLR4 stimulated, but inhibited IL-10 in TLR4 plus TLR2-costimulated 
monocytes (Szabo, 2001). In summary, the regulation of pro- and antiinflammatory cytokines and 
the modulation by ethanol is depending on both, the length of alcohol treatment and on the 
complexity of costimulatory signals (Crew, 2006). 
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The other antiinflammatory cytokine that can control inflammation and inhibit antigen-specific  
T cell proliferation is TGF-β. Alcohol at physiologically relevant concentrations can induce TGF-β 
production in monocytes and augment TGF-β production in response to a bacterial challenge in 
vitro (Szabo et al., 1992). Ethanol-induced elevation in TGF-β may have multiple implications for 
the immune system, including inhibition of inflammatory cytokine production by monocytes and 
other cells, inhibition of T cell proliferation and augmentation of Th2-type immune response. 
Alcohol intake changes pro- and antiinflammatory mediators in the lung 
Changes in cytokine production seem to play an important role in the development of ADRS since 
the acute lung injury is induced by an intense inflammatory response to the initial result, such as 
sepsis and trauma, with an exuberant release of proinflammatory cytokines including TNF-α, IL-1β, 
IL-6 and IL-8 into the alveolar space. This is followed by an influx of activated neutrophils and 
other immune cells (Ware and Matthay, 2000).  
On the other hand alveolar macrophages from alcoholics’ secret less TNF-α when stimulated with 
LPS in vitro (Omidvari et al., 1998). In animal models chronic ethanol treatment is associated not 
only with suppression of TNF-α secretion, but also with suppression of reactive oxygen species and 
reactive nitrogen species (Standiford and Danforth, 1997). 
TGF-β could be one important candidate that might be able to explain the underlying mechanism 
of alcohol-mediated susceptibility to acute lung injury. TGF-β is a pluripotent cytokine with 
multiple effects on tissue injury and repair during lung injury (Pittet et al., 2001). There was no 
evidence of release or activation of TGF-β into the alveolar airspace during ethanol ingestion alone, 
but consistent with the clinical observations ethanol-fed rats released approximately 5 times more 
activated TGF-β into the airspace during endotoxemia (Bechara et al., 2004). 
Further, bronchoalveolar fluid from endotoxemic ethanol-fed rats was able to induce a significant 
permeability defect in intact alveolar epithelial monolayers, derived from control-fed rats, and this 
permeability defect was completely inhibited by neutralizing antibodies to TGF-β (Bechara et al., 
2004).  
Increased TGF-β expression could also contribute to the significant immune suppression that 
renders alcoholics at high risk for pneumonia. TGF-β is secreted by regulatory T cells and is able to 
down-regulate both Th1 and Th2 responses, which is beneficial in modulating the inflammatory 
response of acute inflammation. Excessive TGF-β activation as consequence of ethanol 
consumption would be deleterious to a normal immune response to invading pathogens (D'Souza 
El-Guindy et al., 2007). 
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Finally, impaired responsiveness to granulocyte/macrophage colony-stimulating factor (GM-CSF) 
was found in alveolar macrophages from ethanol-fed rats. Macrophages showed a decrease in  
GM-CSF receptor expression on their surface membrane and a decreased expression and nuclear 
binding of the associated transcription factor PU.1 (Joshi et al., 2005). 
This leads to a global defect in innate immune functions including suppression of TNF-α and other 
proinflammatory cytokines needed to respond to pathogens. In parallel, ethanol induced expression 
and activation of TGF-β can acutely damage the already vulnerable alveolar epithelium. 
Taken together, changes in cytokine production renders alcohol abusers to both ‘inflammatory’ 
diseases such as acute lung injury and to infectious diseases such as pneumonia in which the effects 
of alcohol are immune suppressing (Guidot, 2000). 
Alcoholism and neurodegeneration  
Cytokines are potent regulators of neuroinflammation, implicated in a variety of brain diseases. 
Immune mediators are found in a wide diversity of neurological disorders including Alzheimer’s 
disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis and amyotrophic lateral 
sclerosis (Nguyen et al., 2002). Results of many studies implicate an association between peripheral 
endotoxin (LPS), increase in systemic cytokine synthesis, neuronal activation and altered behavior 
in alcohol abusers (Rivest et al., 2000). In this case, receptor-signaling molecules including CD14 
and TLR4 localized within the brain are activated through systemic LPS and therefore, endotoxin in 
addition to already activated systemic cytokines has direct effects on the brain, resulting in changes 
in behavior including activity, sleep pattern and social interaction (Kelley et al., 2003). 
Additionally in chronic alcoholism, Kupffer cells in the liver are activated by gut-derived LPS to 
synthesize large amounts TNF-α and other cytokines (Chen et al., 1998). 
Systemic TNF-α has shown to activate macrophage-like cells in the brain to increase synthesis of 
additional cytokines and create a long-lasting positive feed forward process of increased 
inflammation (Qin et al., 2004). Elevated levels of TNF-α are associated with demyelization and 
neurodegeneration (Li et al., 2005). In long-term alcohol abuse neurodegeneration and loss of both 
cortical gray and white matter and enlargement of the ventricles has been observed by imaging and 
postmortem studies (Crews et al., 2004). Elevated TNF-α level therefore might be one mechanism 
of neurotoxicity associated with alcohol abuse, since TNF-α appears to potentate glutamate 
excitotoxicity by inhibiting glutamate transporters. Prolonged alcohol consumption associated with 
long-lasting increase in TNF-α may create a hyperglutaminergic state and promote degeneration of 
both gray and white matter (Zou and Crews, 2005).  
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Inflammatory mediators and the pathogenesis of ALD 
The progression of alcoholic liver injury is characterized by the initial appearance of fatty liver, 
followed by inflammation, necrosis and apoptosis, followed by fibrosis and then by cirrhosis (Tilg 
and Diehl, 2000). Every stage of ALD is associated with a pronounced inflammatory and cytokine 
response (Wheeler, 2006). 
One of the primary mechanisms for increased production of inflammatory mediators in response 
to ethanol is due to activation of Kupffer cells in the liver. Kupffer cells are the resident 
macrophages in the liver and are critical to the onset of ethanol-induced liver injury. Ablation of 
Kupffer cells prevents the development of fatty liver and inflammation in rats chronically exposed 
to ethanol (Thurman, 1998).  
Kupffer cells are the first site of exposure to gut-derived LPS and since alcohol consumption is 
associated with impaired barrier function of the intestinal mucosa (Parlesak et al., 2000), increased 
exposure of Kupffer cells to LPS may induce TNF-α production and ethanol-induced liver injury 
(Chen, 1998). The important role for TNF-α in early ethanol-induced liver disease is the fact, that 
the livers of mice lacking TNF-α receptor 1 were completely resistant to the effects of chronic 
alcohol (i.e., steatosis, inflammation and mild necrosis) (Yin et al., 1999).  
 Evidence that gut-derived bacterial toxin plays an important role in the initiation and progression 
of ALD in humans was already published two decades ago (Bode et al., 1982) and is supported by 
numerous experimental and clinical studies showing that increased gut permeability is associated 
with alcohol abuse (Parlesak et al., 2005). Direct evidence of increased LPS translocation across the 
gut mucosa caused by ethanol was obtained in experiments using rats (Mathurin et al., 2000). 
Additionally, endotoxemia was found more frequently in patients with alcohol cirrhosis than in 
patients with non-alcoholic cirrhosis and even more important transient endotoxemia was found in 
non-alcoholic subjects following acute heavy drinking (Fukui et al., 1991, Bode et al., 1993).  
Additionally to the increased exposure, chronic ethanol consumption increases the expression of 
CD14, part of the LPS receptor complex on the surface of Kupffer cells as well as the key CD14 
signaling molecules such as members of the mitogens-activated protein kinase family (MAPK), 
ERK1/2 and p38 (Kishore et al., 2001 and 2002). 
Kupffer cells are activated during early alcohol-induced liver injury and that this process involves 
gut-derived endotoxin. LPS is known to bind CD14, a cell surface protein found on mononuclear 
cells, including Kupffer cells. CD14, without a transmembrane-spanning domain, requires an 
association with toll-like receptors (TLR) to initiate an intracellular signal., Recent experimental 
evidence has demonstrated that mice deficient in CD14 endotoxin receptor or TLRs are resistant to 
ethanol-induced liver injury (Wheeler, 2001). 
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In addition to cytokines, such as TNF-α, Kupffer cells are also capable of producing large amounts 
of potentially damaging free radicals including superoxide. Indeed, products of oxidative stress can 
be measured in rodent livers treated chronically with ethanol. One potential source of superoxide 
within macrophages including Kupffer cells is the phagocytic NADPH oxidase system. This 
multisubunit enzyme complex is assembled on activation by a variety of stimuli and serves an 
important function in immune-mediated pathogen destruction (Wheeler, 2001). 
This initial  activation of the hepatic macrophages then sets into motion a cascade of inflammatory 
events where next to TNF-α other cytokines are produced, depending on the stage of liver disease. 
Some of the initial cytokines that are also induced in early stage of ALD are IL-12, IL-4 and IL-10. 
In a second step, cytokine profile is directed either to a strong inflammatory response (IFN-γ and 
IL-12) or to a profibrogenic cytokine response (IL-4, IL-5 and IL-13).  
In contrast to acute inflammatory reactions, characterized by vascular changes, oedema and 
neutrophilic inflammation, fibrosis typically results from chronic inflammation, defined as an 
immune response that persists for several months and in which inflammation, tissue remodeling 
and repair processes occur simultaneously. 
The Th2 cytokines IL-4, IL-5, IL-13 and IL-21 each have distinct roles in the regulation of tissue 
remodeling and fibrosis. Although the extent to which IL-4 participates in fibrosis varies in 
different diseases, it has long been considered a potent profibrotic mediator. In fact, studies have 
suggested that IL-4 is nearly twice as effective as TGF-β (Buttner et al., 1997, Fertin et al., 1991) 
another potent profibrotic cytokine that has been extensively studied. IL-13 shares many functional 
activities with IL-4 because both cytokines exploit the same IL-4R/STAT6 signaling pathways 
(Zurawski et al., 1993). IL-13 was identified as the dominant effector cytokine of fibrosis (Aliprantis 
et al., 2007). 
IL-5 and eosinophils have also been shown to regulate tissue fibrogenesis. The differentiation, 
activation and recruitment of eosinophils are highly dependent on IL-5, and eosinophils are an 
important source of fibrogenic cytokines, including TGF-β and IL-13. In mice deficient in IL-5 
and/or CCL11 (eotaxin), tissue eosinophilia was abolished and the ability of CD4+ Th2 cells to 
produce the profibrotic cytokine IL-13 was significantly impaired (Mattes et al., 2002). Thus, one of 
the key roles of IL-5 and eosinophils may be to facilitate production of important profibrotic 
cytokines like IL-13 and/or TGF-β, which function as the key mediators of fibrosis. 
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Finally, similar to IL-5, IL-21/IL-21R signaling was recently shown to promote fibrosis by 
facilitating the development of the CD4+ Th2 response. IL-21R signaling was also critical for Th2 
cell survival and for the migration of Th2 cells to the peripheral tissues (Frohlich, 2007). In addition 
to supporting the development of Th2 responses, IL-21 also increased IL-4 and IL-13 receptor 
expression on macrophages (Pesce et al., 2006). 
Interleukin 13-secreting CD4+ cells regulate fibrogenesis indirectly by promoting TGF-β1 
production, which has been linked with the development of fibrosis since TGF-β1 is a potent 
activator of stellate cells and collagen production. In macrophages, the primary level of control is 
not in the regulation of TGF-β 1 mRNA expression, but in the regulation of both the secretion and 
activation of latent TGF-β 1. Once activated, TGF-β signals through transmembrane receptors that 
trigger signaling intermediates known as Smad proteins, which modulate transcription of important 
target genes, including procollagen I and III (Roberts et al., 2003).  
Together these data highlight the importance of Th2 cytokine response in liver disease and their 
role in liver fibrogenesis. The transition to fibrotic liver disease follows a transition from a Th1 
response to a profibrogenic Th2 cytokine production (Wheeler, 2004). 
 
1.1.4 Effects of ethanol on IFN-γ production  
Chronic alcohol consumption has been largely associated with alterations of the immunes system, 
increased susceptibility to opportunistic microbes (Watson et al., 1994) and higher incidences of 
certain forms of cancer (Arjona et al., 2004). Together with IL12, IFN-γ is important for the  
cell-mediated immunity and for the host defense against infection. Since chronic alcohol abuse is 
correlated with reduced serum levels of IFN-γ, alcohol-related changes of IFN-γ production may 
be the key factor in explaining compromised immunity in alcohol abusers (Szabo 1998). 
Interferon γ is an important immunoregulatory protein responsible for several immunological 
effects, including induction of the Fc receptor, major histocompatibility complex class I and II 
expression, regulation of cytokine gene expression (IL-1, IL-6 and tumor necrosis factor) and 
activation of immune effector cells, including B lymphocytes and monocytes.  
The effect of chronic or acute alcohol treatment on Interferon γ production has been center of a 
number of in vivo and in vitro studies: In vitro studies focused either on isolated immunocompetent 
cells from experimental animals or healthy humans. Upon isolation, cells were incubated with and 
without ethanol for certain time periods, followed by measurement of cytokine production, 
intracellular cytokine levels or cytokine mRNA. On the other hand, animals or humans (non-
alcoholics and alcoholics) were exposed to certain alcohol doses in vivo and subsequent 
measurement of serum levels of cytokines was performed (Deacius, 1997). 
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The following chapter summarizes the results of these different in vivo and in vitro studies.  
Vicente-Gutiérrez and colleagues 1991 conducted the first study that focused on immune 
alterations seen in alcoholic cirrhosis and the serum levels of Interferon γ and other cytokines.  
Forty patients diagnosed having alcoholic cirrhosis with histopathological confirmation were 
divided in three groups according to the Child-Pugh classification of severity of liver disease. The 
control group consisted of 23 healthy volunteers. Patients with AC had significantly reduced plasma 
levels of IFN-γ in comparison to controls. No significant difference was noted between the 
cirrhotic patients classified according to the severity of liver disease. 
A direct immunosuppressive effect of ethanol leading to an inhibition of Interferon γ secretion was 
confirmed in 1992 when Peripheral Blood Mononuclear Cells (PBMC) were isolated from healthy 
donors (to exclude any indirect effect of malnutrition or liver disease seen in chronic alcoholics 
with AC). Isolated cells were mitogen-stimulated either with Con A or PHA and treated with 
ethanol for 72 hours at concentrations ranging from 0 to 100 mM. Cell viability was not altered 
after incubation in ethanol-containing medium. The IFN-γ concentrations in cell culture 
supernatant were significantly decreased. The inhibition was dose-dependent and already detectable 
at very low ethanol concentrations (6.25 mM) (Wagner et al., 1992).  
In this study, it was demonstrated for the first time that ethanol at low and moderate 
concentrations inhibits mitogen-induced Interferon γ secretion by human PBMC of healthy donors 
in vitro. 
Sixty-one alcoholics and 49 controls were included to a study by Windle et al., 1993 to investigate 
Interferon γ serum levels and NK cell activity. Patients were screened using the Michigan 
Alcoholism Screening Test (MAST); alcohol consumption was determined by asking standard 
quantity-frequency questions for each alcoholic beverage to calculate the average number of drinks 
per day. For Interferon γ measurement, 20 ml of venous blood were obtained, lymphocytes were 
isolated and activated with Staphylococcal Enterotoxin B (SEB). The average number of drinks per 
day was 6.04 in alcoholics compared to 0.81 in controls. The Interferon γ release by isolated cells 
from alcoholics was 133 units compared to 568 units in control group. This significant decrease in 
Interferon γ production by cells isolated from alcoholics compared to control group confirms 
former results, indicating the ethanol-induced IFN-γ suppression in alcohol abusers and the 
alterations in the activity of isolated lymphocytes. 
In humans, it is difficult to assess the contribution of ethanol to the modulation of cytokine release 
that may be affected by additional factors such as malnutrition. Therefore, Chen et al., (1993) used 
the murine model to study the effect of in vivo chronic and in vitro acute ethanol exposure on 
cytokine production without liver cirrhosis found in humans. 
16  1  INTRODUCTION  
 
 
Animals were fed the Lieber-DeCarli liquid diet for five months. Twenty-seven % of the total 
calories were emerged from alcohol. Control groups were fed an isocaloric liquid diet ad libitum. 
Calories that were contributed by ethanol were substituted with maltose dextran. Spleen cell 
suspensions were prepared and treated with various ethanol concentrations ranging from 0.1–1.0 % 
for 72 hours. The IFN-γ release by spleen cells was reduced after ethanol incubation in vitro. 
However, there were no significant differences in IFN-γ production by spleen cells from mice fed 
ethanol or control diets. In addition, no significant liver damage occurred in ethanol-fed mice; food 
consumption and growth was not affected too. The fact that IFN-γ production was reduced, 
regardless, whether splenocytes were obtained from chronically ethanol-fed mice of from control-
fed mice suggests a direct downregulation of IFN-γ expression by ethanol in this ex vivo animal 
model (Chen et al., 1993). 
This is in agreement with studies where ethanol-feeding had no effect on IFN-γ production in 
ethanol-fed mice by the group of Galluci and Meadows (1996). In this case, mice were given water 
or 20 % (w/v) ethanol ad libitum as the sole fluid source for 2 weeks. Enriched NK cells from 
ethanol-fed mice and controls were tested for proliferation upon IL-2 stimulation and for DNA 
synthesis by [3H]Thymidine uptake. The NK cells of ethanol fed mice showed significantly reduced 
proliferation and a significant lower Thymidine uptake than those of water-fed controls. The 
percentage of apoptotic nuclei was also determined but remained constant in both groups. The 
expression of IFN-γ was assessed using intracellular cytokine staining. Ethanol consumption did 
not affect the IL-2-induced expression of this cytokine at either time point (Galluci and Meadows, 
1996). 
In contrast, a significantly lower IFN-γ expression was observed in mice splenocytes isolated from 
chronically alcohol-fed mice compared to controls (Wang et al., 1995). Splenocytes were obtained 
from mice fed a liquid diet with 5 % (v/v) ethanol for 11 weeks. Cells were isolated and cultured in 
the presence of Con A for 72 hours to induce IFN-γ expression. The cytokines were measured by 
sandwich ELISA. Con A-stimulated IFN-γ expression was significantly suppressed in splenocytes 
by chronic dietary ethanol compared to the controls. 
The goal of the study by Laso et al. was to evaluate the role of NK cells in the production of 
cytokines in patients with chronic alcoholism, analyzing the possible relationship between cytokine 
production and alcohol induced liver disease. A total of 30 chronic alcoholic patients – 11 without 
liver disease (AWLD) and 19 diagnosed to have liver cirrhosis – were included. Production of  
IFN-γ was measured in NK-enriched Peripheral Blood Mononuclear Cells after stimulation with 
IFN-α and IL-2. Only cirrhotic patients with a prolonged ethanol withdrawal period displayed 
abnormal production. Cytoplasmatic IFN-γ levels of NK-enriched Peripheral Blood Mononuclear 
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Cells of AWLD patients showed an increase in intracellular IFN-γ levels. This is was measured in 
ALC patients who were actively drinking. ALC patients who had withdrawn from alcohol showed 
no changes in IFN-γ levels compared to controls but instead had a higher level of Th2-derived 
cytokines such as IL-4 (Laso et al., 1997). 
Two years later the same group conducted a study that focused on the effect of ethanol on the 
imbalanced production of Th1/Th2 cytokines in chronic alcoholism. Again, actively drinking and 
abstinent patients with or without alcoholic liver cirrhosis were examined. This suggest the 
existence of a Th1 pattern of cytokine production in alcoholics of both groups, which was 
normalized in patients with more than 1 year of withdrawal., In contrast, cytoplasmatic expression 
of IL-4 was detected in a higher proportion of cells, and these patients therefore showed a 
predominant Th2 pattern of cytokine production (Laso et al., 1999). 
Alterations in the Th1/Th2 balance were also observed in ethanol-consuming mice in which 
chronic alcohol consumption polarizes the immune response away from Th1-mediated immunity.  
After 7 to 10 days of ethanol consumption by experimental animals, cell-mediated immunity is 
impaired and humoral immunity is enhanced (Jerrells et al., 1995). This is evident by the production 
of the Th1-related cytokine IFN-γ.  
Most immune responses involve multiple cell interactions leading to the question, whether the 
impairment of T cell function results from the direct inhibition of helper T cells or from the 
inhibition of the cells which process and present antigen to Th cells. 
Since antigen presenting cells (APC) influence the development of Th1 and Th2 adaptive immune 
response through IL-12, the ethanol-mediated decrease of interleukin-12 production by APC is 
important for Th2 polarization. To investigate the first onset of alteration in immune parameters 
during ethanol consumption in terms of alterations in Th1 and Th2 function, Starkenburg et al 
(2001) used C57BL/6 and BALB/c mice. Animals were fed a liquid ethanol diet containing 30 % 
ethanol-derived calories or were pair-fed a liquid control diet for 3 to 10 days. To functionally 
assess the kinetic role of alcohol on immune function, spleen cells from BALB/c mice were used as 
APCs in coculture with purified T cells from naïve, solid diet-fed DO11.10 mice. Already after a 
ethanol consumption of 3 days inhibited IFN-γ production by the transgenic T cells in response to 
ovalbumin stimulation by ~40 %. Ethanol impairment of the IFN-γ response continued in 
subsequent days. Single-cell cytokine (ELISPOT) data indicated that ethanol consumption affected 
IFN-γ but not IL-2 secretion. This was explained by a reduced splenic cellularity and MHC class II 
expression in ethanol-fed mice, resulting in functional alterations of Th1 associated IFN-γ 
production (Starkenburg et al., 2001). 
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As mentioned above, a reduced T cell response and suppression of IFN-γ expression have been 
linked to an antigen presenting cell defect, a reduced IL-12 production and a Th2 type cytokine 
induction in animal models of chronic alcohol feeding. The question remains if the same 
mechanisms are involved in reduced T cell proliferation and IFN-γ production after acute alcohol 
intake in healthy volunteers. In healthy individuals, the effect of acute, moderate alcohol intake  
(2 ml of vodka/kg body weight) on IFN-γ production of LPS-stimulated whole blood samples was 
investigated at different post-alcohol time points. Compared to the pre-alcohol or 16-hour post-
alcohol state, IFN-γ levels increased at the 4-hour post-alcohol time point. In addition, the PHA 
stimulation of isolated mononuclear cells 16 hours after alcohol consumption led to significantly 
lower IFN-γ concentrations in supernatants of cells obtained from alcohol consumers in 
comparison to those isolated from control donors (Szabo et al., 1998). 
Furthermore, the reduced IFN-γ production was associated with a reduced T cells activation by 
accessory cells (monocytes). This observations lead to the conclusion that even one occasion 
moderate alcohol intake can reduce allostimulatory T cell activation via decreasing accessory cell 
function. The increased IL-10 and IL-13 concentrations  also observed together with reduced  
IFN-γ production are likely to contribute to both the reduced T cell proliferation and the 
suppressed monocyte accessory cell function (Szabo 2001). 
There is an association between chronic alcohol consumption and an increased risk of cancer. 
Suppression of the immune system can be considered as one mechanism by which ethanol could 
increase the incidence or progression of cancer. Natural killer cells are belonging to the first line of 
defense, not only against infections, but also play a significant role in the cellular resistance to 
malignancy and tumor metastasis. Alcohol-induced changes in the gene and protein expression of 
perforin, granzyme B and IFN-γ could be a mechanism involved in the suppression of NK cell 
cytolytic activity by chronic ethanol consumption.  
This mechanism was investigated in male Fischer 344 rats either pair-fed an isocaloric liquid diet or 
fed an ethanol-containing liquid diet for two weeks. Ethanol substitution provided approximately 
37 % ethanol-derived calories. NK cell cytolytic activity of splenic lymphocytes was determined 
against YAC-1 lymphoma cells by a standard 4-hr chromium-51 release cytolytic assay. Gene 
expression was evaluated by real-time PCR. Alcohol diet in rats at 2 weeks decreased the mRNA 
expression of IFN-γ as compared to pair-fed animals. Additionally, IFN-γ release by splenocytes of 
alcohol-fed animals was suppressed significantly. Hence, ethanol seems to act both at 
transcriptional and translational levels without changing splenocyte or total NK cell number (Dokur 
et al., 2003). 
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The latest study on ethanol-related changes on IFN-γ production was done in 2004 and focused on 
circadian rhythms of granzyme B, perforin and IFN-γ and the cytolytic activity of NK cells. It was 
already shown, that chronic alcohol consumption reduces granzyme B, perforin and IFN-γ and 
therefore NK cell activity but since alterations in the body’s biological rhythms can lead to serious 
diseases including cancer, the question was whether NK cells follow a circadian rhythm and if so, to 
analyze the effect of chronic alcohol consumption. 
Rats were fed an ethanol-containing diet for 14 days. At different times over a day, concentration of 
both IFN-γ protein and mRNA levels of the spleen tissue was measured. 
Under an ethanol-free diet, the highest levels of IFN-γ mRNA were obtained during the daytime, 
the lowest at nighttime. Chronic ethanol feeding blunted the circadian rhythm although mRNA 
levels were not significantly different between the alcohol and the control group.  
However, at protein level, the circadian rhythm of alcohol-fed rats was at highest level during the 
dark phase and at the lowest during the light phase. In addition, the amplitudes, which normally 
characterize a circadian rhythm, were markedly reduced. Suggesting, that the circadian rhythm of 
IFN-γ in splenocytes was disrupted by chronic ethanol consumption (Arjona et al., 2004). 
In conclusion, it is well established that chronic alcoholism is associated with important 
immunological abnormalities involving the production of IFN-γ as well as other cytokines, and 
changes can also be seen after acute one occasion alcohol consumption. The type of change 
observed depends not only on the existence of liver disease, but also on the status of ethanol intake 
and the constancy of withdrawal. Reports on the production of IFN-γ analyzed in chronic 
alcoholism are difficult to compare and the information provided is controversial. Accordingly, low, 
unchanged or increased serum levels have been reported in chronic alcoholism. The same is true 
for its production by isolated PBMC of ethanol-fed mice after in vitro stimulation. Such a variability 
of results could be related in part to the relatively short time of these cytokines and to circadian 
variations in their production (Laso et al., 1999).  
Results that are more consistent were obtained, when isolated cells were used, in this case acute 
ethanol incubation led to a reduction of IFN-γ production in most of the in vitro studies conducted. 
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 1.2 Interferon γ – signals, mechanisms and functions 
Interferon γ (IFN-γ) coordinates a diverse array of immunological functions through transcriptional 
regulation of relevant genes. This following chapter reviews the current understanding of IFN-γ 
signal transduction and its cellular effects as well as its role in host defense. The influence on other 
immunocompetent cells and its significance during infection is described, including up-regulation of 
pathogen recognition, antigen processing and presentation, the antiviral and microbiocidal 
properties, immunomodulation and leukocyte trafficking.  
 
1.2.1 Characteristics of Interferon γ 
The cytokine IFN-γ belongs to the family of interferons, which are closely related by their ability to 
protect cells from viral infections. Based on several criteria, the IFN molecules have been divided 
into two distinct classes. The first class is named type I IFN and includes IFN-α and  
IFN-β molecules, which are the classical interferons induced in response to viral infections 
(Teixeira et al., 2005). 
The second class is solely composed by IFN-γ (type II), which is not related to the type I IFN at 
both the genetic and the protein levels. Although IFN-γ displays most of the biologic activities that 
have been described to the other IFNs, it has a lower specific antiviral activity, but presents more 
immunomodulatory properties than the type I interferons (Farrar and Schreiber, 1993). 
The overall organization of the IFN-γ gene is very similar in different species, comprising (Boehm 
et al., 1997) four exons and three introns. The genomic DNA structure is strongly conserved and 
has been maintained among all species analyzed, and DNA sequence has greater identity in the 
promoter DNA sequence than in the protein-coding regions (Young et al., 1995). 
The human IFN-γ protein consists of 166 amino acids of which 23 amino acids represent a 
hydrophobic signal sequence that is removed before secretion. There are two N-linked 
glycosylation sites and the protein appears to exist functionally as a non-covalent homodimer 
(Young et al., 1995). Two polypeptide chains self-associate in an antiparallel fashion, producing a 
molecule that exhibits a twofold axis of symmetry with an apparent molecular weight of 34 kDa 
(Farrar and Schreiber, 1993, Bach et al. 1997). Only the dimer displays biologic activity, possibly 
because it is the only conformation of the molecule that can induce IFN-γ receptor (IFN-γR) 
dimerization (Farrar and Schreiber 1993). 
For a long time, the production of IFN-γ has been considered to be restricted to activated natural 
killer (NK) cells, CD4+ T helper-1 (Th1) cells, and CD8+ T cytotoxic cells (Farrar and Schreiber 
1993, Boehm et al. 1997).  
24  1  INTRODUCTION  
 
 
However, we now know that these cells are the most potent, but not the only sources of IFN-γ. 
Several studies have identified additional IFN-γ-secreting cell types, including γδ T cells, NKT cells, 
macrophages, dendritic cells, naive CD4+ T cells, and even B cells (Frucht et al. 2001, Szabo et al. 
2003). During the adaptive phase of immune response, IFN-γ is mainly produced by activated  
T cells, whereas NK and NKT cells seem to be the main source during the innate phase (Young et 
al., 1995).  
IFN-γ production is controlled by cytokines secreted by APCs, most notably Interleukin (IL)-12 
and IL-18. These cytokines serve as a bridge to link infection with IFN-γ production in the innate 
immune response (Gollob et al., 2000). Macrophage recognition of many pathogens induces 
secretion of IL-12 and chemokines. These chemokines attract NK cells to the site of inflammation, 
and IL-12 promotes IFN-γ synthesis in these cells. In macrophages, NK and T cells, the 
combination of IL-12 and IL-18 stimulation further increase IFN-γ production (Fukao et al., 2001). 
Negative regulators of IFN-γ production include IL-4, IL-10, transforming growth factor β and 
glucocorticoids (Schroder et al., 2004).  
 
1.2.2 Interferon γ receptor 
The biological actions of IFN-γ can be attributed to its ability to activate or inhibit the expression 
of specific target genes. All biological actions of IFN-γ require binding to specific cell surface 
receptors, expressed on virtually all types of cells (Bach et al., 1996). 
Functional IFN-γ receptor (IFNGR) is comprised of two ligand-binding IFNGR1 chains associated 
with two signal-transducing IFNGR2 chains and associated signaling machinery. IFNGR1 and 
IFNGR2 chains belong to the class II cytokine receptor family, a class of receptors that binds 
ligands in the small angle of a V formed by the two Ig-like folds that constitute the extracellular 
domain (Tau and Rothman, 1999). 
Although binding of IFN-γ to the receptor is the function of the IFNGR1 chain, IFN-γ binds with 
a higher affinity in the presence of the IFNGR2 chain. Signaling is initiated by the formation of a 
multisubunit complex that contains both IFN-γ receptor chains and IFN-γ (Igarashi et al., 1994).  
Both IFNGR chains lack intrinsic kinase/phosphatase activity and so must associate with signaling 
machinery for signal transduction. The IFNGR1 intracellular domain contains binding motifs for 
the Janus tyrosine kinase (Jak) 1 and the cytosolic factor, signal transducer and activator of 
transcription (STAT) 1. The intracellular region of IFNGR2 contains a non-contiguous binding 
motif for recruitment of Jak2 kinase for participation in signal transduction. The IFNGR2 chain is 
not tyrosine phosphorylated during signal transduction (Heim et al. 1995). 
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1.2.3 IFN-γ-associated signal transduction 
Interferon γ primarily signals through the Jak-STAT pathway, a pathway used by over 50 cytokines, 
growth factors and hormones to affect gene regulation. Jak-STAT signaling involves sequential 
receptor recruitment and activation of members of the Janus family of kinases (Jaks 1–3 and Tyk2) 
and the STATs (STATs 1–6, including STAT5a and STAT5b) to control transcription of target 
genes via specific response elements.  
Signal transduction starts with an interaction of the IFN-γ homodimer with two IFN-γR1, thereby 
inducing IFN-γR1 dimerization and the subsequent recruitment of two IFN-γR2 to the complex. 
Each chain is constitutively associated with a specific Janus kinase (JAK) (the IFN-γR1 with JAK1 
and the IFN-γR2 with JAK2) (Igarashi et al., 1994). The aggregation of the receptor components 
brings inactive JAKs into close proximity with one another. Once clustered, JAKs are reciprocally 
activated through sequential auto and transphosphorylation events. After activation, JAKs then 
phosphorylate a specific tyrosine residue near the C-terminus of the IFN-γR1, which serve as a 
docking site to the binding of STAT1 (Heim et al. 1995). 
 
Figure 1-1. The current paradigm for IFN-γ signal transduction JAK: Janus kinase, STAT: signal transducer 
and activator of transcription, IRF: Interferon regulating factor, GAS: Interferon-γ activated sequence, 
ICAM: Intercellular adhesion molecules, MIG: mitogen-inducible gene, INOS: inducible nitric oxide 
synthase, IRF-E: IRE: IRF-binding element, ISRE: IFN-stimulated response element (Schroder et al., 2004) 
 
26  1  INTRODUCTION  
 
 
The recruitment of STAT1 is followed by its phosphorylation on tyrosine residue 701 by the 
receptor-associated JAKs. This phosphorylation leads to a rapid dissociation of the receptor and to 
the formation of STAT1 homodimers (Greenlund et al., 1995). At some point during the early 
phase of activation, STAT1 is also phosphorylated on serine 727 by a process involving  
phosphatidylinositol 3-kinase (PI3-K) and Akt that is required for maximal transcriptional activity 
(Nguyen et al., 2001). The dissociated STAT1 homodimer enters the nucleus and binds to promoter 
elements to initiate or suppress transcription of IFN-γ-regulated genes (Darnell et al., 1998). STAT1 
homodimers bind DNA at GAS elements of consensus sequence (Decker et al., 2002). 
In summary, by activating the cytosolic transcription factor STAT1, IFN-γ initiates the 
transcription of a number of genes containing STAT1-binding sites in their promoter regions. 
Many of these induced genes are transcription factors that are able to further drive the regulation of 
the next wave of transcription. The total number of IFN-γ-regulated genes is estimated to be ~500 
(Boehm et al., 1997). It has been demonstrated that IFN-γ upregulates the transcription of genes 
related to antigen presentation, Th1 phenotype development, chemokine-based recruitment of 
monocytes, T cells, eosinophils and basophils, cellular adhesion, immunoglobulin heavy chain class 
switch, cytokine network, apoptosis, lymphocyte activation, and others (Teixeira et al., 2005). 
The key function of STAT1 in mediating IFN-γ signal transduction is indicated by the phenotype 
of STAT1−/− mice, which showed largely similarity to IFNGR1−/− mice during IFN-γ 
stimulation. In addition, activated STAT1 protein can form a heterocomplex with p48 and this 
heterodimer can bind to other DNA sequences (interferon-stimulated response elements, ISRE) 
present in some IFN-γ-inducible genes, and thus activate their transcription (Majumder et al., 1998). 
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1.2.3.1 Signal Transducer and Activator of Transcription 1 (STAT1) 
Phosphorylation of STAT1 at S727 is essential for maximal ability to activate transcription of target 
genes. A number of different stimuli induce STAT1 serine phosphorylation, including type II IFN, 
lipopolysaccharide (LPS) and IL-2, IL-12, tumor necrosis factor α (TNF-α), and platelet-derived 
growth factor (Gollob et al., 2000). This may be a mechanism, whereby S727 serves as road for 
modulation of IFN-γ signaling by independent extracellular stimuli. For example, LPS signaling 
increases STAT1 S727 phosphorylation independently of Y701 phosphorylation in macrophages, 
thereby augmenting cellular responses to IFN-γ (Schroder et al., 2004).  
The ability of STAT1 to activate or repress gene transcription depends on the presence of other 
transcription factors binding to the promoter element and STAT1 interaction with other factors. 
STAT1 activation is necessary but not sufficient for transcription of a number of genes. Likewise, 
factors such as oncostatin M, which participate in Jak-STAT signaling to produce activated STAT1, 
do not induce transcription of IFN-γ-inducible genes. STAT1 interaction with transcription factors 
such as IRF-9, upstream stimulatory factor-1, specificity protein-1, and heat shock factor-1 have 
been reported and are likely to influence specificity of DNA binding and transactivator ability. In 
some promoters, transcription is maximal when more than one GAS-binding transcriptional 
activator binds to tandem GAS sites in the target gene promoter (Zhang et al., 1998).  
The mechanism of STAT1 entry into the nucleus is still controversial, but the involvement of 
importin-α-1 (NPI-1) is implied. Nuclear entry of STAT1 is apparent at 15 min and almost 
complete after 30 min exposure to IFN-γ (Lillemeier et al., 2001).  
Functional STAT1 is crucial to host response to infection. KO of STAT1 renders mice extremely 
sensitive to infection by viral and microbial pathogens (e.g. vesicular stomatitis viruses, mouse 
herpes virus and L. monocytogenes). 
 
1.2.3.2 Interferon Regulatory Factor 1 (IRF-1) 
Transcription factors belonging to the interferon regulatory factor (IRF) family are necessary for 
Th1 development. The IRF family includes at least 10 members and their expression is either 
constitutive and/or induced upon treatment with IFN-γ and other cytokines or in response to viral 
infections (Coccia et al., 1999).  
Members of the IRF family share similar structure, including an amino-terminal DNA-binding 
domain containing multiple tryptophan residues and a carboxy-terminal transcriptional activation or 
repression domain (Taniguchi et al., 2001).  
IRF-1 drives inducible expression of many target genes through interaction with the IRF-E site. 
This specificity overlaps with the ISRE consensus site, recognized by ISGF3, which is induced by 
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type I IFN and to a lesser extent, type II IFN. In this way, IRF-1 is able to induce a subset of the 
full spectrum of IFN-inducible genes (Schroder et al., 2004).  
One characteristics of IRF-1−/− mice is a defect in the development of thymic CD8+ cells, 
although maturation of CD4+ cells was normal (Matsuyama et al., 1993). The defect in CD8+ TCR-
α/β+ cells and decreased levels of MHC class I are a consequence of reduced expression of 
transporter associated with antigen processing-1 (TAP-1) and the low molecular weight protein-2 
(LMP-2) (Penninger, 1998). Mice lacking TAP-1, LMP-2 or IRF-1 all have a similar phenotype, 
characterized by a developmental block in MHC class-I-restricted thymocytes (Hombach, 1995). 
This MHC class I defect in IRF-1−/− mice only partially explains the impaired positive and 
negative selection of T cells in the thymus of these mice (Penninger et al., 1998). IRF-1 also seems 
to regulate genes in developing T cells that are crucial in signal transduction in thymocytes and 
lineage-specific differentiation of CD8+ cells. Although CD4+ T cell maturation occurred normally 
in IRF-1−/− mice, profound phenotypic changes were detected: IRF-1−/− mice possessed a 
greater number of memory/effector CD4+ T cells at the expense of the naive cell subset; and all 
CD4+ T cells (memory and naive) displayed an altered profile of inducible cytokine production. 
After stimulation, a decreased production of IL-2 and IFN-γ (Th1 cytokines) and an increased 
production of IL-3, -4, -5 and -6 (Th2 cytokines) were observed. This shift to Th2 cytokine 
production has important implications for the clearance of pathogens, since the balance between 
the Th1- and Th2-related cytokines will determine whether the immune response is protective, 
non-protective, or pathogenic ( McElliot et al., 1997). These results illustrate a role for IRF-1 in the 
homeostasis of T cell subset frequencies and cell functions. 
IRF-1−/− mice also exhibited a severe natural killer (NK) cell deficiency (Ogasawara et al., 1998). 
NK cell development was restored when IRF-1−/− bone marrow cells were cultured in the 
presence of IL-15, a cytokine that induces proliferation of mitogen-activated CD4+ and CD8+  
T cells and is also crucial to NK cell activation, cytotoxicity, cytokine production and proliferation 
(Nguyen et al. 1999).  
 
1.2.3.3 Negative regulation of IFN-γ signaling 
Elevated levels of IFN-γ can be dangerous, and it is clear that both IFN-γ production and the 
response to this cytokine must be tightly regulated in order to achieve a balance between beneficial 
and harmful effects. Other cytokines including IL-4, IL-10, and IL-13 contribute to some extent to 
this regulation by antagonizing IFN-γ functions. In addition, negative regulators act to limit signal 
transduction in response to IFN-γ (Brysha et al., 2001). 
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STAT1 activation is inhibited within 1 h of IFN-γ treatment, despite the continued presence of 
extracellular IFN-γ, and so mechanisms must exist to control the extent of ligand stimulation of 
IFN-γ signaling. These mechanisms (Figure 1-2) involve every level of the pathway (Darnell et al., 
1998) and include downregulation of receptor/ligand complex, degradation of signaling 
intermediates and inactivation of positive regulators by dephosphorylation, and activation of 
specific suppressors (Starr et al., 1999). 
In case of IFN-γ, following signal transduction, the IFN-γ/IFNGR1 complex internalizes and 
enters the endosomal pathway, where the complex dissociates. In many cell types, the IFNGR1 
chain recycles to the cell surface in its uncoupled, dephosphorylated form, and the ligand is 
degraded (Starr et al., 1999). Dephosphorylation of the activated IFNGR1 subunit occurs rapidly 
following stimulation with IFN-γ (Stark et al., 1998). 
 
 
Figure 1-2. Negative regulation of IFN-γ signaling. JAK: Janus kinase, STAT: signal transducer and activator 
of transcription, IRF: Interferon regulating factor, GAS: Interferon-γ activated sequence, IRF-E: IRF-binding 
element, ISRE: IFN-stimulated response element, SOCS: suppressors of cytokine signaling PTP: tyrosine 
phosphatase (Schroder et al., 2004). 
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One of the preferentially inducible targets of IFN-γ is a specific feedback inhibitor, SOCS-1, which 
associates with Jak1/2, interfering with tyrosine kinase activity and inhibiting downstream IFN-γ 
signaling. SOCS-1 is an intracellular SH2 domain-containing protein and is part of a family of eight 
proteins each of which comprise a C-terminal SOCS box (Krebs et al., 2001). SOCS-1 expression is 
induced by IFN-γ and overexpression of SOCS-1 inhibits IFN-γ signaling (Brysha et al., 2001). On 
the other hand, mice lacking SOCS-1 die from a complex disease characterized by liver 
degeneration and massive inflammation (Kile et al., 2001). Another SOCS protein, SOCS-3, is also 
induced by IFN-γ and negatively regulates IFN-γ signaling, although perhaps less effectively than 
SOCS-1 (Schroder et al., 2004).  
 
1.2.4 Molecular effects of Interferon γ 
1.2.4.1 Class I antigen presentation pathway 
Types I and II IFN upregulate multiple functions within the class I antigen presentation pathway to 
increase the quantity and diversity of peptides presented on the cell surface in the context of class I 
MHC. Upregulation of cell-surface class I MHC by IFN-γ is important for host response to 
intracellular pathogens, as it increases the potential for cytotoxic T cell recognition of foreign 
peptides and thus promotes the induction of cell-mediated immunity (Hisamatsu et al., 1996).  
IFN-γ stimulation induces a replacement of the constitutive proteasome subunits with 
‘immunoproteasome’ subunits. Inducible proteasome replacement is thought to be a mechanism by 
which IFN-γ can increase the quantity, quality and repertoire of peptides for class I MHC loading. 
The quantity is increased, as overall expression levels of proteasome are increased. The cleavage 
specificity of the immunoproteasome may allow production of peptides better able to bind class I 
MHC and thereby increase efficiency in the system. As a whole, this serves to increase levels and 
diversity of epitopes presented for CD8+ T cell recognition in the context of class I MHC and thus 
increases immune surveillance (Groettrup et al. 2001). 
 
1.2.4.2 Class II antigen presentation pathway 
Of the IFNs, only IFN-γ can efficiently upregulate the class II antigen-presenting pathway and thus 
promote peptide-specific activation of CD4+ T cells (Mach et al., 1994). IFN-γ treatment further 
upregulates class II MHC molecules in cells constitutively expressing class II MHC, such as B cells, 
DCs, and cells of the monocyte/macrophage lineage. IFN-γ is also able to induce class II MHC 
expression in cells that do not constitutively express this gene, such as skin fibroblasts, vascular 
endothelial cells, thyroid epithelial cells and astrocytes (Chang et al., 1995). 
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As a result of class II MHC molecule induction, these cells acquire an ability to function as antigen-
presenting cells, and can thus participate in the process of specific immune recognition (Mach et al., 
1994). 
IFN-γ is known as the most potent inducer of class II MHC expression but is also important for 
the expression of other MHC-encoded genes involved in antigen-presentation such as TAP-1 and 
TAP-2, and proteasome subunits. IFN-γ promotes the translocation of antigenic peptides from the 
cytosol to the endoplasmatic reticulum, where the peptide binds to the MHC molecules. IFN-γ 
alters the proteolytic specifity of proteasomes, facilitating the generation of peptides for antigen 
presentation (Tanaka et al. 1994). 
 
1.2.4.3 IFN-γ and the development of Th1 response 
Beginning with the activation of the T cell receptor (TCR) by the appropriate peptide-MHC 
complex, naive CD4+ T cells rapidly undergo a differentiation process that leads to the 
development of two functionally distinct cell subsets. These subsets are characterized by the 
production of cytokine pattern. Th1 cells that secrete IFN-γ are efficient in eliminating intracellular 
pathogens. Th2 cells produce IL-4, IL-5, IL-10 and IL-13, which affect humoral immunity to 
helmintic parasites and are responsible for immune responses to persistent allergens (Abbas et al., 
1996). IL-12 and IL-4 are known to be the major Th1- and Th2-inducing cytokines, respectively 
(Abbas et al., 1996). The Th1/Th2 balance is extremely important and may determine whether the 
immune response is appropriate or leads to severe immunopathologies. Overproduction of Th1 
cytokines has been implicated in delayed-type hypersensitivity reactions and autoimmune diseases. 
On the other hand, the basis for allergic disorders remains on the dysregulation of the Th2 
phenotype (Abbas et al., 1996). 
IFN-γ is the principal Th1 effector cytokine, and it has a crucial role in Th1 differentiation. IFN-γ 
has the ability to act in a great number of cell types that are involved in Th differentiation. It 
induces IL-12 production by antigen presenting cells (APC), such as dendritic cells and 
macrophages (Snijders et al., 1998, Szabo et al., 2003). These APCs provide the first contact of naive 
CD4+ T cells with the antigen; therefore, this IL-12 production is of great importance on the 
differentiation pathway towards a Th1 phenotype. In addition to its role on APC, IFN-γ exerts 
effects on the CD4+ T cells themselves. This cytokine is capable of enhancing the development of 
Th1 effector cells from BALB/c mice by increasing naive CD4+ T cells responses to IL-12 
(Wenner et al., 1996).  
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IFN-γ also exerts direct inhibitory effects on Th2 cytokines, reducing the levels of IL-4 and IL-5 
production. The IFN-γ signaling pathway activates T-bet protein, the Th1-specific and Th2-
suppresing transcription factor (Lighvani et al., 2001, Afkarian et al., 2002). In fact, ectopically 
expression of T-bet was able to repress IL-4 and IL-5 in Th2 cells (Szabo et al. 2000).  
On the other hand, the Th2-induced transcription factor GATA-3 specifically controls the 
expression of Th2 cytokines (Zhang et al., 1999). 
Loss of IL-4 receptor responsiveness may be another mechanism that suppresses Th2 development 
in polarizing Th1 cells (Huang and Paul, 1998). Other studies have shown that IFN-γ directly 
suppresses IL-4 gene expression through IRF-1 and 2, which bind to three distinct IL-4 promoter 
sites and act as transcriptional repressors (Elser et al., 2002).  
Besides the counteracting roles of IFN-γ in the Th2 differentiation process, IFN-γ has a role in 
inhibiting the proliferation of Th2 cells. Th1 cells decreased their expression of the b chain of the 
IFN-γR while Th2 cells did not, suggesting a mechanism by which IFN-γ could inhibit selectively 
the proliferation of Th2 clones (Pernis et al., 1995).  
 
1.2.4.4 Effect on B cells 
B cells contribute to the humoral immunity by production of antibodies. IFN-γ also has regulatory 
roles in the control of immunoglobulin isotypes produced by activated B cells (Vilcek et al., 1998). 
The best-characterized action of IFN-γ directed toward B cells is the ability to influence Ig heavy-
chain switching. Ig class switching is significant because the different Ig isotypes promote distinct 
effector functions in the host. By favoring the production of certain Ig isotypes while inhibiting the 
production of others, IFN-γ can facilitate interactions between the humoral and cellular effector 
pathways of the immune response and increase the host defense against certain bacteria and 
viruses. In vitro, IFN-γ is able to direct immunoglobulin class switching from IgM to the IgG2a-
subtype in LPS-stimulated murine B cells and to IgG2a and IgG3 in murine B cells that have been 
stimulated with activated T cells. Moreover, IFN-γ blocks IL-4-induced Ig class switching in murine 
B cells from IgM to IgG1 or IgE (Stark et al., 1998). 
Unlike the upregulating effect of IFN-γ on surface MHC expression in macrophages, the induction 
of MHC class II expression by IL-4 in B cells is downregulated. Thus, IFN-γ reduces the capability 
of antigen recognition and presentation by B cells (O’Neill et al., 1999). 
 IFN-γ was shown to be involved in the regulation of proliferation and apoptosis of lymphocytes, 
too. It is able to inhibit lipopolysaccharide (LPS-)-induced B cell proliferation, antigen recognition 
and presentation by B cells (O’Neill et al., 1999). 
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1.2.5 Interferon γ – role in host defense 
1.2.5.1 Host defense against viral infection 
During viral infections, some of the most prominent cytokine produced are the interferons, named 
for their ability to interfere with viral replication. The IFN system regulates innate and adaptive 
immunity to viral infection. Viral invasion directly triggers induction of type I IFNs, through a 
mechanism involving IRF-3 and IRF-7 (Malmgaard, 2004).  
IFN-γ-induced antiviral mechanisms include induction of key antiviral enzymes, most notably PKR, 
which is a serine/threonine kinase greatly induced by type I and II IFN stimulation. PKR is inactive 
in its constitutive form and requires an activating signal for autophosphorylation. dsRNA, a 
necessary intermediate in replication of RNA viruses, is the best characterized activator of PKR, 
although other agents such as heparin are able to activate PKR. Association of PKR with dsRNA is 
likely to cause a conformational change that unmasks the catalytic domain responsible for PKR 
autophosphorylation. PKR is then activated for dsRNA-independent phosphorylation of specific 
cellular substrates (Goodbourn et al., 2000).  
One of these substrates is the eIF-2α subunit, a rate-limiting factor in the normal cellular 
translational machinery. Phosphorylation by PKR prevents recycling of eIF-2–GTP from its 
guanosine 5’-diphosphate-bound form, thereby inhibiting viral and cellular protein synthesis 
(Schroder et al., 2004) resulting in rapid inhibition of translation (Stark et al., 1998). 
 
1.2.5.2 Antimicrobial functions 
One of the most important effects of IFN-γ on macrophages is the activation of microbiocidal 
effector functions. Macrophages activated by IFN-γ display increased pinocytosis and receptor-
mediated phagocytosis as well as enhanced microbial killing ability. IFN-γ-activated microbiocidal 
ability includes induction of the NADPH-dependent phagocyte oxidase (NADPH oxidase) system, 
priming for NO production, tryptophan depletion and upregulation of lysosomal enzymes 
promoting microbe destruction (Decker et al., 2002). 
Macrophages kill bacteria, viruses, protozoa, helminthes, fungi and tumor cells primarily by 
production of ROS and reactive nitrogen intermediates (RNI) via induction of the NADPH 
oxidase system and iNOS, respectively (Stark et al., 2005).  
IFN-γ also promotes microbe destruction by augmenting surface expression of the high-affinity 
FcγRI on mononuclear phagocytes, promoting antibody-dependent, cell-mediated cytotoxicity. 
Complement-mediated phagocytosis is also upregulated by IFN-γ through increased complement 
secretion and complement receptor expression on mononuclear phagocytes (Decker et al., 2002). 
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1.2.5.3 Immunomodulation and leukocyte trafficking 
The ability of IFN-γ to coordinate the transition from innate immunity to adaptive immunity 
distinguishes it from the other IFNs. Mechanisms by which IFN-γ coordinates this transition 
include aiding in the development of a Th1-type response, directly promoting B cell isotype 
switching to IgG2a, and regulation of local leukocyte-endothelial interactions (Collins et al., 1993) 
Another important action is the ability of IFN-γ to augment the expression of the adhesion 
receptor ICAM-1 on vascular endothelial cells, leading to an increased adhesion of LFA-1 
expressing cells. In this activity too, IFN-γ acts cooperatively with TNF-α or IL-1, leading to the 
recruitment of lymphocytes to a local inflammatory site (Boehm et al., 1997). 
Unstimulated leukocytes cycle continuously between the blood and the lymph. IFN-γ and NO 
produced at the site of inflammation cause local dilation of the blood vessels, thereby decreasing 
the local blood flow rate and causing gathering of blood in leaky vessels. Specific leukocyte subsets 
are instructed by the cytokine/chemokine milieu to extravasate into the tissue via interactions 
between adhesion molecules presented on leukocyte and endothelial surfaces. IFN-γ regulates this 
process by upregulating expression of chemokines (e.g. IP-10, MCP-1, MIG, MIP-1α/β, RANTES) 
and adhesion molecules (e.g. ICAM-1, VCAM-1) (Boehm et al., 1997).  
Many IFN-γ-inducible genes are also TNF-α-inducible, and these genes are often superinduced by 
the combination of these factors TNF-α is a macrophage-derived cytokine secreted in response to 
LPS, which can act in an autocrine manner to mediate many LPS-induced effects via NF-κB. IFN-γ 
priming of TNF-α responses is responsible for the priming of a subset of LPS-induced genes. In 
many cases, synergistic induction by the combination of these factors may be a result of the 
combined presence of STAT1 and NF-κB-binding sites in the promoter elements of responsive 
genes (Pine, 1997). Synergy may also be a result of cross talk between the IFN-γ and TNF-α 
signaling pathway. 
Synergy between LPS- and IFN-γ-induced transcription factors in expression of target genes also 
contributes to the priming phenotype. Genes such as IRF-1, IP-10, ICAM-1, and iNOS contain 
STAT1 and NF-κB-binding sites in their promoter, and maximal transcription requires both 
signals. This is a demonstrated in IFN-γ-dependent gene hyperinduction in response to LPS for a 
number of genes and is likely to be a global mechanism for the synergistic, coordinate regulation of 
large coexpression groups (Gao et al., 1997). 
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1.2.6 Interferon γ in disease and therapeutic application 
A better understanding of the roles of IFN-γ in the intact organism is emerging from studies with 
animals in which either the gene encoding IFN-γ or the gene encoding the IFNGR1 chain of the 
IFN-γ receptor has been inactivated by gene targeting (Huang et al. 1993). 
IFN-γ −/− and IFNGR1−/− mice showed no overt developmental defects, and their immune 
system appeared to develop normally. However, these mice show deficiencies in natural resistance 
to bacterial, parasitic and viral infections. The lack of functional IFN-γ is a decreased ability to 
resist infections with Listeria, Mycobacteria, with parasites such as Leishmania and viruses (Kamijo 
et al., 1993). 
Other changes seen in those animals include an increased resistance to the toxic action of bacterial 
LPS and a decreased production of some other cytokines such as TNF-α, IL-1, IL-6, and IL-12 
(Vilcek et al., 1998) 
Patients with inactivating mutations of the human IFNGR1 or IFNGR2 chains show clinical 
indications similar to the mouse models. Human loss-of-function mutations in the IFNGR1 or 
IFNGR2 chain are closely associated with severe susceptibility to poorly virulent mycobacteria 
(Doffinger et al., 2000). 
In addition to recurrent infection, infants with deficient production of IFN-γ exhibited decreased 
neutrophil mobility and NK cell activity, highlighting the importance of IFN-γ in the inflammatory 
response and immunoregulation. It is interesting that natural IFN-γ polymorphisms have been 
correlated with increased longevity. It has been proposed that a slightly dampened inflammatory 
status caused by an IFN-γ polymorphism, which is not able to significantly affect the individual’s 
ability to clear infections, may prevent inflammation-related diseases such as cardiovascular disease, 
neurodegeneration and diabetes (Campell et al., 1991, Lio et al., 2002).  
Allergic diseases have been closely related to the Th2 immune responses, which are characterized 
by high levels of interleukin IL-4, IL-5, IL-9 and IL-13. These cytokines are key players in the 
development of chronic allergic inflammatory disorders, usually characterized by 
hyperresponsiveness, reversible obstruction and inflammation of the airways. Accumulating 
evidence have shown that altering cytokine-producing profile of Th2 cells by inducing Th1 
responses may be protective against Th2-related diseases such as asthma and allergy. Interferon γ, 
the principal Th1 effector cytokine, has shown to be crucial for the resolution of allergy-related 
immunopathologies. In fact, reduced production of this cytokine has been correlated with severe 
asthma (Teixeira et al., 2005). 
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The suppressive effects of IFN-γ on allergic diseases have been shown to be mediated by various 
mechanisms such as the regulation of allergen presentation to T lymphocytes, differentiation of 
naïve T cells toward Th1 phenotype and inhibition of Th2 cell differentiation, inhibition of effector 
cell recruitment to the site of inflammation, induction of apoptosis in T cells and eosinophils, 
blockage of IgE isotype switch in B cells and induction of nitric oxide (NO) production.  
In fact, the potent inhibitory property of IFN-γ on Th2 responses and allergic inflammation has 
suggested that it might be a possible treatment approach in such diseases. However, initial studies 
have shown an unexpected toxicity and several side effects related to IFN-γ administration to 
allergic patients (Teixeira et al., 2005). 
In view of its other immunoregulatory actions, recombinant IFN-γ has been tested in humans. 
Many of the trials were in patients with malignancies. The value of IFN-γ in neoplastic diseases has 
not been confirmed in controlled clinical studies. The use of IFN-γ for the treatment of some 
chronic infectious affecting macrophages (leishmaniasis, toxoplasmosis, tuberculosis) is under 
consideration. In Germany, low doses of IFN-γ are licensed for the treatment of patients with 
rheumatoid arthritis (Vilcek et al., 1998). 
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1.3 Mechanisms in regulation of  Interferon γ expression  
1.3.1 Cellular source of Interferon γ 
Interferon γ is a pleiotropic cytokine that plays an essential role in both the innate and the adaptive 
phase of the immune response. Natural killer (NK) cells, CD8+ and CD4+ Th1 cells are the most 
potent, but not the only, source of IFN γ. A number of studies have identified additional IFN-γ-
secreting cell types, including macrophages, dendritic cells, naïve CD4 T cells and even B cells 
(Szabo et al., 2004). 
1.3.1.1 Natural Killer (NK) cells 
NK cells constitute a population of bone marrow-derived, low-density, large granular lymphocytes 
that make up 10–15 % of circulating PBMC, but in some organs, e.g., the liver, they represent up to 
45 % of tissue-infiltrating lymphocytes (Whiteside et al., 1994). Phenotypically, they are defined 
phenotypically by their expression of CD56 and lack of CD3 (Gong et al., 1994).  
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in the early 
defense against microbial infection or tumor transformation. Thus, playing an important role in 
host defense against pathogens and malignancy (Cooper et al., 2001). They are capable of 
spontaneously killing tumor and virus-infected cells, which have downregulated one or more major 
histocompatibility complex (MHC) molecules and/or expressed certain stress antigens on their 
surface. They kill target cells without MHC restriction and prior activation. By killing virus-infected 
cells and causing the release of proinflammatory substances, e.g., TNF-α, NK cells provide the 
necessary signal to the immune system for inducing virus-specific immunity (Ahmad et al., 2003).  
Upon stimulation, NK cells secrete large amounts of cytokines including Interferon γ (IFN-γ), 
tumor necrosis factor α (TNF-α) and granulocyte-macrophage colony-stimulating factor (GM-CSF), 
and chemokines such as CC chemokine ligand 3 (CCL3), macrophage inflammatory protein 1-α 
(MIP1-α), CCL4 (MIP1-β) and CCL5 (RANTES)(Cooper et al., 2001).  
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1.3.1.2 Natural killer cells – functions in host defense 
Natural killer (NK) cells constitute the first line of host defense against invading pathogens. They 
are activated in an early phase of a viral infection. NK cells are also cytotoxic, namely by inducing 
apoptosis of cells recognized as targets. NK cells identify their targets through a set of activating or 
inhibitory receptors that recognize pathogen-encoded molecules, self-proteins whose expression is 
upregulated in transformed or infected cells, or self-proteins that are expressed by normal cells but 
downregulated by infected or transformed cells (Ahmad et al., 2003).  
The production cytokines and chemokines are important in initiating an inflammatory response and 
in determining the nature and strength of the pathogen-specific immunity. NK cells represent a 
major source of IFN-γ in addition to activated T cells. An immediate production of this cytokine 
from NK cells is a crucial factor in inducing effective antiviral, cellular immunity in the host. In 
addition to directly killing virus-infected cells by releasing cytotoxic molecules such as perforin and 
granzymes, NK cells also kill target cells by Fas/FasL, TNF-α, and TRAIL/DR-4 and DR-5 
interactions. The NK cell-secreted, soluble factors such as IFN-γ and TNF-α also play a role in 
inhibiting virus replication by inducing an antiviral state in host cells.. Furthermore, NK cells play 
important immunoregulatory roles by interacting with T and B cells and APC (Cooper et al., 2001). 
In vivo studies in animal models have demonstrated that depletion of NK cells may result in the 
inability of the host to control viral infections (Walzer et al., 2005).  
The infected host usually responds to a viral infection by enhanced NK cell activity. Viruses may 
directly activate NK cells by encoding a viral protein that is recognized by an activating receptor on 
their surface; Viruses can also activate NK cells indirectly by inducing expression of stress-inducible 
proteins or cytokines in the host. The virus-induced cytokines that activate NK cells include type 1 
IFN (IFN-α and -β), IL-15, IL-18, IL-12, and IL-21. These cytokines positively affect different 
aspects of NK cell activation, proliferation and survival (Walzer et al., 2005). 
In summary, NK cells were originally identified by their ability to kill malignant and virally infected 
cells without prior sensitization. However, the complexity of balancing signals required to control 
NK cell function and Interferon γ production highlights the importance in host defense and their 
immunomodulatory properties.  
The next chapter deals with one of these signals, Interleukin 12, the most important activator of 
NK cells and Interferon γ production. 
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1.3.2 Regulation of Interferon γ production by Interleukin 12  
Interleukin 12 is one of the most efficient inducers of IFN-γ gene expression, either acting alone or 
in synergy with other cytokines (Young et al., 1997).  
 
1.3.2.1 Interleukin 12 – characteristics and biological effects 
Interleukin 12 is a heterodimer composed of two disulfide-linked subunits, p35 and p40 encoded 
on different chromosomes. The p40 subunit is homologous to cytokine receptors, whereas the p35 
subunits are similar to other soluble cytokines comprising four α-helices such as IL-6 and 
granulocyte colony-stimulating factor (CG-CSF). When coordinately expressed within a cell, 
biologically active p70 is secreted. This cytokine is produced by a variety cells including monocytes, 
neutrophils and B cells, but the major producer of IL-12 are macrophages and dendritic cells 
(Trinchieri et al., 1994). 
It is induced by pathogenic organisms, including Gram-positive and Gram-negative bacteria, 
parasites, viruses and fungi. Microbial products induce T cell-independent production of IL-12 by 
cells of the innate immune system via Toll-like receptor signaling (Watford et al., 2004). 
IL-12 is also produced in a T cell-dependent manner through the engagement of antigen-presenting 
cells with CD40 ligand on T cells (Jacobson et al., 1995). 
IL-12 regulates both the innate and adaptive immunity. A major action is the induction of IFN-γ 
production in NK, T cells, B cells and even antigen-presenting cells. IFN-γ promotes cell-mediated 
immunity, which in turn is essential for the response to intracellular pathogens. IL-12 also induces 
T cell proliferation and enhances the cytolytic activity of NK and T cells (Trinchieri et al., 1994). 
The development of naïve CD4 T cells into either Th1 or Th2 cells that produce IFN-γ or IL-4 is a 
process that is essential for an effective adaptive immune response. IL-12 is the main cytokine that 
regulates the Th1 differentiation (Watford et al., 2004). 
 
1.3.2.2 The Interleukin 12 signal transduction pathway 
Interleukin 12 signals through the IL-12 receptor complex composed of the IL-12Rβ1 and the  
IL-12Rβ2 chains (Szabo et al., 2003), which are structurally related to the type I cytokine receptor 
superfamily. The affinity of IL-12 for either subunit alone is low, but coexpression of both subunits 
generates human IL-12 high-affinity binding sites. IL-12p40 interacts predominantly with the β1 
subunit, whereas p35 interacts with the β2 subunit. IL-12 receptor subunits are expressed on 
T cells, natural killer cells and DC. Receptor expression correlates with cellular responsiveness to 
IL-12 (Watford et al., 2004). 
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Like other cytokine receptors, IL-12 subunits lack intrinsic enzymatic activity. Instead, IL-12Rβ1 
binds the Janus kinase (Jak) family member Tyk 2, whereas IL-12Rβ2 associates with Jak2 (Presky et 
al., 1996). Signal transduction by IL-12 is initiated by ligand-induced autophosphorylation and 
transphosphorylation of receptor-associated Jaks, and the Jaks in turn phosphorylate tyrosines 
located in the intracellular domain of the receptor subunits. These phosphorylated tyrosines serve 
as docking sites for signal transducers and activators of transcription (STAT) and potentially other 
signaling molecules (Watford et al., 2004). 
There are seven members of the STAT family of transcription factors that share a number 
of features critical for transcription factor functions: an N-terminal STAT dimerization domain, a 
DNA-binding domain, a Src homology (SH2) domain, a conserved tyrosine residue and a  
C-terminal transactivation domain. One of the important STATs activated by IL-12 is STAT4 
(Watford et al., 2004). 
Upon cytokine stimulation, STAT4 becomes phosphorylated on a conserved tyrosine residue and 
forms dimers through the intermolecular association of the SH2 domain of one STAT molecule 
with a conserved phosphotyrosine of another (Watford et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3. Signaling pathway of Interleukin 12 (Lammas et al., 2003) 
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Only as dimers, STATs can translocate to the nucleus and bind to DNA. Apart from direct binding 
of STAT4 to response elements, transcriptional activation can also require other transcription 
factors. STATs can form complexes with these transcription factors and initiate or suppress 
transcription (Shuai et al., 2003). 
 
1.3.2.3 Inhibitors of IL-12-induced Interferon γ production 
During many infections, there is an initial peak of NK cell activity followed by a dramatic decrease 
a few days later This is also seen in clinical trials in which the treatment with a single dose of IL-12 
augmented both the cytolytic activity and IFN-γ production in cancer patients. Following IL-12 
treatment, however, led to a dramatical decrease in cytokine production indicating a loss of 
responsiveness, which contributes to an ineffectiveness of IL-12 treatment in clinical trials (Wang et 
al., 2000). 
At least two cytokines (IL-10 and TGF-β) have been shown to play a role in the inhibition of NK 
cell responses during infection. TGF-β, a product of many cell types including macrophages and 
NK cells, has been shown to inhibit NK cell IFN-γ production (Liebermann et al., 2002). 
Therefore, TGF-β is described as an immunosuppressive antiinflammatory cytokine. The inhibition 
of IFN-γ gene expression is mediated via binding of SMAD (Small Mothers Against 
Decapentaplegic) proteins to the IFN-γ promotor region. In addition, TGF-β inhibits T-bet activity 
leading to an indirect inhibitory effect on IFN-γ production (Young 2006). 
The situation with IL-10 is more complex since both inhibitory and stimulatory effects have been 
attributed to this cytokine. In contrast to the inhibitory effects of IL-10 on accessory cell functions, 
IL-10 has immunostimulatory effects on NK cell proliferation and cytotoxicity. In combination 
with IL-18, it even augments the ability of NK cells to produce IFN-γ (Liebermann et al., 2002). 
In addition, type I IFNs are potent inhibitors of IL-12 production. The effects of IL-10 and of  
type I IFNs (which belong to the same cytokine superfamily) seem to depend on the applied 
individual model and system (Liebermann et al., 2002). 
The suppressor of cytokine signaling family (SOCS) is known to inhibit intracellular pathways of a 
number of cytokines. In case of IL-12/IFN-γ, SOCS-1 has been shown to inhibit both signaling 
pathways (Eyles et al., 2002). In addition, SOCS-3 has been reported to be a negative regulator of  
IL-12 signaling by preventing STAT 4 binding to the IL-12Rβ2 subunit (Yamamoto et al., 2003). 
Another family of transcriptional inhibitors, the protein inhibitors of activated STATs (PIAS) also 
negatively regulates cytokine signaling. Binding of PIAS to STAT4 is preventing STAT4-dependent 
gene transcription (Arora et al., 2003, Shuai et al., 2003). 
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1.3.3 Regulatory pathways 
1.3.3.1 Cofactors of IL-12-induced Interferon γ production 
Although IL-12 alone can stimulate NK cells to produce IFN-γ, when in case of combination with 
other cytokines it has more potent effects, leading to the production of high levels of IFN-γ.  
TNF-α alone fails to stimulate NK cell production of IFN-γ, but when combined with IL-12, a 
potent synergy occurs (Lieberman et al., 2002). 
Other cytokines related to acute inflammation are also stimuli that synergize in NK cell activity. 
The closely related proinflammatory cytokines IL-18 and IL-1 can both enhance IL12-induced 
production of IFN-γ in vitro with IL-18 being much more potent than IL-1. In some infections, NK 
cell production of IFN-γ has a 95 % reduction in IL-18−/− mice (Fehninger et al., 1999, 
Lieberman et al., 2002). 
Other cell surface ligands have shown to enhance NK cell responses and IFN-γ production. One 
involved in the regulation of innate responses is CD44 that is able to enhance the production of 
IL-12 and IFN-γ. Following infections NK cells express the activated form of CD44, which is able 
to bind low molecular weight hyaluronic acid, normally found at sites of inflammation, suggesting a 
possible mechanism that regulates innate resistance at local site of infection (Lieberman et al., 2002). 
A common feature of many stimuli that enhance the effects of IL-12 is the activation of NF-κB 
family of transcription factors. Thus IL-1, IL-18, TNF-α, as well as signaling through CD44 is 
dependent on NF-κB. Since there is an NF-κB binding site in the promoter of IFN-γ, it can be 
concluded that both STAT4 and NF-κB are required in the production of high levels of IFN-γ 
(Lieberman et al., 2002). 
 
1.3.3.2 Induction of Interferon γ independently of IL- 12/STAT4 
IL-12 and STAT4 play a critical role in the activation of NK cell responses and resistance to 
infections. However, IL-12/STAT4 independent pathways lead to NK cell production of IFN-γ. 
Other transcription factor, such as NF-κB (as described above) and the T-box transcription factor, 
T-bet have been implicated in the NK cell IFN-γ gene expression (Lieberman et al., 2002). 
Two other cytokines are potent IFN-γ inducers: IL-2 and IL-15. Like IL-12, IL-2 also utilizes the 
Jak/STAT pathway, but primarily activates STAT3 and STAT1. However, in NK cells IL-2 is able 
to phosphorylate STAT4, which correlates with the ability of IL-2 to enhance IFN-γ production 
(Lieberman et al., 2002). 
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Another cytokine that mediates similar biological functions as IL-12 is IL-23, secreted by activated 
dendritic cells. IL-23 is a heterodimer of the p40 subunit of IL-12 and a subunit p19 (Oppmann et 
al., 2001). The IL-23 receptor complex consists of an IL-12Rβ1 chain and an IL-23R chain related 
to IL-12Rβ2 and gp130. The Jak/STAT pathway is utilized in IL-23 signaling with activation of 
Jak2 and Tyk2 and subsequent STAT1 and STAT3, STAT4 and STAT5 activation. 
IL-23 is not able to initiate the Th1 differentiation but may be involved in sustaining IFN-γ 
production (Szabo et al., 2004). 
 
1.3.4 Regulation of Interferon γ gene expression 
The IFN-γ gene is remarkably similar in genomic structure among all species where DNA was 
cloned and sequenced. The intron and exon sizes are very similar between species too, and 
interestingly, the promoters are even more conserved than the exons (Young 1996). 
 
1.3.4.1 Methylation of the IFN-γ promoter region 
Promoter DNA methylation is a major epigenetic mechanism for silencing genes and establishing 
commitment in cells differentiating from their precursors (Tong et al., 2005). DNA methylation 
changes chromatin structure and possibly inhibits the recruitment of transcription factors to the 
target genes. In fact, certain transcription factors (i.e., CREB) bind with a low affinity to the 
methylated recognition elements, and this reduction in affinity has been correlated to low promoter 
activity (Yano et al., 2003). In the conserved promoter region of IFN-γ, there are a number of 
potential methylation sites. In the human IFN-γ promoter, there is a conserved CpG target for 
methylation at position -54 critical for promoter functions. The importance of this site is reflected 
in the fact that it is present in mouse, rat and canine promoters, indicating that it has been 
conserved through evolution (Young 1996). In analysis of the murine CD4+ T helper cells, a 
correlation was observed between the degree of methylation and IFN-γ gene expression. In 
addition to the data obtained with the murine T cells, a similar correlation between gene expression 
and IFN-γ promoter methylation was observed in primary human T cells (Visconti et al., 2000). 
The consequences of promoter methylation were also observed in the recruitment of transcription 
factors to the responsive regions. Among several transcription factors that have been shown to 
recognize the methylation-sensitive promoter region of the IFN-γ gene, the recruitment of 
phospho-CREB and CREB to the promoter were significantly lower in Th2 cells as compared with 
Th1 cells. In summary, the methylation of the promoter plays an important role in the regulation of 
the IFN-γ gene expression (Yano et al., 2002). 
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1.3.4.2 Enhancer and silencer elements in the IFN-γ DNA 
The levels and cell specificity of gene expression are generally controlled by distal regulatory 
modules (enhancers and silencers) that may be located in introns or intergenic regions and are able 
to potentiate or repress gene transcription. Typically, multiple regulatory modules are associated 
with a single gene, and different combinations of modules are used to control gene expression in 
different cell types at different developmental stages or under different conditions of stimulation 
(Lee et al., 2001).  
Hardy et al. identified a DNAse-hypersensitive site in the promoter and first intron, indicating that 
specific regions of the genomic DNA are accessible to DNASe I. The presence of these regions 
suggests that they are involved in the transcriptional control of the IFN-γ gene (Hardy et al., 1989). 
Sequence analysis revealed the presence of clustered binding sites for three relevant transcription 
factors, the Th1-restricted transcription factor T-bet and the inducible transcription factors NFAT 
and AP-1. Lee et al. (2001) confirmed by chromatin immunoprecipitation (ChIP) assays that the 
highly conserved non-coding sequences were occupied by these transcription factors and that the 
region possessed functional enhancer activity. 
 
1.3.4.3 Transcription factors in IFN-γ gene expression  
Transcriptional control of IFN-γ is mediated by multiple positive and negative regulatory elements 
located proximal and distal to the 5’-end of the coding sequence and within the first intron of the 
IFN-γ gene (Young et al., 2004). These elements bind a number of transcription factors, including 
NF-κB, NFAT, STATs, T-bet, AP-1, CREB-ATF, GATA-3 and Ying-Yang 1, all of which 
cooperate to regulate induction of IFN-γ gene expression (Kiani et al., 2001, Malmgaard et al., 
2004). 
The number of regulatory sites and transcription factors discovered lately to be involved in IFN-γ 
gene expression is still growing and makes it quite difficult to fully understand IFN-γ gene 
regulation. In addition, the requirement of transcription factors is depending on both cell type and 
inducing signal (Sica et al., 1997). 
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1.3.4.3.1 Nuclear Factor kappa B (NF-κB) 
At least seven NF-κB binding elements have been identified in the human IFN-γ genomic DNA. 
These elements are present in the promoter and first, second and third intron. The importance of 
the NF-κB proteins in regulating IFN-γ expression is dependent on the extracellular signals that the 
T cell or natural killer cell receives (Young, 1996). 
NF-κB is often activated by cell stimuli that synergize with IL-12. The combination of STAT4 
activation by IL-12 and NF-κB by IL-18 is likely to be required for optimal IFN-γ production. 
Other cytokines that are able to influence IFN-γ production such as IL-1 and TNF-α also act 
through NF-κB activation as well (Lieberman et al., 2002). 
NF-κB can indirectly promote IFN-γ production through expansion of cells producing the 
cytokine or through induction of IFN-γ inducing cytokines such as IL-2 (Malmgaard, 2004). 
 
1.3.4.3.2 T-box expressed in T Cells (T-bet) 
T-bet is the only known member of the T-box family of transcription factors specifically expressed 
in the lymphoid system, with its expression restricted to the spleen, thymus, lymph node and lung. 
All T-box transcription factors contain a 200-amino acid DNA-binding domain called the T-box. 
Genes within the T-box family are not only conserved across diverse species, but have also been 
maintained throughout evolution (Szabo et al., 2003). 
T-bet is known to activate the IFN-γ promoter both in NK and Th1 cells. Several T-bet-responsive 
elements in the promoter region of IFN-γ have been identified (Maalmgaard, 2004). 
In CD4 T cells, T-bet is rapidly and specifically induced in developing Th1 but not Th2 cells. T-bet 
expression appears to be controlled by two signaling pathways: the TCR and the IFNγR/STAT1 
signal transduction pathways, but not by the IL-12/STAT4 pathway. Thus, IFN-γ from diverse 
sources such as NK cells, macrophages and dendritic cells induces expression of T-bet, which can 
cause chromatin remodeling of the IFN-γ gene. This increase in local IFN-γ causes a positive 
feedback loop, promoting Th1 differentiation (Szabo et al., 2004). 
T-bet also induces IL-12Rβ2 chain expression, followed by optimal IFN-γ production through 
IL-12/STAT4 signaling (Mullen et al., 2001). 
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1.3.4.3.3 Nuclear Factor of Activated T cells (NFAT) 
Transcription factors of the nuclear factors of activated T cell (NFAT) family were originally 
identified in lymphocytes as a nuclear complex binding to the interleukin-2 (IL-2) promoter in 
activated T cells (Shaw et al., 1988). Until today five members of the NFAT family have been 
isolated and characterized (NFAT1−5). Their expression is not limited to T cells, since one 
member is present in almost every cell type including other cells of the immune system as well as 
non-immune cells (Hogan et al., 2003). Four of these proteins are regulated by calcium signaling. 
The only non-calcium-regulated NFAT-protein is NFAT5 (Lopez-Rodriguez et al., 1999). 
NFAT1, NFAT 2 and NFAT4 are expressed in by T cells and their role in the regulation of T cell 
function and development has been extensively characterized. 
The activation of NFAT proteins is induced by receptors coupled to the calcium-signaling pathway, 
such as the antigen receptors that are expressed by T- and B cells, the Fcγ receptors that are 
expressed by monocytes and natural killer cells, or the Fcε receptors that are expressed by mast cells 
(Macian, 2005). 
In Th cell differentiation NFAT proteins act together with STAT proteins to determine the 
Th1/Th2 lineage. During early stages of naïve T cell activation NFAT proteins bind to the 
promoters of both IFN-γ and IL-4, after T cell activation has been initiated in either direction, the 
inappropriate locus is progressively silenced. This cell-type specific binding is accompanied by 
changes in chromatin accessibility and histone acetylation (Avni et al., 2002). 
Whether individual NFAT proteins have selective roles in Th cell activation is quite controversial. 
Since the loss of NFAT1 promotes Th2 differentiation and NFAT1 deficiency impairs IFN-γ 
production leading an increase in IL-4 production and increased IgG1 and IgE titers. By contrast, 
NFAT2-deficient T cells show impaired production of IL-4 and other Th2 cytokines, indicating 
that NFAT2 is required for Th2 promotion, whereas NFAT1 and NFAT4 promote Th1 activation. 
However constitutively active forms of NFAT1 and NFAT2 are able induce the transcription of 
Th1 and Th2 cytokines (Kiani et al., 2001, Monticelli et al., 2002). 
 
1.3.4.3.4 GATA-binding protein 3 (GATA-3) 
A binding site for GATA-3 has been found in the promoter region of IFN-γ, and binding to this 
regulator element is correlated with the inhibition of IFN-γ gene expression in developing Th1 
cells. In addition, this gene regulation is independent of GATA-3-induced IL-4 expression 
(Malmgaard 2004).  
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1.3.4.3.5 Small Mothers Against Decapentaplegic (SMAD) 
In case of infections with Gram-negative organisms and obligate intracellular pathogens, both pro-
and antiinflammatory cytokines are released to modulate IFN-γ expression by NK cells. TGF-β is 
an immunosuppressive cytokine implicated in the negative regulation of IFN-γ. SMAD proteins are 
regulators of transcription, which transduce signals from TGF-β receptors. In most cases, TGF-β 
signaling is accomplished by SMAD2, SMAD3 and SMAD4 (Yu et al., 2006). 
The interaction of pro- and antiinflammatory pathways is important for integrated responses to the 
cell’s total output: proinflammatory cytokines such as IL-12, IL-15 and IL-18 (important in IFN-γ 
expression) antagonize antiinflammatory TGF-β signaling by downregulating TGF-βRII, SMAD2 
and SMAD3 (Carson 1995). On the other hand, TGF-β was found to repress monokine-induced 
IFN-γ gene expression and T-bet expression via SMAD-depending signaling (Yu et al., 2006). 
 
1.3.4.3.6 Activator Protein 1 (AP-1) 
The AP-1 family of transcription factors consists of several Fos- and Jun-related proteins. Dimers 
of proteins from the Fos and Jun family bind to AP-1-responsive DNA sequences via leucin zipper 
structure. Heterodimers have higher DNA affinity and transcriptional activity than homodimers. 
AP-1 family members can also form complexes with other transcription factors, such as NF-κB 
and NFAT. AP-1-modulated gene expression can either result in activation or repression depending 
on the on the partner of dimerisation. The activation of AP-1 is regulated through kinases. In case 
of c-Jun phosphorylation by protein kinase C and MAPK c-Jun N terminal kinase (JNK) enhance 
DNA binding activity of c-Jun. AP-1 is known as an important transcription factor in 
immunocompetent cells, but its role in IFN-γ induction is quite controversial (Foletta et al., 1998).  
Barbulescu et al., (1997) investigated the involvement of AP-1 in IFN-γ regulation. A complex of 
c-Jun/ATF-2 (activating transcription factor 2) seems to be involved in the modulation of IFN-γ 
gene expression. Upon stimulation with IL-18, phosphorylated c-Jun accumulated in the nucleus of 
mouse T cells leading to an enhanced c-Jun binding to the AP-1 element. In contrast, IL-12 showed 
no enhancement of c-Jun activation. Surprisingly, stimulation with both cytokines led to a far 
higher binding activity compared to the stimulation with IL-18 alone. The authors therefore 
conclude that IL-12 resulted in STAT4 phosphorylation and IL-18 induced c-Jun activation. 
Furthermore, the dimeric complex of STAT 4 and c-Jun was able to activated gene expression 
through binding to the AP-1 response element (Nakahira et al., 2002). 
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Findings in the human NK3.3 cell line support a similar mechanism, where IL-2 and IL-12 in 
combination stimulate IFN-γ, but only IL-2 is able to induce the AP-1 transcription factor (Ye et al., 
1995). Subsequently, increased transcription activity and binding of AP-1 was only present in IL-2- 
stimulated cells (Azzoni et al., 1996). 
Regarding the fact that STAT4  was not found to bind to the IFN-γ promoter region, the authors 
favor a model were STAT4 is able to induce IFN-γ gene expression through the enhancement of 
AP-1-binding to the promoter site ( Barbulescu et al., 1998). 
 
1.3.4.3.7 Yin-Yang 1 (YY-1) 
Yin-Yang is a ubiquitous DNA binding protein with both enhancer and silencer activities, being 
able to bind to a highly conserved region in the IFN-γ promoter region. This region was 
characterized as a silencer element, able to bind a multiprotein-complex. The complex contained an 
AP-2 like protein and the DNA binding protein Yin-Yang (Young et al., 2002). 
Further studies have identified at least one more functional YY-1 binding site in the IFN-γ 
promoter. Additionally, this binding site overlaps with an AP-1 binding site. 
The fact that overexpression of c-Jun compensated the repressive effect of YY-1, suggests a model, 
where binding of YY-1 suppresses IFN-γ expression in the absence of activating stimuli. Upon cell 
stimulation, the activation of AP-1 leads to the competition of AP-1 and YY-1 for the overlapping 
binding region. AP-1 displays YY-1 from the DNA and initiates gene expression (Ye et al., 1996). 
 
 2 Objectives 
 
Many studies conducted by different groups already described the immunomodulatory properties 
of alcohol. Acute ethanol treatment is associated with immunosuppression caused by changes in 
cytokine patterns. Interferon γ is considered to play a key role in alcohol-mediated cytokine 
expression. 
The aim of the present study was to investigate the mechanisms that lead to alcohol-induced 
Interferon γ suppression. The question was whether ethanol is able to interfere with intracellular 
signaling molecules or transcription factors, if mRNA expression was influenced or if 
posttranscriptional mechanisms caused changes in Interferon γ production.  
 
Consequently, the goal of the current study was to: 
 
• find a suitable model to study the ethanol-related changes in cytokine expression 
• induce cytokine production  through specific stimulances 
• study ethanol-related changes in cytokine production 
• investigate intracellular signaling pathways and the effect of ethanol 
• examine changes in mRNA-expression of IFN-γ 
• determine intracellular IFN-γ accumulation 
• elucidate posttranscriptional effects of ethanol 
• identify the unknown protein that is able to either bind or degrade IFN-γ as a consequence 
of ethanol-treatment 
 3 Material and Methods 
 
3.1 Material 
3.1.1 Cell line and PBMC 
Cells Source 
Buffy Coats (heparinized, cell-enriched) Blutzentrale Katharinenhospital, Stuttgart, 
Germany 
NK-92 cells, human natural killer lymphoma (ACC 488) Deutsche Sammlung von Mikroorganismen 
und Zellkulturen (DSMZ), Braunschweig, 
Germany 
 
3.1.2 Chemicals and reagents 
3.1.2.1 Cells and cell culture 
Product Manufacturer 
2-Propanol, ROTIPURAN® ≥ 99.8 %, p.a., ACS, ISO Carl Roth GmbH & Co, Karlsruhe, Germany 
Alpha Modification of Eagle’s Medium, without 
Ribosides & Deoxyribosides, with Earle’s salts, with 
L-Glutamine, endotoxin tested, sterile filtered 
PAA Laboratories GmbH, Pasching, Austria 
Biocoll (1.077 g/ml) Biochrom Berlin, Germany 
Carbon dioxide Sauerstoffwerke Friedrichshafen, Germany 
Fetal Calf Serum (FCS) PAA Laboratories GmbH, Pasching, Austria  
Horse Serum (HS) PAA Laboratories GmbH, Pasching, Austria  
Penicillin-Streptomycin  
(10 000 IU/ml – 10 000 µg/ml) 
PAA Laboratories GmbH, Pasching, Austria 
Phosphate Buffered Saline (PBS) PAA Laboratories GmbH, Pasching, Austria 
Recombinant Human Interleukin-2 (IL-2) Pierce Biotechnology Inc., Rockford, USA 
RPMI 1640, ohne Phenolrot, mit Glutamin PAA Laboratories GmbH, Pasching, Austria 
RPMI 1640, ohne Phenolrot, ohne Glutamin PAA Laboratories GmbH, Pasching, Austria 
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3.1.2.2 Cell incubation experiments 
Product Manufacturer 
Albumin, bovine serum, Fraction V,  
approx. 99 %, Protease-free 
Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Alpha Modification of Eagle’s Medium, without 
Ribosides & Deoxyribosides, with Earle’s salts, with  
L-Glutamine, endotoxin tested, sterile filtered 
PAA Laboratories GmbH, Pasching, Austria 
Dulbecco’s PBS (phosphate buffered saline), without 
Ca & Mg 
PAA Laboratories GmbH, Pasching, Austria  
Ethanol, ROTIPURAN®, > 99.8 %, p.a.  Carl Roth GmbH & Co., Karlsruhe, Germany 
LPS Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
monoclonal anti-human IFN-γ R1 Ab R&D Systems Europe GmbH, Wiesbaden-
Nordenstadt, Germany 
Penicillin-Streptomycin (10000 IU/ml – 10000 µg/ml) Life Technologies, Paisley, USA 
PHA (Phytohemagglutinin) PAA Laboratories GmbH, Pasching, Austria 
Protease Inhibitor Cocktail for use in cell culture Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Protease Inhibitors 
- Aprotinin from bovine lung, cell-culture-tested 
- Bestatin hydrochloride 
- Leupeptin  
- trans-Epoxysuccinyl-L-Leucylamido- 
  (4-Guanodino)Butane, E64 
- Pepstatin A 
Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Recombinant human Interleukin 12 R&D Systems Europe GmbH, Wiesbaden-
Nordenstadt, Germany 
Recombinant human Interferon γ R&D Systems Europe GmbH, Wiesbaden-
Nordenstadt, Germany 
Salmon Sperm DNA solution Gibco Life Technologies, Eggenstein, Germany 
SYTOX Green Molecular Probes, Göttingen, Germany 
Triethylamin Riedel-de Haen, Seelze, Germany 
Triton X-100 Boehringer Mannheim GmbH, Mannheim, 
Germany 
Trypan blue solution, 0.4 %, liquid, sterile-filtered, cell-
culture-tested 
Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
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3.1.2.3 ELISA (Enzyme Linked Immunosorbent Assay) 
Product Manufacturer 
Fetal Calf Serum (FCS)  PAA Laboratories GmbH, Pasching, Austria 
H2SO4 Carl Roth GmbH & Co., Karlsruhe, Germany  
Human Phospho-IFN-gamma R1 DuoSet IC R&D Systems Europe GmbH, Wiesbaden-
Nordenstadt, Germany 
KCl Merck KGaA, Darmstadt, Germany 
KH2PO4 Carl Roth GmbH & Co., Karlsruhe, Germany  
MBLTMHuman IL-18 ELISA kit MEDICAL & BIOLOGICAL 
LABORATORIES CO., LTD, Nagoya, Japan 
Na2CO3 Merck KGaA, Darmstadt, Germany 
Na2HPO4 ⋅2 H2O Merck KGaA, Darmstadt, Germany  
NaCl Carl Roth GmbH & Co., Karlsruhe, Germany 
NaHCO3 Fluka Chemie AG, Buchs, Schweiz 
OptEIATM ELISA Sets  
- Human TNF-α 
- Human TGF-β 
- Human IL-2 
- Human IL-10 
- Human IL-12 
- Human IFN-γ 
- Human IP-10 
BD Bioscience, Heidelberg, Germany 
 OptEIA™ Substrate Reagent Set 
- Substrate Reagent A (Hydrogenperoxid) 
- Substrate Reagent B (Tetramethylbenzidin) 
BD Bioscience, Heidelberg, Germany 
Tween 20 Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany  
 
3.1.2.4 Fluorescence Activated Cell Sorting (FACS) 
Product Manufacturer 
Dulbecco’s PBS (phosphate buffered saline), without Ca 
& Mg 
PAA Laboratories GmbH, Pasching, Austria  
FCS (Fetal Calf Serum)  PAA Laboratories GmbH, Pasching, Austria 
IOTest®-Ab 
- CD3-FITC/CD4-PE 
- CD3-FITC/CD16 + CD56-PE 
- CD45-FITC/CD14-PE 
- CD3-FITC/CD19-PE 
- CD3-FITC/CD8-PE 
- IG1-FITC/IgG1-PE 
Immunotech, Marseille, France 
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PE-conjugated IgG1 Ab  Beckman Coulter 
Phycoerythrin (R-Pe)-conjugated monoclonal anti human 
IL-12Rβ1 Ab Clone 69310 
R&D Systems Europe GmbH, Wiesbaden-
Nordenstadt, Germany 
Phycoerythrin (R-Pe)-conjugated monoclonal anti-human 
IL-12Rβ2 Ab Clone 2B6 
BD, Biosciences Pharmingen, San Diego, USA 
Sodium azide Merck AG, Darmstadt, Germany 
 
3.1.2.5 Sample preparation (cell lysates, nuclear extracts) 
Product Manufacturer 
β-Glycerol phosphate Roth, Karlsruhe, Germany 
Benzamidine Roth, Karlsruhe, Germany 
Dithiothreitol Sigma-Aldrich Chemie GmbH,  Steinheim, 
Germany 
Dulbecco’s PBS (Phosphate buffered Saline), without Ca 
& Mg 
PAA Laboratories GmbH, Pasching, Austria 
EDTA Roth, Karlsruhe, Germany 
Glycerol Merck, Darmstadt, Germany 
HEPES Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
KCl Merck, Darmstadt, Germany 
MgCl2 Merck, Darmstadt, Germany 
NaCl Merck, Darmstadt, Germany 
NaF Sigma-Aldrich Chemie GmbH,  Steinheim, 
Germany 
NP-40 Alternative Calbiochem, Bad Soden, Germany 
Phenylmethanesulfonyl Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Protease-Inhibitors 
- Pefablock 
- Pepstatin 
- Chymostatin 
- Aprotinin 
- Leupeptin 
Sigma-Aldrich Chemie GmbH,  Steinheim, 
Germany 
Sodium orthovanadate Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Sodium-Pyrophosphate Merck, Darmstadt, Germany 
Tris-HCL Roth, Karlsruhe, Germany 
Triton X-100 Merck, Darmstadt, Germany 
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3.1.2.6 Protein assay 
Product Manufacturer 
BSA (bovine serum albumin) Merck, Darmstadt, D 
Bio Rad Protein Assay Dye Reagent concentrate Bio-Rad Laboratories, München, D 
 
3.1.2.7 Western blotting 
Product Manufacturer 
6-Aminocapronacid Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
APS Carl Roth GmbH & Co, Karlsruhe, Germany 
Blotting grade blocker non fat dry milk Carl Roth GmbH & Co, Karlsruhe, Germany 
BSA (Bovine Serum Albumin) Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
GAPDH/anti mouse kind gift of Ute Albrecht, Düsseldorf 
Glycerol, approx. 95 % Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Glycine for electrophoresis, minimum 99 % Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Mercaptoethanol 38 % Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Methanol 100 % Carl Roth GmbH & Co, Karlsruhe, Germany 
NaCl Carl Roth GmbH & Co, Karlsruhe, Germany 
Phospho-c-jun (Ser63)(54B3) Rabbit mAb Cell Signaling Technology, Inc., USA 
Phospho-STAT4 Rabbit polyclonal Ab Zymed, San Francisco, USA 
Pierce ECL Western Blotting Substrate  PIERCE, Rockford IL, USA 
Polyacrylamide Mix 30 % Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Polyclonal Goat Anti-Rabbit Immunoglobulines/HRP Dako Cytomation, Glostrup, Denmark 
Rainbow Marker Amersham, Buckinghamshire, UK 
SDS, ultrapure, ≥ 99 % Carl Roth GmbH & Co, Karlsruhe, Germany 
STAT4 Rabbit polyclonal Ab Santa Cruz Biotechnology, Santa Cruz, USA 
TEMED (N,N, N’,N’-Tetramethylenediamine) Fluka, Buchs, Germany 
Tris PUFFERAN, ≥ 99 %,  p.a. Carl Roth GmbH & Co, Karlsruhe, Germany 
Tween 20 Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
  
56  3  MATERIAL AND METHODS  
 
 
3.1.2.8 RNA-Isolation 
Product Manufacturer 
2-Propanol, ROTIPURAN®, > 99,8 %, p.a., ACS, ISO Carl Roth GmbH & Co., Karlsruhe, Germany 
DEPC (Diethylpyrocarbonat), > 97 % Carl Roth GmbH & Co., Karlsruhe, Germany 
Ethanol, ROTIPURAN®, > 99,8 %,  p.a. Carl Roth GmbH & Co., Karlsruhe, Germany 
Trichlormethan/Chloroform, > 99 %, DAB Carl Roth GmbH & Co., Karlsruhe, Germany 
TRIzol Reagent Invitrogen GmbH, Karlsruhe, Germany 
 
3.1.2.9 cDNA-Synthesis 
Product Manufacturer 
Dichloridphenyltrichlorethan (DTT) Invitrogen GmbH, Karlsruhe, Germany 
dNTP Mix (Deoxynucleotide Mix),  Eppendorf AG, Hamburg, Germany 
First Strand Buffer (5 ×) Invitrogen GmbH, Karlsruhe, Germany 
Random Primer (3 µg/µl) Invitrogen GmbH, Karlsruhe, Germany 
Reverse Transcriptase (200 U/µl) Invitrogen GmbH, Karlsruhe, Germany 
3.1.2.10 PCR 
Product Manufacturer 
10 × Hot-MasterTM-Taq-Buffer, pH 8.5; 25 mM Mg2+ Eppendorf AG, Hamburg, Germany 
18S Competimers (Classic II) Ambion Inc., Austin, TX, USA 
18S Primer Pair (Classic II) Ambion Inc., Austin, TX, USA 
2 × iQTM SYBR Green Supermix Bio-Rad Laboratories GmbH, München, 
Germany 
dNTP Mix (Deoxynucleotide Mix), 10 nM each dNTP Eppendorf AG, Hamburg, Germany 
Hot-MasterTM Taq DNA Polymerase (5 U/µl) Eppendorf AG, Hamburg, Germany 
NucleoSpin Extract II Kit Macherey-Nagel GmbH & Co. KG, Düren, 
Germany 
 
3.1.2.11 Electrophoresis 
Product Manufacturer 
Ethidiumbromid Carl Roth GmbH & Co., Karlsruhe, Germany 
Boric acid Carl Roth GmbH & Co., Karlsruhe, Germany 
Track-ItTM 100 bp DNA Ladder Invitrogen GmbH, Karlsruhe, Germany 
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SeaKem LE Agarose Cambrex Inc., Rockland, ME, USA 
Tris-(hydroxymethyl)-aminomethan ICN Biomedicals GmbH, Eschwege, Germany 
Ethylenediaminetetraacetic acid disodium salt dihydrate, 
for molecular biology, > 99 % 
Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
 
3.1.3 Equipment and expendable items 
3.1.3.1 Generally used items 
Product Manufacturer 
Beakers, volumetric flask, graduated cylinder, Erlenmeyer 
flask 
Carl Roth GmbH & Co., Karlsruhe, Germany 
Aluminum foil  
Still Heraeus Holding GmbH, Hanau, Germany 
SANOclav, autoclave Wolf GmbH, Bad Überkingen-Hausen, 
Germany 
Heat sterilization oven Memmert GmbH + Co. KG, Schwabach, 
Germany 
Digital balance 510-37 (± 10 mg) Gottl. Kern & Sohn, Albstadt, Germany 
Analytical balance (± 0.01 mg) Sartorius, Wolfinger GmbH, Germany 
Vortex-Genie 2 Scientific industries Inc., Bohemia N.Y., USA 
Centrifuge 3200, table centrifuge Eppendorf AG, Hamburg, Germany 
Reaction tubes 1.5 ml, 2 ml Eppendorf AG, Hamburg, Germany 
Pipettes Eppendorf AG, Hamburg, Germany 
Multipette® plus Eppendorf AG, Hamburg, Germany 
Glass pipettes 10, 20 ml 
Multimed Wicker GmbH, Kirchheim u. Teck, 
Germany 
Disposable pipettes 10 ml, 20 ml Sarstedt AG & Co., Nümbrecht, Germany 
Disposable pipette tips Sarstedt AG & Co., Nümbrecht, Germany 
Pasteur pipettes Hirschmann Laborgeräte. GmbH & Co, 
Eberstadt, Germany 
Falcon Tubes, Cellstar® PP tubes with screw cap, 15 ml, 
50 ml 
Greiner, Frickenhausen, Germany 
Parafilm M, LABORATORY FILM Pechiney Plastic Packaging, Chicago, USA   
Gentle Skin®, gloves  Rösner- Mautby Meditrade® GmbH, 
Kiefersfelden, Germany 
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3.1.3.2 Cell culture 
Product Manufacturer 
Culture bottles 25 cm², 75 cm² Sarstedt AG & Co., Nümbrecht, Germany 
Culture bottles 175 cm² Greiner Bio-One GmbH, Frickenhausen, 
Germany 
MCO-20AIC Automatic CO2 Incubator Sanyo Electric Biomedical Co. Ltd., Bad 
Nenndorf, Germany 
Fireboy plus, Bunsen burner INTEGRA Biosciences AG, Chur, Switzerland 
Pipettus® Hirschmann Laborgeräte GmbH & Co, 
Eberstadt, Germany 
Laminar flow Biosafe 2 Dipl.-Ing W. Ehret GmbH, Emmendingen, 
Germany 
 
3.1.3.3 Cell incubation experiments 
Product Manufacturer 
GS-6R centrifuge Beckman Coulter GmbH Krefeld, Germany 
Light optical microscope Olympus, Hamburg, Germany 
Neubauer counting chamber Assistent, Kirchheim u. Teck, Germany 
Disposable injection, sterile, 20 ml B. Braun Melsungen AG, Germany 
Filter unit Filtropur S0.2 Sarstedt AG & Co., Nümbrecht, Germany 
TC-plate 24 well, sterile, with lid  Greiner bio-one Cellstar® GmbH, 
Frickenhausen, Germany 
TC-plate 96 well, sterile, U-shape Greiner bio-one Cellstar® GmbH, 
Frickenhausen, Germany 
Lid For microplate, sterile, standard Greiner bio-one Cellstar® GmbH, 
Frickenhausen, Germany 
Combitips plus 1 ml, 5 ml Eppendorf AG, Hamburg, Germany 
Centrifuge 5417 R Eppendorf AG, Hamburg, Germany 
Plastic boxes with lids Emsa Werke Wulf GmbH & Co, Emsdetten, 
Germany 
BioFolie Vivascience, Göttingen, Germany 
Fluorstar  BMG, Freiburg, Germany 
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3.1.3.4 ELISA 
Product Manufacturer 
Nunc-ImmunoTMmicroplatte (Maxi SorpTMSurface) Nunc, Wiesbaden, Germany 
Multi-channel pipette 300 Eppendorf, Hamburg, Germany 
little plastic vessels  
φ 340 pH/Temperature Meter Beckman Inc., Fullerton, CA, USA 
 
3.1.3.5 FACS 
Product Manufacturer 
BD FACSCalibur BD Bioscience, Heidelberg, Germany 
 
3.1.3.6 Sample preparation (cell lysates, nuclear extracts) 
Product Manufacturer 
Cooling centrifuge 5417 R Eppendorf AG, Hamburg, Germany 
 
3.1.3.7 Protein assay 
Product Manufacturer 
Cary 1 Bio UV-Visible Spectrophotometer Varian, Inc., Darmstadt, Germany 
Disposable kuvette (semimicro-) PMMA MB 
layer depth 10 mm 
MBT BRAND, Gießen, Germany 
 
3.1.3.8 Western Blotting 
Product Manufacturer 
Mini Vertical Gel System Neolab, Heidelberg, Germany 
Electrophoresis Power Supply EPS 300 and 600 Pharmacia, Sweden 
Electroblotting System, Semi-Dry Hep-1 Panther  Owl Separation Systems, Portsmouth, USA  
Thermostat 3401 Eppendorf AG, Hamburg, Germany 
PVDF-Membrane Hybond-P Amersham, Buckinghamshire, UK 
HyperfilmTM ECL Amersham, Buckinghamshire, UK 
Whatman chromatography paper Whatman International Ltd., England 
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3.1.3.9 RNA-Isolation, cDNA-Synthesis and PCR 
Product Manufacturer 
Cary 1 Bio UV-Visible Spectrophotometer Varian Inc., Darmstadt, Germany 
Mastercycler Gradient Eppendorf AG, Hamburg, Germany 
RoboCyclerTM 40 Accessories Stratagene, La Jolla, CA, USA 
iCyclerTM Thermal Cycler Bio-Rad Laboratories GmbH, München, 
Germany  
Electrophoresis Power Supply EPS 300 Pharmacia Biotech 
Multi-Tubes RNAse-/DNAse-free  
(2.0 ml; 1.7 ml, 0.65 ml) 
Carl Roth GmbH & Co., Karlsruhe, Germany 
Multi TM-Dolphin Tubes, certified RNAse/DNAse free 
(2.0 ml) 
SorensonTM BioScience, Inc. Carl Roth 
GmbH + Co., Karlsruhe, Germany 
Thin-wall 8-Tube Strip Biozym Scientific GmbH, Oldendorf, 
Germany 
Biosphere filtered Tips, sterile, non-pyrogenic, DNA-free, 
RNAse-free, ATP-free (10 µl; 100 µl; 1000 µl) 
Sarstedt AG & Co., Nümbrecht, Germany 
Digital camera E.A.S.Y 440K Herolab GmbH,  Wiesloch, Germany 
 
 
3.2 Software 
Product Manufacturer 
MS-Office Microsoft GmbH 
Corel Photo-Paint 8 Corel Inc., Canada 
TINA 2.09g Raytest Isotopenmessgeräte, Straubenhardt, 
Germany 
iCycler-Software Bio-Rad Laboratories GmbH, München, 
Germany 
Statistica Version 6.0 StatSoft, Inc., Tulsa, USA 
Slide Write Plus, Version 6 Advanced Graphics Software Inc., Carlsbad, 
USA 
BMG-FluoStar 1.0 BMG, Offenburg, Germany 
Photometer Software (easykin) SLT, Crailsheim, Germany 
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3.3 Methods 
3.3.1 Cells and cell cultivation  
With respect to cell handling, cell culture procedure and cell incubation experiments, sterile working 
conditions were applied. Materials and equipment were primarily disinfected, sterilized or 
autoclaved before their application at the laminar flow. UV-light was turned on 30 minutes before 
and after using the laminar flow.  
 
3.3.1.1 Preparation and activation of human Peripheral Blood Mononuclear Cells  
For studying the effect of low ethanol concentrations on cytokine expression, we used PHA-
activated or LPS-stimulated human Peripheral Blood Mononuclear Cells (PBMC). The change of 
cell composition within 4 day of PHA-activation was measured using flow cytometry as well as 
surface expression of to different IL-12 receptor subunits. 
Cell culture medium 
RPMI 1640  500 ml 82.5 % 
FCS (heat inactivated ) 100 ml 16.5 % 
Penicillin-Streptomycin  
(10 000 IU/ml – 10 000 µg/ml) 
6 ml  
 
PBMC were isolated from buffy coats of healthy donors through gradient density centrifugation 
using Ficoll. In a first step, donor blood was diluted 1:2 using RPMI-Medium. The suspension was 
then layered carefully on 14 ml of Ficoll. After centrifugation at 400 g for 30 min (without brake), 
the interphase was carefully collected and diluted 1:1 with RPMI. PBMCs were washed twice and 
suspended in RPMI with glutamine. Cell number was determined and PBMC were cultured at a 
starting concentration of 1 × 106 cells/ml. 
For T cell activation studies, PBMC were cultured in RPMI 1640 containing 16.5 % FCS, 2 %  
L-glutamine, 0.01 % penicillin-streptomycin and were stimulated with 2 µg/ml PHA at indicated 
times. 
PHA solution (24 µg/ml) 
PHA  1.2 mg  
RPMI-Medium 50 ml  
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3.3.1.2 NK-92 cell line 
NK-92 cell line 
Cell type human natural killer lymphoma 
DSMZ no. ACC 488 
Origin established from the peripheral blood of a 50-year-old man with non-
Hodgkin lymphoma (large granular lymphocyte) in 1992; cells were 
described as having azurophilic granula and strong cytotoxic activity 
Morphology cells growing in clumps in suspension 
Doubling time ca. 40–50 hours 
 
Human NK cell lymphoma NK-92, an interleukin-2 dependent cell line, is one of few cell lines with 
phenotype and functions similar to normal peripheral blood NK cells. NK-92 may serve as a model 
for NK cell cytokine studies. IL-2, IL-12 and IL-18 regulate NK cell cytokine production. 
Since natural killer cells are the main source of Interferon γ, we established the NK-92 cell line in 
our laboratory. NK-92 cells were used to investigate the effect of different ethanol concentrations 
on Interferon γ protein synthesis, mRNA expression, transcription factor activation (AP-1, 
STAT4), intracellular accumulation and proteolytic degradation upon IL-12 stimulation. 
Cell culture medium 
α-Modification of Eagle’s 
medium, α-MEM 
500 ml 75.1 % 
FCS (heat inactivated ) 83 ml 12.5 % 
horse serum (heat inactivated) 83 ml 12.5 % 
IL-2 solution 333 µl  
IL-2  10 ng/ml 
 
Cultivation was carried out in a humidified atmosphere at 37 °C and 5 % CO2. Cells were 
subcultured every two to three days and split with a density 1:5 or 1:10.  
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3.3.2 Cell incubation experiments 
Before starting experiments, cell number and seeding density were determined. To obtain a 
sufficient amount of cells, cell number was increased by successively raising the size and number of 
cell culture bottle and volume of applied cell suspension and cell culture medium 
The Neubauer counting chamber was used for determining the cell number. Therefore, the cells 
were spinned down for 10 minutes at 1500 rpm and afterwards the cell pellet was suspended in 
10 ml starvation medium. For the counting procedure, cell suspension was diluted with Trypan blue 
solution in a proportion of 1:50. Cells of four squares were counted, each with a defined volume of 
0.1 µl. Calculation of cell number per ml was as follows: 
Cell number/ml = MV × DF × 104 
MV  counted cell number divided by number of counted squares 
DF dilution factor 
 
For the incubation experiment, cell density was 2.5 × 106 cells/ml. Cell suspension was then diluted 
with starvation medium to obtain the required total volume for the corresponding experiment. 
Starvation medium 
α-Modification of Eagle’s 
medium, α-MEM 
500 ml  
FCS (heat inactivated ) 12.5 ml 2.5 % 
 
After determination of cell density, cells were seeded in cell culture plates and underwent a 
starvation phase of 4–16 hours (depending on experiment and examined factor) in the incubator 
with 37 °C, 5 % CO2 and 94 % humidity, where NK-92 cells were maintained in starvation medium 
in order to avoid the influence of IL-2, FCS and HS on IFN-γ production. 
IL-12 stock standard 
IL-12 5 µg 0.02 % 
BSA PBS solution 0.1 % 25 µl  
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IL-12 incubation solution 
IL-12 stock standard diluted in 
α-MEM 
1 : 111 1.8 µg/ml 
BSA-PBS-solution 0.1 % 25 µl  
 
Ethanol incubation solution 36 ‰ 
Ethanol, ≥ 99.8 % 227.7 µl  
Starvation medium 47.7 ml  
 
Ethanol incubation solution 24 ‰ 
Ethanol incubation solution 
36 ‰ 
2.7 ml  
Starvation medium 1.4 ml  
 
Ethanol incubation solution 12‰ 
Ethanol incubation solution 
36 ‰ 
1 ml  
Starvation medium 2 ml  
 
At the beginning of each experiment, cells were incubated at five different experimental conditions: 
negative control, i.e. neither treated with IL-12 nor ethanol, a positive control, i.e. cells treated 
exclusively with IL-12, and three conditions, where cells were treated with IL-12 and incubated 
either with 1 ‰, 2 ‰, or 3 ‰ ethanol. The final concentration of the IL-12 solution in each well 
was 75 ng/ml. Every experiment was performed in duplicates. Additionally, ethanol-treated cells 
were kept in alcohol vapor chambers. 
Ethanol solution/alcohol vapor chamber  
deionized water ethanol ≥ 99,8 %  
200ml 252 µl   1 ‰ 
200ml 506 µl   2 ‰ 
200ml 758 µl   3 ‰ 
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These alcohol vapor chambers were plastic boxes with lids containing open beakers with an 
aqueous solution of the corresponding ethanol concentration. Additionally, the lids were equipped 
with a gas-permeable plastic foil allowing gas diffusion. Alcohol vapor chambers were kept in the 
incubator. The negative and positive controls were kept in the incubator. Samples were taken at 
indicated times. Regarding sample preparation and determination of IFN-γ levels, see section 
sample preparation.  
IFN-γ solution 
IFN-γ standard 90 ng/vial 24 ng/ml 
Starvation medium 3750 µl  
 
Experiments were protein stability and degradation was examined, IFN-γ was added to each sample 
at a final concentration of 2000 pg/ml. 
 
3.3.3 Cell viability measurement 
To confirm that applied ethanol concentrations were not toxic to isolated PBMC or NK-92 cells, 
cell viability was assessed using SYTOX Green Nucleic Acid Stain. 
SYTOX Green solution 
Sytox Green (5 mM) 4.2 µl 10 µM 
RPMI ad 2100 µl  
 
Triton X-100 solution 
Triton X-100 2 ml 4 % 
RPMI 48 ml  
 
DNA stock standard 
Ready mixed Salmon Sperm 
DNA 
10 mg 1 % 
Deionized water 1 ml  
DNA stock standard was aliquoted and stored at –20°C 
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Principle. This method is based on the fact that polar nucleic acid stains such as SYTOX Green 
are cell-impermeant, i.e. excluded from live cells, but permeates cell walls of cells with damaged 
plasma membranes or dead cells by penetrating into the nucleus and staining DNA. In this case, 
SYTOX Green is used in combination with Triton X-100. After brief incubation of cells with the 
SYTOX Green nucleic acid stain, dead cells fluorescence bright green (λ emission = 530 nm) when 
excited with a 470–490 nm (λ absorption) source (Haugland edit. 2002). After an additional 
incubation with Triton X-100, a non-ionic detergent, which lyses cells (Ahn et al., 1997), 
fluorescence of total DNA, is measured. The calculated difference between the two measurements 
of fluorescence corresponds to the number of SYTOX Green-negative (i. e. viable) cells. 
Assay procedure. Cells with a density of 6.25 × 105/ml were seeded in 96-well plates and 
incubated with ethanol medium at a final concentration 0, 1, 2, or 3 ‰ for 24 hours in an incubator 
of 37 °C and 5 % CO2. Because of the intended fluorescence measurement, colorless RPMI 
medium was used. The measurement was repeated 10-times per experimental condition. In 
addition, ethanol-treated cells were kept in ethanol vapor chambers as already described. After 
incubation, cells were spinned down at 800 rpm for 10 minutes and cell supernatants (200 µl) were 
removed. Regarding DNA measurement, serially diluted DNA standards (8 concentrations, starting 
with 3000 ng DNA/well or 75 µg/ml, dilution ratio 1:3) were prepared of ready mixed Salmon 
Sperm DNA solution and run with each measurement as well. After addition of 10 µl SYTOX 
Green to each cavity and an incubation time of 5 minutes fluorescence was measured at 485 nm for 
the first time. After an additional incubation for 45 minutes with 50 µl Triton X-100 per well, 
fluorescence was measured again.  
Calculation of results. The amount of living cells was calculated via the difference between total 
DNA (SYTOX Green positive cells after Triton X-100 treatment) and DNA of initially dead cells 
(SYTOX Green positive cells before Triton X-100 treatment). The amount of DNA of dead cells 
was calculated by the help of a calibration curve with a sigmoid function supported by Slide Write 
plus software:  
Calculation of cell number per ml was as follows: 
Fluorescence intensity = a0 + a1/(1+exp(–(c[log(DNA per well)] –a2)/a3)) 
Coefficients of this equation were determined by non-linear iterative regression (Levenberg-Marquardt 
Algorithms). Due to a finally relative evaluation in the end, the relative amount of DNA of living cells can be 
referred to as the relative amount of living cells. 
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3.3.4 ELISA – Enzyme-Linked Immunosorbent Assay  
At the end of each cell culture experiment, supernatants were collected and stored at  
–80 °C. Interferon γ secretion in response to IL-12 stimulation and/or ethanol incubation in cell 
culture supernatant from human PBMC or NK-92 cells were measured by Enzyme-linked 
Immunosorbant Assay. Commercially available kits (Human IFN-γ BD OptEIA™ ELISA Set) 
were used according to the supplier’s protocol. If necessary supernatants were diluted 1:10 or 1:50. 
Principle. ELISA is a solid-phase enzyme immunoblotting assay using immobilized antibody for 
assessing the antigen content of a sample. The ‘sandwich’ or two-site ELISA requires two 
antibodies that bind to epitopes on the antigen. One antibody binds as ‘capture’ antibody to the 
bottom of the microwell plate. The added antigen from sample is able to complex with the 
antibody. A labeled second antibody (‘detection’ antibody) is necessary to detect this complex. The 
enzyme bound to the second antibody, in this case horseradish peroxidase, is able to react with 
added colorimetric substrate. The more antigen the sample contains, the more detection antibody is 
bound, and a greater color change can be measured as increasing optical density (Wilson and 
Walker 2005, Lottspeich and Zorbas 1998). 
Coating buffer 
NaHCO3 4.2 g 0.84 % 
NaCO2 1.78 g 0.356 % 
Deionized water ad 500 ml   
pH-value adjusted at pH 9.5; aliquoted at 10.5 ml; stored at –20°C 
 
Coating reagent  
Coating buffer  10.5 ml  
Capture antibody 42 µl  
(per microwell plate, freshly prepared within 15 min. before usage) 
 
Assay procedure. Microwell plates were coated with 100 µl coating reagent per well, sealed with 
aluminum foil and incubated overnight at 4 °C.  
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25× Wash buffer 
NaCl 200 g 20 % 
Na2HPO4⋅2H2O 29 g 2.9 % 
KH2PO4 5 g 0.5 % 
KCl 5 g 0.5 % 
Deionized water ad 1000 ml  
pH-value adjusted with NaOH at pH 7.0, aliquoted (40 ml); stored at –20°C 
 
1× Wash solution  
Wash buffer (1×) 900 ml  
Tween 20 450 µl 0.05 % 
 
Microwells were washed 3-times with 300 µl wash solution per well by an automated washer. After 
the last wash, the plates were tapped on an absorbent paper to remove residual wash solution.  
Assay diluent  
FCS 16.5 ml 16.5 % 
Wash buffer (1×) ad 100 ml  
for two microwell plates, freshly prepared 
 
IFN-γ stock standard 
Recombinant human IFN-γ  90 ng/vial 90 ng/ml 
Deionized water ad 1.0 ml  
After reconstitution, stock standard was aliquoted and stored at –80°C  
 
Thereafter, microwells were blocked with 200 µl blocking buffer per well and incubated for 1 hr at 
room temperature under permanent agitation. Meanwhile, a serially diluted IFN-γ standard (dilution 
ratio 1:2) with the highest concentration of 1200 pg/ml and appropriate dilutions of samples were 
prepared. After another wash, 100 µl of each standard and sample were pipetted in duplicates into 
the microwell plate, followed by sealing the plate again and incubating it for another 2 hours at 
room temperature under permanent agitation.  
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Working detector  
Assay diluent 10.5 ml  
Detection antibody 42 µl  
Enzyme reagent 42 µl  
per microwell plate, freshly prepared within 15 min before usage 
 
After five total washes, the plate was incubated with 100 µl working detector per well for 1 hr.  
Substrate reagent  
Substrate reagent A 5.5 ml  
Substrate reagent B 5.5 ml  
per microwell plate, freshly prepared within 15 min before usage 
 
Stop solution 
H2SO4 (25 %) 25 ml 12.5 % 
Deionized water 50 ml  
 
After a final wash (7-times), 100 µl of substrate reagent were added to each well and the plate was 
incubated unsealed under permanent agitation in the dark until intense blue stain appeared in wells 
with the highest standard IFN-γ concentration. The reaction was interrupted by adding 50 µl of 
stop solution to each well (color change into yellow). Optical density was measured at a wavelength 
of 450 nm with an ELISA plate reader within 30 minutes. 
Calculation of results. For quantification of IFN-γ, IFN-γ concentration was calculated by the 
help of a standard curve supported by the ‘Slide Write’ program. Standards were run with each 
assay in duplicates. The function of the standard curve was as follows:  
y = a0 + (a1 × x) / (a2 + x) 
Coefficients of this equation were calculated with the Levenberg-Marquardt algorithm. The standard curve 
was constructed by blotting the mean absorbance of each standard on the vertical axis 
(y-axis) versus the corresponding IFN-γ concentrations on the horizontal axis (x-axis). 
 
 
 
 
70  3  MATERIAL AND METHODS  
 
 
3.3.5 Flow cytometry (FACS) 
Flow cytometry is a technique for counting, examining and sorting cells suspended in a stream of 
fluid. It allows simultaneous multiparametric analysis of the physical and biological characteristics 
of single cells. 
This method was used in a first step to characterize the cell population of isolated PBMC. This was 
important to describe the changes of lymphocyte subsets in PBMC treated with PHA for 4 days. 
Additionally two PE-conjugated antibodies were used to examine the influence of low ethanol 
concentrations on the expression of IL-12 receptor subunits on PHA-activated T cells. 
Principle: A laser light of a single wavelength is directed onto a hydro-dynamically focused stream 
of fluid. A number of detectors are aimed at the point where the stream passes through the light 
beam; one in line with the light beam (Forward Scatter or FSC) and several perpendicular to it (Side 
Scatter (SSC) and one or more fluorescent detectors. Each suspended cell passing through the 
beam scatters the light in some way and fluorescent chemicals found in the cell or on the surface 
are excited into emitting light at a lower frequency than the light source. This combination of 
scattered and fluorescent light is picked up by the detectors, and by analyzing fluctuations in 
brightness at each detector (one for each fluorescent emission peak) it is then possible to 
extrapolate various types of information. FSC correlates with the cell volume and SSC depends on 
the inner complexity of the particle (i.e. shape of the nucleus), the amount and type of cytoplasmic 
granules or the membrane roughness. 
In the field of molecular biology, it is especially useful when used with fluorescence tagged 
antibodies. These specific antibodies bind to antigens on the target cells and help to give 
information on specific characteristics of the cells being studied in the cytometer.  
Staining buffer 
FCS 10 ml  
Sodium azide 450 mg  
PBS 490 ml  
 
Assay procedure. PBMCs were isolated as described earlier and kept at a starting concentration of 
1 × 106 cells/ml. After incubation, cell suspensions were washed twice with PBS and spinned down 
for 5 min. at 1500 rpm and 4 °C. The pellet was resuspended in 500 µl staining buffer. To six 
samples of each experiment (50 µl) 10 µl of each antibody combination (IOTest®-Antikörper: CD3-
FITC/CD4-PE, CD3-FITC/CD16+ CD56-PE, CD45-FITC/CD14-PE, CD3-FITC/CD19-PE, 
CD3-FITC/CD8-PE) or isotype matched control (IgG1-FITC/IgG1-PE) were added. 
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Incubation lasted 30 min and was finished by adding 100–200 µl of staining buffer. Cells were 
washed twice with PBS, resuspended in 1.5 ml of staining buffer and analyzed by flow cytometry. 
To examine IL-12R expression by cytofluorometric analysis cells were cultured for 6 days in 6 well 
plates either unstimulated or PHA activated and were stained with PE-conjugated Ab. The IL-12 
receptor β1 and IL-12 receptor β2 R-Phycoerythrin-conjugated rat anti human monoclonal Ab 
react with the 12Rβ1 e.g. IL-12Rβ2 subunit expressed on T cells and NK cells. Cytofluorometric 
analysis for both receptor subunits was performed using standard methods. 
1 × 105 cells were incubated with 10 µl of 2B6 or 2B10 for 45 min. Control samples were stained 
using isotype controls FITC-conjugated IgG1 Abs. The mixture of IgG1-FITC/IgG1-PE isotypic 
control permits the non-specific part of the staining obtained on leucocytes to be determined with 
combinations of IgG1-isotype antibodies conjugated to FITC or PE. During specific staining, the 
boundary between negative and positive events must be adapted for each experiment depending on 
the signal obtained with the isotypic control.  
Table 3-1. Antibody combinations used to determine leukocyte subpopulations 
Subpopulation FITC-/PE-labeled Ab 
B cells CD3-FITC/CD19-PE 
Th cells CD3-FITC/CD4-PE 
cytotoxic T cells CD3-FITC/CD8-PE 
NK cells CD3-FITC/CD56-PE/CD16-PE 
monocytes CD45-FITC/CD14-PE 
isotype control IgG1-FITC/IgG1-PE 
Table 3-2. Cell surface (CD-) marker on leukocyte subpopulations 
Cell type 
Lymphocytes 
Marker monocytes Th1/Th2 cells cytotoxic 
T cells 
B cells NK cells 
CD3 − +++ +++ − − 
CD4 + +++ − − − 
CD8 − − +++ − − 
CD14 +++ − − − − 
CD16/56 − − − − +++ 
CD19 − − − +++ − 
CD45 ++ +++ +++ +++ +++ 
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Calculation of results: Isotype control monoclonal antibodies were used to estimate the non-
specific binding of target primary antibodies to cell surface antigens. Non-specific binding is due to 
Fc receptor binding or other protein-protein interactions. Isotype controls were used at identical 
concentrations and staining conditions as the target primary antibodies. Before samples were 
analyzed, the FSC Amp Gain and SSC voltage was adjusted to appropriately display the scatter 
properties of the isolated PMBC. The isotype controls were necessary to place the negative 
population in the lower-left quadrant of the plot.  
Stored data files were analyzed after acquisition in complete using WinMDI Ver. 2.8. 
 
3.3.6 Sample preparation  
In the following, sample preparation for western blotting, real-time reverse transcription PCR (RT-
PCR), the determination of intracellular IFN-γ concentration and IFN-γ measurement in cell 
supernatants by ELISA are described. At each point in time of experimental specimen, collection of 
samples for each experimental condition was taken in duplicates. Protein concentration of cell 
lysate was determined in order to get a standardization factor. Regarding calculation of intracellular 
IFN-γ concentration, the amount of IFN-γ was related to the amount of protein from the same 
assay.  
 
3.3.6.1 Supernatant samples 
At each point in time of sample drawing, the whole content of each well was transferred into a 
reaction tube. In case of having a cell suspension, samples were spinned down for 10 minutes at 
1400 rpm and 4 °C. The supernatant was removed and stored at –20 °C until measurement of 
IFN-γ concentration by ELISA.  
 
3.3.6.2 RT-PCR samples 
At the end of the stimulation experiment, cells were washed twice with phosphate buffered saline 
(PBS), lysed with 500 µl TRIzol reagent, transferred to a tube and frozen at –80 °C.  
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3.3.6.3 Cell lysate samples  
Cell lysis buffer 
NaCl (5 M) 6.8 ml 136 mM 
Tris-HCL (1 M, pH 7.4) 5 ml 20 mM 
Glycerol 25 ml 10 % 
EDTA (0.5 M, pH 8) 1 ml 2 mM 
β-Glycerol-phosphate 2.76 g 50 mM 
Na-Pyrophosphate 2.23 g 20 mM 
Benzamidine (1 M) 1.1 ml 4 mM 
Sodium orthovanadate  
(100 mM) 
2.5 ml 1 mM 
Deionized water, ad 250 ml, pH-value was adjusted at 7.4 
Triton X-100  1 % 
Cell lysis buffer was aliquoted at 15 ml and stored at –20 °C 
Pefablock (200 mM) 15 µl 0.2 mM 
Aprotinin (5 mg/ml) 15 µl 5 µg/ml 
Leupeptin (5 mg/ml) 15 µl 5 µg/ml 
Added only before usage of lysis buffer and after warming to 4 °C 
 
After removing the supernatant, the cell pellet was washed twice with PBS for 5 minutes at 1400 
rpm and 4 °C. Then the cell pellet was lysed, by resuspending with 50 µl lysis buffer and subsequent 
incubation for 10 minutes on ice. A following centrifugation step for 20 minutes at 1400 rpm and  
4 °C separated cell lysate from cell waste. Gained supernatant or cell lysate was stored at –80 °C. 
 
3.3.6.4 Nuclear extract samples 
Nuclear extract were prepared to examine STAT4 activation using western blot. 
After removing the supernatant, the cell pellet was washed twice with PBS for 5 minutes at 1400 
rpm and 4 °C. Then the cell pellet was lysed by resuspending with 200–800 µl buffer A and 
subsequent incubation for 10 minutes on ice. A following centrifugation step for 2 minutes at 
1400 rpm and 4 °C separated cell lysate from nucleus fraction. 
Supernatant was removed; pellet was again dissolved in 100–200 µl of buffer C and incubated for 
30 min on ice. A second centrifugation step followed. Supernatant was then stored at –20 °C. 
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Buffer A 
HEPES (0.5 M, pH 7.9) 20 µl 10 mM 
MgCl2 (1 M) 0.75 µl 1.5 mM 
KCl (1 M) 5 µl 10 mM 
Deionized water, ad 100 ml. Buffer A was aliquoted at 1 ml and stored at –20 °C. 
DTT (1 M) 0.5 µl 0.5 mM 
PMSF (250 mM) 1 µl 0.2 mM 
Natriumorthovanadat  10 µl 1 mM 
Aprotinin (5 mg/ml) 0.6 µl 3 µg/ml 
Leupeptin (5 mg/ml) 5 µl 5 µg/ml 
Pepstatin (5 mg/ml) 5 µl 5 µg/ml 
Chymostatin (25 mg/ml) 5 µl 5 µg/ml 
NaF (2.5 M) 2 µl 5 mM 
NP-40 Alternative 1 µl 0.1 %  
Added only before usage of buffer A and after warming to 4 °C 
 
Buffer C  
HEPES (0.5M, pH 7.9) 4 µl 20 mM 
NaCl (5 M) 8.4 ml 400 mM 
MgCl2 (1 M) 150 µl 1.5 mM 
EDTA (0.5 M, pH 8) 40 µl 0.2 mM 
Glycerol 25 ml 10 % 
Deionized water, ad 100 ml, buffer A was aliquoted at 1 ml and stored –20 °C. 
DTT (1 M) 0.5 µl 0.5 mM 
PMSF (250 mM) 1 µl 0.2 mM 
Natriumorthovanadat  10 µl 1 mM 
Aprotinin (5 mg/ml) 0.6 µl 3 µg/ml 
Leupeptin (5 mg/ml) 5 µl 5 µg/ml 
Pepstatin (5 mg/ml) 5 µl 5 µg/ml 
Chymostatin (25 mg/ml) 5 µl 5 µg/ml 
NaF (2.5 M) 2 µl 5 mM 
NP-40 Alternative 1 µl 0.1 %  
Added only before usage of buffer A and after warming to 4 °C 
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3.3.6.5 Protein samples 
A small fraction of each diluted cell lysate or nuclear extract sample (20 µl) was stored at –20 °C for 
determining protein concentration via Bio Rad Protein Assay. 
 
3.3.7 Protein assay 
Protein concentration of cell lysate samples and nuclear extract samples was determined. For this 
purpose, the ‘Bradford method’ was used. 
BSA stock standard 
BSA 100 mg 0.1 % 
Deionized water ad 10 0ml  
 
BSA standard solutions  
BSA stock standard (µl) Deionized water (ml) BSA concentration [µg/ml] (after adding Dye Reagent) 
0 8 0 
10 7.99 1 
20 7.98 2 
40 7.96 4 
80 7.92 8 
100 7.90 10 
150 7.85 15 
200 7.80 20 
270 7.73 27 
350 7.65 35 
400 7.60 40 
Standard solutions were aliquoted at 800 µl/vial and stored at –20 °C 
 
Principle. The dye ‘Coomasssie Brilliant Blue’ binds to proteins. At low pH values, the free dye 
has absorption maxima of 470 and 650 nm, but when bound to protein, has an absorption 
maximum of 595 nm (Wilson and Walker 2005). 
Assay procedure. Samples for protein analysis were diluted 1:200 with deionized water. 
Afterwards, the ‘Dye Reagent’ was added to samples and standards at a proportion of 1:5. After 
vortexing, absorption was measured at 595 nm.  
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Calculation of results. Protein concentrations were calculated based on a linear standard curve. 
Standards were run with each assay. The standard curve was obtained by plotting the mean 
absorbance for each standard on the ordinate (y-axis) versus the corresponding protein 
concentration on the abscissa axis (x-axis).  
 
3.3.8 Western blotting 
Western blotting was proceeded in order to examine if STAT4 or AP-1 are involved in IL-12-
induced IFN-γ production in NK-92 cells. Separation of proteins was performed by SDS-PAGE 
(Sodium Dodecyl Sulfate Poly Acrylamide Gel Electrophoresis). The electrotransfer of proteins was 
preceded in semi-dry conditions. Visualization was done by ECL method. 
Principle. Western blotting is a technique for detecting electrophoretically separated proteins by 
electroblotting and subsequent immunodetection. The separated proteins in a PAA-gel are 
transferred onto a membrane (here: PVDF) via electroblotting. A sandwich of gel and membrane is 
located between two parallel electrodes and a current is passed, that allows the proteins to 
electrophorese out of the gel and onto the membrane, referred as blot. The use of enzyme-linked 
second antibodies enables to detect specific proteins. First, the primary antibody binds to the 
protein of interest. Secondly, the enzyme-linked secondary antibody (here: HRP, Horseradish 
peroxidase-linked IgG) detects the primary antibody. Concerning visualization, enhanced 
chemiluminescence method (ECL) was used. The linked enzyme HRP oxidizes the substrate 
luminol, followed by light emission. The emitted light is detected by exposing the blot to a 
photographic film (Wilson and Walker 2005). 
SDS  
SDS 50 g 10 % 
Deionized water ad 500 ml  
 
APS  
APS 50 g 10 % 
Deionized water ad 500 ml  
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Tris (pH 8.8) 
Tris-Base 45.5 g 1.5 M 
Deionized water ad 250 ml  
 
Tris (pH 6.8) 
Tris-Base 30.3 g 1 M 
Deionized water ad 250 ml  
 
Assay Procedure. At the beginning, the SDS-PAGE was prepared. A single cassette was formed 
with two glass plates and two Teflon spacers. The cassette was stacked upright in the casting stand. 
The SDS-PAA-gel was composed of two gel layers. Firstly, the separating gel was applied, overlaid 
with isopropanol and abandoned until it was set. Before stacking gel preparation, the isopropanol 
was poured off and the gel was washed with deionized water. Thereafter, the stacking gel was 
mixed and poured into the cassette to the top of the plate. A comb was inserted to form slots for 
the later applied samples. When the gel was polymerized, the comb was removed and the cassette 
was filled with electrode buffer. 
Separating gel (7.5 %) 
deionized water 1.06 ml  
PAA-Mix (30%) 3.06 ml  
Tris Base 1.5 M ( pH 8.8) 3.125 ml  
SDS 10 % 125 µl 0.26 % 
APS 10 % 125 µl 0.26 % 
TEMED  5 µl  
 
Stacking gel 
Deionized water 1.7  ml  
PAA-Mix (10 %) 425 µl  
Tris Base 1.0 M (pH 6.8) 313 µl  
SDS 10 % 25 µl 0.01 % 
APS 10 % 25 µl 0.01 % 
TEMED  2.5 µl  
APS and TEMED were added just before gel application, starting polymerization 
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5× Electrode buffer  
SDS 5 g 0.5 % 
Tris Base 15.1 g 1.51 % 
Glycin 94 g 9.4 % 
Deionized water ad 1 L  
 
Electrode buffer  
Electrode buffer, 5× 200 ml  
Deionized water ad 1 L  
 
Loading buffer 
Glycerol 10 g 10 % 
SDS 3 g 3 % 
Tris-Base 757 mg  62.5 mM 
Bromphenolblau 10 mg 0.01 % 
2-Mercaptoethanol  8 ml 8% vol 
Deionized water ad 100 ml  
 
Meanwhile, samples were diluted to a predetermined concentration and volume in order to have the 
same concentration of protein (20 µg/µl) in each sample. For denaturation and reduction, samples 
were mixed with loading buffer (2-times concentrated) 1:1 and the mixture were heated to 95 °C 
for 5–7 minutes. For visualization of the migration front of the proteins in the gel, the dye molecule 
bromphenol blue was added to the loading buffer. Then each sample was loaded onto the gel with 
a ‘Hamilton’ syringe. To determine the protein size a colored molecular weight marker (Rainbow-
marker) was used. For running the gel, the electrophoresis chamber was filled with electrode buffer 
and the cassette was placed in. The anode was connected to the bottom, the cathode to the top of 
the chamber and the first run of the gel was at 80 V for approximately 45 minutes until the 
bromphenol front reached the borderline between stacking gel and separating gel. The second run 
was at 120 V for approximately 2 hours and was stopped when the dye molecule reached the 
bottom of the gel. Then power was turned off, plates were separated, the separating gel was 
removed and the gel was decreased into a dish containing cathode buffer.  
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Anode buffer 1 
Tris-base 36.34 g 3.6 % 
Methanol 100 % 200 ml 20 %vol 
Deionized water ad 1 L  
 
Anode buffer 2 
Tris-base 3.02 g 0.3 % 
Methanol 100 % 200 ml 20 %vol 
Deionized water ad 1 L  
 
Cathode buffer 
6-Aminocapronacid 5.2 g 0.5 % 
Methanol 100 % 200 ml 20 %vol 
Deionized water ad 1 L  
 
Thereafter, an electrotransfer of the proteins onto a PVDF membrane was performed. PVDF 
membrane (tailored to the same size as the gel) was activated by incubating it in methanol for 
several seconds, 5 minutes in deionized water and for 15 minutes in anode buffer 2. The transfer 
stack assembly consisted of 5 layers: 6 ‘Whatman’ filter papers moistened with anode buffer 1 and 
placed on the anode plate of blotter, 3 papers moistened with anode buffer 2 and placed on top of 
the latter papers, followed by the activated PVDF membrane and the gel and completed by 
6 papers moistened with cathode buffer. Finally, the cathode plate of blotter was placed on top of 
the transfer stack. The semi-dry transfer apparatus was connected to power and the limiting 
amperage was set to 0.8 mA/cm2 of the gel surface. The transfer was performed in about 1 h and 
15 min. 
10× TBS, Tris-buffered saline 
Tris 24 g 2.4 % 
NaCl 87 g 8.7 % 
Deionized water ad 1 L  
pH-value adjusted at 7.6 with pure HCl 
 
 
 
80  3  MATERIAL AND METHODS  
 
 
TBS-T 
TBS 10× 500 ml  
Tween 20 5 ml  
Deionized water         ad 5000 ml  
Stored at 4 °C, used within one week 
 
Blocking solution 
BSA                        2.5 g                            5 % 
TBS-T           ad 50 ml  
Deionized water ad 1 L  
 
After blotting, PVDF membrane was washed 3 times for 20 minutes with TBS-T solution under 
permanent agitation. Afterwards, the surface of the membrane was blocked with 5 % BSA solution 
over night under permanent agitation and afterwards washed again as described before. The 
membrane was incubated with primary antibody diluted 1:500 in TBS-T for 2 hours at room 
temperature under permanent agitation. After a next wash, the membrane was incubated with 
secondary antibody diluted 1: 1000 with TBS-T for 1 hr. After a final wash, detection was carried 
out by using ‘ECL Western Blotting Substrate’. Equal amounts of the development solutions A and 
B were poured onto the membrane. The membrane was then wrapped into foil and exposed to a 
photographic film for a few seconds. To demonstrate equal loading, the same membrane was 
reprobed by repeating the working procedure after blocking, using the antibody against GAPDH or 
Histone 1.  
Analysis of results. Because of immunodetection and visualization via ECL, results were 
expressed as bands on the photo film. The bands of the positive and negative control were 
compared for documenting effects of IL-12 stimulation and ethanol treatment. 
 
3.3.9 RT-Polymerase Chain Reaction (RT-PCR) 
To examine changes in IFN-γ mRNA expression upon IL-12 stimulation or ethanol treatment RT-
Polymerase Chain Reaction (RT-PCR) was used. After incubation experiments total RNA was 
isolated, quality and quantity was determined by photometry. Subsequently 1 µg of total RNA was 
reversed transcribed into cDNA. Real-time reverse transcription PCR analyses were performed. 
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3.3.9.1 Isolation of total RNA 
Principle. TRIZOL Reagent is a ready-to-use reagent for the isolation of total RNA from cells and 
tissues. The reagent, a mono-phasic solution of phenol and guanidine isothiocyanate, is an 
improvement to the single-step RNA isolation method developed by Chomczynski and Sacchi. 
During sample homogenization or lysis, TRIZOL Reagent maintains the integrity of the RNA, 
while disrupting cells and dissolving cell components. Addition of chloroform followed by 
centrifugation separates the solution into an aqueous phase and an organic phase. RNA remains 
exclusively in the aqueous phase. After transfer of the aqueous phase, the RNA is recovered by 
precipitation with isopropyl alcohol. After removal of the aqueous phase, the DNA and proteins in 
the sample can be recovered by sequential precipitation. 
Procedure. After incubation experiment 100 µl of TRIzol were added to each sample. Isolation of 
total RNA was started by incubation with 100 µl chloroform for 3 min at room temperature, 
followed by centrifugation for 15 min (11500 rcf/4 °C). The aqueous phase (RNA-phase) was 
completely removed. Total RNA can be precipitated using 250 µl ice-cold isopropanol. The 
following centrifugation step (10 min/11500 rcf/4 °C) leads to a RNA-pellet. This pellet is washed 
twice with 500 ml 75 % ethanol. Isolated RNA was dissolved in DEPC-H2O samples were stored 
at −80°C. 
 
3.3.9.2 UV spectroscopy of RNA yield 
Quantity of isolated RNA was measured by UV spectroscopy. This is a commonly used and easy 
method for quantification of RNA. The absorbance of a diluted RNA sample was measured at 
wavelengths of 260 nm and 280 nm. The nucleic acid concentration was calculated using the Beer-
Lambert law, which predicts a linear change in absorbance with concentration.  
cRNA [µg/ml] =  OD260 ⋅ 40 µg/ml ⋅ dilution factor 
OD Optical density at 260 nm 
 
Besides, of the quantity of RNA the purity was determined by 260/280-ratio. The absorbance at  
260 nm is used to estimate the RNA concentration.  
The other wavelength (280 nm) is used in the numerator of the ratio analysis to detect sample 
impurities. For pure RNA the 260/280 ratio is 1.8-2.0. Lower ratio levels are a sign of protein 
contamination. 
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3.3.9.3 cDNA Synthesis 
Reverse Transcription (RT reaction) is a process in which single-stranded RNA is reverse 
transcribed into complementary DNA (cDNA) by using total cellular RNA, a reverse transcriptase 
enzyme, a primer, dNTPs, and an RNase inhibitor. The resulting cDNA can be used in RT-PCR 
reaction. The reverse transcriptase enzyme ‘SuperScriptTM Reverse Transcriptase’(Invitrogen) was used 
according to the manufacturer’s protocol. 
nuclease-free water (DEPC-H2O) 
DEPC (Diethylpyrocarbonate) 10 µl  
dd H2O 10 ml  
 
RNA samples were diluted with sterile nuclease-free water to a concentration of 1 µg/11 µl. 1 µl of 
random-primer (Invitrogen) was added (150 ng/µl). A negative control tube only contained 
nuclease-free water instead of RNA. RNA was incubated in a thermal cycler with heated lid. Tubes 
were quickly chilled on ice.  
RT core mix 
First strand buffer 4 µl 
DTT (0.1 M) 2 µl 
dNTP-Mix 1 µl 
SupersScript II Reverse 
Transcriptase (200 U/µl) 
1 µl 
 
Meanwhile a RT core mix was prepared on ice, 8 µl was added to each sample, and tubes were 
spinned briefly. The RT was performed at 42 °C for 50 min, followed by a heating step of 70 °C for 
15 min. Samples were then kept at 4 °C or stored at –20 °C.  
 
3.3.9.4 Primer 
PCR parameters such as suitable primers, annealing temperature and cycle number were optimized 
using PHA-induced PBMC as positive control. Three different human IFN-γ primer sequences 
were tested in advance. 18S rRNA was used as internal control to assure constant expression level 
across the sample set being studied.  
 
 
  
3  MATERIAL AND METHODS  83   
IFN-γ oligonucleotides 
source sequence melting point length bp 
Overbergh 
et al., 2003 
forward: 5’-TCAGCTCTGCATCGTTTTGG-3’ 
reverse: 5’-AAGTCTACATCGCCTATTACCTTG-3’ 
60 °C 
64 °C 
110 bp 
Rentzsch 
et al., 2003 
forward: 5’-AGCTCTGCATCGTTTTGGGTT-3’ 
reverse: 5’-AACCCTACAACAGACCCACA-3’ 
62 °C 
60 °C 
108 bp 
Rad et al., 
2002 
forward: 5’-CTTGGCTTTTCAGCTCTGCATC-3’ 
reverse: 5’-CCTTGAGAAAAGAATCCGTAAAACTTC-3’ 
66 °C 
62 °C 
151 bp 
 
18S rRNA 
source sequence melting point  
Parlesak  
et al., 2004 
forward: 5’-AAGTCTTTGGGTTCCGGG-3’ 
reverse: 5’-GGACATCTAAGGGCATCACA-3’ 
54 °C 
60 °C 
 
 
Oligonucleotide were ordered from Invitrogen GmbH in HPSF-purified form, solubilized with the 
respective amount of TE buffer and stored at –20 °C. 
 
3.3.9.5 Real-time RT-PCR 
Real-time reverse transcription analyses were performed in an iCycler™ Thermal Cycler according 
to the manufacturer’s instructions. This technique continuously monitors the cycle-by-cycle 
accumulation of fluorescently labeled PCR product. As a template, cDNA at a concentration of  
10 ng cDNA/ml for IFN-γ and 0.1 ng cDNA/ml for 18S rRNA was used. To 20 µl of reaction 
mixture 5 µl of cDNA sample was added.  
Reaction mixture 
Nuclease-free water 5.9 µl 
2× iQ™ SYBR® Green 
Supermix 
12.5 µl 
12.5 µM Primer forward 0.8 µl 
12.5 µM Primer forward 0.8 µl  
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Assay Procedure: Samples were loaded in 8er stripes and placed in the fluorescence thermocycler. 
Initial denaturation (95 °C for 180 s) of the hot start enzyme (iTaq™-DNA polymerase, Biorad) 
was followed by 45 cycles, each consisting of 95 °C for 30 s, the primer-specific annealing 
temperature for 30 s and the elongation phase for 120 s at 72 °C. At the end of each run melting 
curve profiles were obtained by cooling the sample to 65 °C for 15 s and heating at 0.20 °C/s up to  
95 °C with continuous measurement of fluorescence to confirm amplification of specific transcript. 
Cycle-to-cycle fluorescence emission reading was monitored and analyzed using iCycler software.  
 
3.3.9.6 Calculation of mRNA Copy Number 
For the quantitative evaluation of the IFN-γ gene expression by Real-time PCR the calibration with 
DNA solutions of known copy number was necessary. Therefore, 75 µl of PCR product were 
isolated using NucleoSpin Extract II kit (Macherey-Nagel GmBH). The concentration of DNA was 
measured at 260 nm and the number of copies was calculated as followed: 
Number of copies/µl = cDNA [g/µl] ⋅ 6.022 ⋅ 1023 [mol-1 ]/basepairs ⋅average MW of DNA 
MW Molecular Weight of DNA 660 [g/mol] 
 
DNA-Standard was then adjusted to 2 × 106 copies/µl and aliquoted to 50 µl to avoid multiple 
thawing and freezing cycles and stored at –20 °C. In each run, two samples of the standard curve 
were used to prepare serial dilutions and included as control.  
 
3.3.10 Statistical evaluation 
Data were initially evaluated for normal distribution. To compare means between two groups, 
Student’s t-test was used. To calculate the significance of differences among means for more than 
two groups analysis of variance (ANOVA) was used. If the level of significance (p) was less than 
0.05, levels of significance among negative control, IL-12 stimulated and ethanol incubations were 
evaluated with Dunnett’s or Tukey’s post hoc test. The statistical evaluation was performed with 
STATISTICA, Version 6.0.  
 
 
 
 4 Results 
 
4.1 Interferon γ production by human Peripheral Blood 
Mononuclear Cells  
4.1.1 Effect of PHA activation, LPS stimulation and ethanol treatment on 
IFN-γ production by human Peripheral Blood Mononuclear Cells 
(PBMC) 
4.1.1.1 Effect of PHA activation and LPS stimulation  
Interferon γ can either be stimulated by non-viral agents called superantigens such as PHA, or by 
LPS know as a potent inducer of human T-lymphocyte proliferation and cytokine production 
(Ulmer et al., 2000). In the present study, we tested the ability of both substances to stimulate 
Interferon γ production in Peripheral Blood Mononuclear Cells (PBMC).  
1 × 106 cells were stimulated with PHA at a concentration of 2 µg/ml or LPS at a concentration of 
1 µg/ml. The degree of stimulation varied from donor to donor, but was comparable to the level of 
response to PHA activation or LPS stimulation for all experiments.  
In Table 4-1 and Figure 4-1, the concentration of IFN-γ in cell supernatant of unstimulated, PHA-
activated or LPS-stimulated PBMC is compared. LPS at a concentration of 1 µg/ml caused a highly 
significant stimulation of IFN-γ production in isolated human PBMC. The addition of PHA at a 
concentration of 2 µg/ml led to a highly significant increase of IFN-γ production not only 
compared to untreated cells, but also compared to cells stimulated with 1 µg/ml LPS.  
Table 4-1. Effect of PHA and LPS on the absolute IFN-γ concentration in supernatants of isolated human 
PBMC. Cells (106/2.4 ml) were cultured with medium alone or PHA (2 µg/ml) or LPS (1µg/ml) for 72 hours. 
Results are given as absolute mean values with SD; sF-test (ANOVA, monofactorial, significance of 
stimulation), post hoc test: Tukey’s Honest-Significant-Difference-Test, n.c.: negative control, SD: standard 
deviation. 
 absolute IFN-γ concentration [pg/ml] 
 significance of stimulation 
stimulation N mean SD sF-test 
p (Tukey´s)  
vs PHA 
p (Tukey´s) 
 vs LPS 
n.c. 14 36 33 0.0001 0.0001 
PHA 14 70842 58939  0.0001 
LPS 14 2388 3146 
<0.0001 
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Figure 4-1. Comparison of absolute IFN-γ concentration in cell culture supernatants of untreated, PHA-
activated and LPS-stimulated PBMC. IFN-γ levels were determined via ELISA. Results are given as absolute 
mean values ± SEM; sF-test (ANOVA), post hoc test: * Tukey’s test (versus n.c.) * * * = p-value < 0.001. 
 
4.1.1.2 Effect of ethanol treatment 
To investigate the effect of different ethanol concentrations on IFN-γ concentration in cell 
supernatant of PHA-activated or LPS-stimulated PBMC, isolated cells were seeded in cell culture 
plates and were activated with PHA at a concentration of 2 µg/ml or LPS at a concentration of  
1 µg/ml. Ethanol addition led to concentrations of 1 ‰ (22 mM) and 3 ‰ (66 mM). Additionally, 
ethanol-treated cells were kept in alcohol vapor chambers during incubation time to guarantee 
constant alcohol concentrations. Samples were taken 72 hours upon incubation start. 
The results on the effect of low ethanol concentration on IFN-γ production by human PBMC are 
given in Table 4-2a and depicted in Figure 4-2.  
For further evaluation, absolute mean values were transformed into relative mean values. This was 
necessary since the degree of stimulation varied from donor to donor. The absolute value of IFN-γ 
concentration of PHA-activated PBMC without ethanol treatment was set to 100 % for PHA-
activated cells with ethanol treatment. The absolute value of IFN-γ concentration of LPS-
stimulated PBMC without ethanol was set to 100 % and used as a comparison for all LPS-
stimulated preparations.  Relative mean values are shown in Table 4-2b and Figure 4-3. 
 
 
 
   *** 
  *** 
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Table 4-2. Effect of two different ethanol concentrations on the IFN-γ production by PHA-activated or 
LPS-stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by PHA or LPS and 
treated with two different ethanol concentrations for 72 hours. IFN-γ was determined using ELISA. Table a) 
absolute mean values; b) relative mean values (PHA, 72 hours = 100 %, LPS, 72 hours = 100 %); N: number 
of cases; SD: standard deviation; eF-test: (ANOVA: significance of ethanol concentration); post hoc test: 
Tukey’s Honest-Significant-Difference-Test). 
a absolute IFN-γ  concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 14 36 33 
1 14 35 22 n.c. 
3 14 28 33 
0.7398  
0 14 70842 58939 0.2554 0.0001 
1 14 42232 18173  0.0001 PHA 
3 14 2090 1369 
<0.0001 
  
0 14 2388 3146 0.9503 0.0001 
1 14 1641 1248  0.0001 LPS 
3 14 56 47 
<0.0001 
  
 
b relative IFN-γ concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 14 100 38 
1 14 166 154 n.c. 
3 14 167 347 
0.6596  
0 14 100 29 0.016 0.0001 
1 14 69 23  0.0001 PHA 
3 14 4 2 
<0.0001 
  
0 14 100 27 0.8890 0.0001 
1 14 107 65  0.0001 LPS 
3 14 5 7 
<0.0001 
  
 
Ethanol treatment resulted in a significant decrease of IFN-γ production. The absolute mean value 
in cell supernatants of PHA-activated PBMC treated with 66 mM (3 ‰) ethanol was suppressed in 
a highly significant manner compared to untreated cells. The same effect is seen in LPS-stimulated 
cells. The transformation of absolute values to relative values (PHA, 0 ‰ = 100 %) led to a highly 
significant reduction of IFN-γ  production not only compared to untreated cells, but also compared 
to those incubated with 22 mM (1 ‰) ethanol.  
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a)      b) 
Figure 4-2. Absolute IFN-γ concentrations in cell culture supernatants of a) PHA-activated and b) LPS-
stimulated PBMC. Data of 14 experiments performed in duplicates. Results are given as absolute mean values 
± SEM; eF-test (ANOVA, significance of ethanol concentration); post hoc test: * Tukey’s test (versus 0 ‰): 
**** = p-value < 0.001;  ♦Tukey’s test (versus 1 ‰): ♦♦♦ = p-value < 0.01 
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a)      b) 
Figure 4-3. Relative IFN-γ concentrations in cell culture supernatants of a) PHA-activated and b) LPS-
stimulated PBMC. Data represent the relative mean values and SEM of 14 experiments performed in 
duplicates. eF-test (ANOVA, significance of ethanol concentrations) post hoc test: * Tukey’s test (vs 0 ‰): 
* = p-value < 0.05, **** = p-value < 0.001;  ♦Tukey’s test (versus 1 ‰): ♦♦♦ = p-value < 0.001 
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4.2 Other cytokines produced by human Peripheral Blood 
Mononuclear Cells  
4.2.1 Effect of PHA and LPS stimulation on the production of seven 
cytokines by human Peripheral Blood Mononuclear Cells (PBMC) 
To test the capability of PHA and LPS to stimulated T-lymphocyte cytokine production, seven 
IFN-γ-related cytokines were determined in cell supernatants of ethanol-treated PBMC using 
ELISA. Samples were drawn from LPS- or PHA-stimulated cells at 12 hours to test for TNF-α, at 
32 hours upon incubation start to measure the concentrations of TGF-β, Interleukin 10, Interleukin 
12 and Interleukin 18 as well as IP-10 and at 72 hours to determine Interleukin 2 concentrations. 
In Table 4-3 the absolute cytokine concentration of seven different cytokines in cell supernatants of 
PHA- or LPS-treated cells is given. 
Table 4-3. Effect of PHA and LPS stimulation on the concentration of TNF-α (12 h), TGF-β (32 h), IL-2  
(72 h), IL-10 (32 h), IL-12 (32 h), IL-18 (32 h) and IP-10 (32 h) in supernatants of isolated human PBMC. 
Cells (106/2.4 ml) were cultured with medium alone, with PHA (2 µg/ml) or LPS (1 µg/ml) for indicated 
hours. Results are given as absolute mean values with SD; sF-test (ANOVA), post hoc test: Tukey’s test, n.c.: 
negative control 
 absolute cytokine concentration [pg/ml] 
 significance of stimulation 
Cytokine stimulation N mean SD eF-test 
p (Tukey´s)  
vs PHA 
p (Tukey´s) 
 vs LPS 
n.c. 12 7 14 0.0009 0.0001 
PHA 12 1153 818  0.0516 TNF-α 
LPS 12 1840 870 
<0.0001 
  
n.c. 12 234 152 
PHA 12 242 106 TGF-β 
LPS 12 252 107 
0.9367  
n.c. 14 13 13 0.0001 0.9998 
PHA 14 5675 3492  0.0001 IL-2 
LPS 14 29 38 
<0.0001 
  
n.c. 8 5 3 0.0242 0.0001 
PHA 7 200 150  0.0001 IL-10 
LPS 8 680 171 
<0.0001 
  
n.c. 12 2 3 0.0001 0.0058 
PHA 12 43 26  0.0495 IL-12 
LPS 12 26 16 
<0.0001 
  
n.c. 4 8 3 
PHA 3 13 9 IL-18 
LPS 4 10 2 
0.4888  
n.c. 12 785 1218 0.0001 0.9861 
PHA 12 18189 5336  0.0001 IP-10 
LPS 12 577 588 
<0.0001 
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Figure 4-4. Comparison of absolute cytokine concentrations in cell culture supernatants of untreated, PHA 
activated and LPS stimulated PBMC. a) TNF-α, b) IL-2, c) IL-10, d) IL-12 and e) IP-10. Cytokine levels were 
determined via ELISA. Results are given as absolute mean values ± SEM; sF-test (ANOVA, significance of 
stimulation) post hoc test: * Tukey’s test (versus n.c.): * = p-value <0.05, *** = p-value < 0.001;  
 
 
  *** 
 *** 
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  *** 
 * 
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In our model system of isolated human PBMC, the stimulation with PHA or LPS had no 
significant effect on the production of TGF-β or Interleukin 18. For TNF-α, IL-2, IL-12 and IP-10 
a highly significant increase in cytokine release can be observed upon PHA stimulation, additionally 
IL-10 production is induced.  
LPS on the other hand caused a highly significant increase in TNF-α and IL-10 concentration and 
was also able to lead to higher IL-10 levels in cell culture supernatants. No effect of LPS is seen for 
IL-2 and IP-10 (see Figure 4-4). 
 
4.2.2 Effect of ethanol on seven cytokines produced by Peripheral Blood 
Mononuclear Cells (PBMC) 
To answer the question, if other cytokines produced by PHA- or LPS-stimulated cells were affected 
by low ethanol concentrations in the same way as IFN-γ, seven IFN-γ-related cytokines were 
determined in cell supernatants of ethanol-treated PBMC using ELISA. 
To investigate the effect of different ethanol concentrations on cytokine concentration in cell 
supernatant of PHA-activated or LPS-stimulated PBMC, isolated cells were seeded in cell culture 
plates and were activated with PHA at a concentration of 2 µg/ml or LPS at a concentration of  
1 µg/ml.  
Ethanol addition led to concentrations of 1 ‰ (22 mM) and 3 ‰ (66 mM). Additionally, ethanol-
treated cells were kept in alcohol vapor chambers during incubation time to guarantee constant 
alcohol concentrations. Samples were taken 12, 32 and 72 hours upon incubation start. 
The following chapters 4.2.2.1 – 4.2.2.7 deal with the effect of ethanol on TNF-α, TGF-β, IL-2,  
IL-10, IL-12, IL-18 and IP-10 concentration in cell supernatants of isolated human PBMC. 
 
4.2.2.1 Effect of ethanol treatment on TNF-α production by PBMC 
As seen in chapter 4.2.1, TNF-α production can be induced in PBMC by both PHA and LPS 
stimulation. The addition of ethanol at a concentration of 66 mM to the cell culture medium led to 
a significant decrease only in LPS-stimulated cells (Table 4-4a and Figure 4-5), when absolute mean 
values are compared. 
The transformation of absolute mean values into relative mean values, where absolute cytokine 
concentrations of PHA- or LPS-stimulated PBMC without ethanol was set to 100 %, led to relative 
mean values shown in Table 4-4b and Figure 4-6.  
In this case, the addition of ethanol (66 mM) caused a highly significant decrease in relative values 
of TNF-α level in both LPS- and PHA-treated cells, but this decrease was not dose-dependent, 
since the addition of 22 mM of ethanol had no effect on TNF-α concentration. 
92  4  RESULTS  
 
 
Table 4-4. Effect of two different ethanol concentrations on the TNF-α production by untreated, PHA-
activated or LPS-stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 12 hours. TNF-α 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard deviation; 
eF-test: (ANOVA: significance of ethanol concentration; post hoc test: T-test: Tukey’s test). 
a absolute TNF-α concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 12 7 14 
1 12 389 731 n.c. 
3 12 79 140 
0.0842 
0 12 1153 818 
1 12 1394 1282 PHA 
3 12 529 665 
0.0893 
 
0 12 1840 870 0.5512 0.0201 
1 12 2175 935  0.0013 LPS 
3 12 931 448 
0.0013 
  
 
b relative TNF-α concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 12 100 54 
1 12 8800 15036 n.c. 
3 12 5515 12234 
0.0842   
0 12 100 4 0.3184 0.0001 
1 12 111 27  0.0001 PHA 
3 12 38 17 
<0.0001 
  
0 12 100 14 0.0721 0.0001 
1 12 120 20  0.0001 LPS 
3 12 55 28 
<0.0001 
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Figure 4-5. Absolute TNF-α concentration in cell culture supernatants of LPS-activated PBMC. Data of 12 
experiments performed in duplicates. Results are given as absolute mean values ± SEM; eF-test (ANOVA, 
significance of ethanol concentration) post hoc test: * Tukey’s test (versus 0 ‰): * = p-value < 0.05;  ♦Tukey’s 
test (versus 1 ‰): ♦♦ = p-value < 0.01 
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Figure 4-6. Relative TNF-α concentration in cell culture supernatants of LPS-activated PBMC. Data 
represent the relative mean of values and SEM of 12 experiments done in duplicates. eF-test (ANOVA, 
significance of ethanol concentration), post hoc test: * Tukey’s test (versus 0 ‰): * * * = p-value < 0.001. ♦ 
Tukey’s test (versus 1 ‰): ♦♦♦ = p-value < 0.001. 
 
 
 
 
     * 
  *** 
      ♦♦ 
   ♦♦♦ 
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4.2.2.2 Effect of ethanol treatment on TGF-β production by PBMC 
Human Peripheral Blood Mononuclear Cells isolated from healthy donors showed no change in 
TGF-β production upon LPS- or PHA-activation. The results in the following Table 4-5 
demonstrate, that the addition of ethanol had no effect on the TGF-β concentration as well, leading 
to the conclusion that in our cell culture model the production of TGF-β cannot be induced by 
LPS or PHA and is not affected by ethanol. 
Table 4-5. Effect of two different ethanol concentrations on the TGF-β production by untreated, PHA-
activated or LPS stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 32 hours. TGF-β 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard deviation; 
eF-test: (ANOVA: significance of ethanol concentration) 
a absolute TGF-β concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 12 234 152 
1 12 283 149 n.c. 
3 12 311 101 
0.3852 
0 12 242 106 
1 12 261 88 PHA 
3 12 284 135 
0.6581 
0 12 252 107 
1 12 247 82 LPS 
3 12 284 116 
0.6373 
 
b relative TGF-β concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 12 100 22 
1 12 138 83 n.c. 
3 12 150 58 
0.1146 
0 12 100 11 
1 12 119 53 PHA 
3 12 129 70 
0.3872 
0 12 100 9 
1 12 103 28 LPS 
3 12 119 43 
0.2709 
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4.2.2.3 Effect of ethanol treatment on Interleukin 2 production by PBMC 
The following Table 4-6 shows the absolute (a) and relative (b) IL-2 concentration in cell 
supernatants of LPS- and PHA-activated human PBMC additionally treated with two different 
ethanol concentrations (22 mM and 66 mM). As seen in chapter 4.2.1, Table 4.3, only PHA was 
able to induce a significant IL-2 production.  
Table 4-6. Effect of two different ethanol concentrations on the IL-2 production by untreated, PHA-
activated or LPS-stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 72 hours. IL-2 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard deviation; 
eF-test: (ANOVA: significance of ethanol concentration) 
a absolute IL-2 concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 14 13 13 
1 14 13 7 n.c. 
3 14 29 28 
0.0463 
0 14 5675 3492 
1 14 4531 2427 PHA 
3 14 5640 3619 
0.5701 
0 14 29 38 
1 14 21 5 LPS 
3 14 37 21 
0.2544 
 
b relative IL-2 concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 14 100 53 0.9260 0.0478 
1 14 152 150  0.1066 n.c. 
3 14 439 612 
0.0398 
  
0 14 100 29 
1 14 78 19 PHA 
3 14 96 36 
0.1173  
0 14 100 47 0.9706 0.0301 
1 14 109 68  0.0516 LPS 
3 14 203 158 
0.0201 
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Comparing relative mean values of untreated and LPS-stimulated cells the addition of 66 mM of 
ethanol led to an increase in IL-2 production (Figure 4-7). Concerning the low amount of IL-2 
produced in non-PHA-stimulated preparation, the question remains, whether the results for 
negative control and LPS-stimulation are of physiological relevance. 
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Figure 4-7. Relative IL-2 concentrations in cell culture supernatants of LPS-activated PBMC. Data represent 
the relative mean of values and SEM of 14 experiments done in duplicates. eF-test (ANOVA, significance of 
ethanol concentration), post hoc test: * Tukey’s test (versus 0 ‰):  * = p-value < 0.05 
 
 
4.2.2.4 Effect of ethanol treatment on Interleukin 10 production by PBMC 
After an incubation time of 32 hours, cell supernatants of ethanol-treated PBMC were removed and 
IL-10 concentration was determined using ELISA. The absolute concentrations are shown in Table 
4-7a, the relative mean values in Table 4-7b. 
Untreated cells were barely able to produce IL-10, whereas LPS led to the highest IL-10 
concentrations in cell culture supernatants.  
LPS-challenged cells additionally treated with 66 mM ethanol had a significant lower IL-10 
concentration (Figure 4-8). This effect is even more prevalent in relative data, where IL-10 is 
decreased in incubations with 66 mM compared to untreated cells and additionally compared to 
incubations with 22 mM (Figure 4-9). 
 
 
 * 
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Table 4-7. Effect of two different ethanol concentrations on the IL-10 production by untreated, PHA-
activated or LPS-stimulated PBMC. PBMC (106/2.4 ml)  were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 32 hours. IL-10 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard deviation; 
eF-test: (ANOVA: significance of ethanol concentration; post hoc test: T-test: Tukey’s test). 
a absolute IL-10 concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 8 5 3 
1 10 40 72 n.c. 
3 10 6 3 
0.1543  
0 7 200 150 
1 6 162 66 PHA 
3 10 110 104 
0.2883  
0 8 680 171 0.9648 0.0409 
1 8 655 160  0.0522 LPS 
3 8 424 270 
0.0239 
  
 
 
b relative IL-10 concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 8 100 37 0.0005 0.7027 
1 8 256 83  0.0024 n.c. 
3 8 127 71 
0.0003 
  
0 7 100 17 
1 6 90 26 PHA 
3 8 79 84 
0.7682  
0 8 100 7 0.9396 0.0058 
1 8 96 23  0.0124 LPS 
3 8 57 36 
0.0035 
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Figure 4-8. Absolute IL-10 concentrations in cell culture supernatants of LPS-stimulated PBMC. Data of 8 
experiments performed in duplicates. Results are given as absolute mean values ± SEM; eF-test (ANOVA, 
significance of ethanol concentration) post hoc test:  *Tukey’s test (versus 0 ‰): * = p-value < 0.05 
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Figure 4-9. Relative IL-10 concentrations in cell culture supernatants of LPS-stimulated PBMC. Data 
represent the relative mean of values and SEM of 8 experiments done in duplicates. eF-test (ANOVA, 
significance of ethanol), post hoc test: * Tukey’s test (vs 0 ‰): ** = p-value < 0.01,  ♦ Tukey’s test (vs 1 ‰): 
♦ = p-value < 0.05. 
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 ** 
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4.2.2.5 Effect of ethanol treatment on Interleukin 12 production by PBMC 
Interleukin 12 production was measured 32 hours upon incubation start in cell supernatants of 
PHA- or LPS-treated isolated human PBMC with the addition of two ethanol concentrations. Only 
PHA-activated cells produced verifiable amounts of IL-12 within this period (Table 4-8). In 
supernatants of cells treated with 66 mM of ethanol the increase in IL-12 production was observed 
compared to both untreated and cells treated with 22 mM (Figure 4-10). These findings are pointed 
out by the transformation into relative data, where the addition of ethanol (66 mM) led to a highly 
significant increase in IL-12 production by PHA-activated cells (see Table 4-8b and Figure 4-11). 
Table 4-8. Effect of two different ethanol concentrations on the IL-12 production by untreated, PHA-
activated or LPS-stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 32 hours. IL-12 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard 
deviation; eF-test: (ANOVA: significance of ethanol concentration; post hoc test: T-test: Tukey’s test). 
a absolute IL-12 concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 12 2 3 
1 12 3 6 n.c. 
3 12 7 17 
0.4115  
0 12 43 26 0.7765 0.0010 
1 12 55 34  0.0061 PHA 
3 12 114 62 
0.0007 
  
0 12 10 2 
1 12 12 4 LPS 
3 12 12 4 
0.3567  
 
b relative IL-12 concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 12 100.0 47 
1 12 226 183 n.c. 
3 12 846 1882 
0.2159  
0 12 100 13 0.6138 0.0002 
1 12 140 74  0.0008 PHA 
3 12 312 161 
<0.0001 
  
0 12 100 33 
1 12 106 49 LPS 
3 12 141 89 
0.2411  
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Figure 4-10. Absolute IL-12 concentrations in cell culture supernatants of PHA-activated PBMC. Data of 12 
experiments performed in duplicates. Results are given as absolute mean values ± SEM; eF-test (ANOVA, 
significance of ethanol concentration) post hoc test:  *Tukey’s test (versus 0 ‰): ** = p-value < 0.01; ♦Tukey’s 
test (versus 1 ‰): ♦♦ = p-value < 0.01 
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Figure 4-11. Relative IL-12 concentrations in cell culture supernatants of PHA-activated PBMC. Data 
represent the relative mean of values and SEM of 12 experiments done in duplicates. eF-test (ANOVA, 
significance of ethanol concentration), post hoc test: * Tukey’s test (versus 0 ‰): *** = p-value < 0.001, 
♦ Tukey’s test (versus 1 ‰): ♦♦♦ = p-value < 0.001. 
 
 
 
   ** 
  *** 
     ♦♦ 
   ♦♦♦ 
  
4  RESULTS  1 0 1   
4.2.2.6 Effect of ethanol treatment on Interleukin 18 production by PBMC 
In our cell culture model, IL-18 was not produced in namable amounts, neither on LPS nor on 
PHA stimulation. The effect of ethanol on IL-18 production is therefore negligible (see Table 4-9). 
Table 4-9. Effect of two different ethanol concentrations on the IL-18 production by untreated, PHA-
activated or LPS-stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 32 hours. IL-18 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard deviation; 
eF-test: (ANOVA: significance of ethanol concentration). 
a absolute IL-18 concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD 
eF-test 
 
0 4 8 2 
1 8 13 8 n.c. 
3 8 6 3 
0.0877 
0 3 13 9 
1 2 25 3 PHA 
3 7 12 6 
0.0854 
0 4 10 2 
1 6 12 4 LPS 
3 7 12 4 
0.7148 
 
b relative IL-18 concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 4 100 29 
1 4 174 152 n.c. 
3 4 58 26 
0.2400 
0 3 100 53 
1 2 245 130 PHA 
3 4 116 93 
0.2436 
0 4 100 15 
1 4 123 35 LPS 
3 4 119 43 
0.6011 
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4.2.2.7 Effect of ethanol treatment on IP-10 production by PBMC 
To compare the amount of IP-10 produced by PBMC treated with ethanol, PBMC were activated 
with PHA or LPS. The addition of ethanol led to final concentrations of 22 mM or 66 mM. 
PHA-stimulation induced a 20-fold higher IP-10 production compared to untreated or LPS-
challenged PBMC (Table 4-10). Significant effects of ethanol were only observed in non-stimulated 
cells, when absolute mean values were transformed to relative values. The amount of IP-10 
traceable in cell supernatants of non-stimulated cells dropped to 69 % ± 22 % when cells were 
incubated with cell culture medium containing 66 mM ethanol (Figure 4-12). 
Table 4-10. Effect of two different ethanol concentrations on the IP-10 production by untreated, PHA-
activated or LPS-stimulated PBMC. PBMC (106/2.4 ml) were maintained in RPMI medium, activated by 
PHA (2 µg/ml) or LPS (1 µg/ml) and treated with two different ethanol concentrations for 32 hours. IP-10 
was determined using ELISA. Table a): absolute mean values; b): relative mean values (related to 
concentrations in ethanol-free samples with equal stimulation); N: number of cases; SD: standard deviation; 
eF-test: (ANOVA: significance of ethanol concentration; post hoc test: T-test: Tukey’s test). 
a absolute IP-10 concentration [pg/ml] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 12 785 1218 
1 12 394 383 n.c. 
3 12 689 1223 
0.6242 
0 12 18189 5336 
1 11 20445 8785 PHA 
3 12 23346 5831 
0.1885 
0 12 577 588 
1 12 802 919 LPS 
3 12 1036 1245 
0.5074 
 
b relative IP-10 concentration [%] 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
♦T-test 
vs 1 ‰ 
T-test 
 vs 3 ‰ 
0 12 100 14 0.6741 0.0282 
1 12 90 42  0.1682 n.c. 
3 12 69 22 
0.0320 
  
0 12 100 12 
1 12 102 51 PHA 
3 12 132 30 
0.0497  
0 12 100 25 
1 12 143 101 LPS 
3 12 168 97 
0.1416  
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Figure 4-12. Relative IP-10 concentrations in cell culture supernatants of unstimulated PBMC. Data 
represent the relative mean of values and SEM of 12 experiments done in duplicates. eF-test (ANOVA, 
significance of ethanol), post hoc test: * Tukey’s test (versus 0 ‰):  * = p-value < 0.05 
 
 
 
4.3 Proliferation of  human Peripheral Blood Mononuclear 
Cells (PBMC) 
4.3.1 Effects of PHA activation and ethanol treatment on proliferation of 
human Peripheral Blood Mononuclear Cells (PBMC) 
4.3.1.1 Effect of PHA activation 
Phytohemagglutinin is a commonly used activator of lymphocytes. PHA is a polypeptide belonging 
to the group a lectines. It is able to bind to certain surface-glycoproteins and -glycolipids on 
lymphocytes. Its structure is responsible for connecting T cells and antigen-presenting cells leading 
to polyclonal T cell activation. In this study, PHA confirmed its efficiency as a strong inductor of 
cytokine release and cell proliferation (Table. 4-11, Figure 4-13). 
Results shown in Table 4-11 and Figure 4-13 accent the proliferative response of isolated PBMC 
treated with PHA.  
The amount of DNA per cavity is almost stable in cells untreated within 9 days of in-vitro 
cultivation, whereas the addition of PHA leads to a three-times higher DNA content within 7 days 
of incubation and 9 days upon stimulation the amount of DNA is increased 3.6-fold.  
 
 * 
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Table 4-11. Effect of PHA stimulation on the absolute amount of DNA of human PBMC (104/120 µl) per 
cavity at incubation start and day 7 and 9 in cells treated 2 µg/ml PHA. The amount of total DNA was 
determined using SYTOX green. Absolute mean values, N: number of cases; SD: standard deviation, Inc: 
incubation, stim: Stimulation n.c.: negative control, sF-test: (ANOVA: significance of stimulation), post hoc 
test: *t-test: Student’s t-test. 
 absolute amount of DNA/cavity [ng/cav] 
 significance of stimulation 
Inc [d] stim N mean SD sF-test *t-test 
n.c. 14 41 4 
0 
PHA 14 41 4 
 
n.c. 14 36 8 
7 
PHA 14 110 24 
< 0.0001 
n.c. 14 37 12 
9 
PHA 14 132 44 
< 0.0001 
< 0.0001 
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Figure 4-13. Absolute amount of DNA of PHA-activated PBMC per cavity. Data represent the absolute 
mean of values and SEM of 14 experiments done in duplicates. sF-test (ANOVA, significance of stimulation), 
post hoc test: *t- test: Student’s t-test (versus n.c., at each time point):,  * * * = p-value < 0.001.  
 
4.3.1.2 Effect of ethanol treatment 
Many of the immunosuppressive effects of acute alcohol treatment have been linked to decreased 
production of inflammatory cytokines. On the other hand, a decline in cell number and viability can 
also be observed. To find out whether low ethanol concentrations used in this study are responsible 
for a lower cytokine release or if this is due to lower cell numbers, we used SYTOX Green to 
determine cell proliferation and viability.  
The results on the effect of low ethanol concentration on the absolute amount of DNA of PHA-
activated human PBMC are given in Table 4-12a. 
   *** 
    *** 
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For further evaluation, absolute mean values were transformed in relative mean values. The 
absolute amount of DNA per cavity of PHA-activated PBMC without ethanol treatment was set to 
100 %. Relative mean values are shown in Table 4-12b. 
Table 4-12. Effect of two different ethanol concentrations on the absolute and relative amount of DNA per 
cavity at incubation day 7 and 9 in cells treated with 22 mM and 66 nm of ethanol. The amount of total DNA 
was determined using SYTOX Green. Table a) absolute mean values; b) relative mean value (PHA, 72 hours 
= 100 %); N: number of cases; SD: standard deviation; eF-test: (ANOVA: significance of ethanol 
concentration). 
a absolute amount of DNA/cavity [ng/cav] 
 significance of ethanol concentration 
Inc 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 14 110 24 
1 14 106 26 day 7 
3 14 105 26 
0.8640 
0 14 132 44 
1 14 121 27 day 9 
3 14 122 33 
0.6591 
 
b relative amount of DNA/cavity [%] 
 significance of ethanol concentration 
Inc 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 14 100 2 
1 14 96 8 day 7 
3 14 95 9 
0.8880 
0 14 100 5 
1 14 96 18 day 9 
3 14 96 18 
0.6718 
 
The results in Table 4-12 document no significant effect of low ethanol concentrations on 
proliferation compared to untreated cells. Neither the absolute amount nor the relative amount of 
DNA per cavity of PHA-activated human Peripheral Blood Mononuclear Cells (PBMC) is affected 
by alcohol concentrations of 22 or 44 mM (1 ‰ or 3 ‰).  
 
 
 
 
 
 
106  4  RESULTS  
 
 
4.4 Fluorocytometric analysis of  human Peripheral Blood 
Mononuclear Cells (PBMC) 
4.4.1 Effect of PHA-activation on morphological parameters of 
Peripheral Blood Mononuclear Cells (PBMC) 
The morphological parameters of cells can be assessed as a response of a particle to an incident 
beam, resulting from interaction between reflection and refraction phenomena. Light scatter 
collected at a narrow angle from the incident beam (forward scatter, or FSC) can be considered 
proportional to the cell size; whereas light scatter collected at 90° (side scatter, or SSC) can be 
considered proportional to the cell granularity. 
a) b)  
Figure 4-14. Forward/Side-Scatter dot plot of a) freshly isolated human Peripheral Blood Mononuclear Cells 
and of b) cells stimulated with PHA for 4 days. 
 
4.4.2 Expression of Clusters of Differentiation (CD) in PBMC 
Immunofluorescent staining was used to identify and quantitate the number of cells that express 
specific surface antigens (CD marker). The following Figure 4-15 shows two color density plots of 
FACS scans done with freshly isolated Peripheral Blood Mononuclear Cells using different CD-
antibody combinations. Isotype control monoclonal antibodies were used to estimate the non-
specific binding of target primary antibodies to cell surface antigens. Isotype controls were used at 
identical concentrations and staining conditions as the target primary antibodies. Before samples 
were analyzed, the FSC Amp Gain and SSC voltage was adjusted to appropriately display the scatter 
properties of the isolated PMBC. The isotype controls were used to allocate the ‘negative’ 
population (99 % of the cells) in the lower-left quadrant of the plot. The percentage of cells that 
were considered PE-positive were then found in the upper left quadrant of the density plot, those 
FITC-positive in the lower right panel. The upper right panel (quadrant 2) contains all cells that 
express both CD-antigens, on their cell surface. 
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a)  b)   c)  
 
d)  e)   f)   
Figure 4-15. Flowcytometry results in representative cases. Two color analysis of freshly isolated PBMC. All 
samples were subsequently stained as described in material and methods with two-color antibody 
combinations containing b) CD3-FITC/CD19-PE, c) CD3-FITC/CD4-PE, d) CD3-FITC/CD8-PE, 
e) CD3-FITC/CD56-PE/CD16-PE, f) CD45-FITC/CD14-PE Using a) IgG1-FITC/IgG1-PE as isotype 
control conjugates to exclude background fluorescence. 
 
4.4.3 The effect of PHA stimulation on cell composition of Peripheral 
Blood Mononuclear Cells 
In vitro lymphocyte activation is a standard approach for evaluating cell-mediated response to a 
variety of stimuli, including polyclonal mitogens (i. e. PHA), antigens or cytokines. In this study, we 
wanted to investigate T cell activation using an assay that measures cell surface expression of 
certain CD antigens using multiparameter flow cytometry. The change in phenotype of lymphocyte 
subsets is shown in Table 4-5. The cells were analyzed directly upon isolation and 4 days untreated 
or PHA-activated.  
Lymphocyte subsets were characterized as follows: B cells: CD3−/CD19+(Figure 4-15b, upper left 
panel), Th cells: CD3+/CD4+ (Figure 4-15c, upper right panel), cytotoxic T cells: CD3+/CD8+, 
Figure 4-15d, upper right panel), NK cells: CD3−/CD56+/CD16+ (Figure 4-15e, upper left panel) 
Monocytes CD45+/CD14+  (Figure 4-15f, upper right panel). 
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The data prove the ability of PHA to stimulate T cell activation leading to 94 ± 2 % CD 3+/CD56− 
cells during 4 days of incubation. At the same time, the percentage of monocytes dropped from  
17 ± 1 % to 1 ± 2 % percent during PHA-activation, as well as the fraction of NK cells from 
13 ± 1 % percent to 2 ± 1 %  percent. On day 4 of incubation, no B cells were detected. The 
results of two independent experiments are shown in Table 4-13 and the percentage of each cell 
subset is diagrammed in Figures 4-16 to 4-18. 
Table 4-13. Effect of 4-day-incubation and PHA stimulation on the phenotype of PBMC subtypes. Analyzed 
using FACSscan. The percentage of each cell subtype compared to total cell number is given as mean value. 
N: number of cases; SD: standard deviation, n.c.: negative control, Inc: incubation, stim: stimulation 
 Relative cell number [%] 
Cell subtype Inc [d] stim N mean SD 
0 9 3 
n.c. 
3 0 B-lymphocytes 
4 
PHA 
2 
0 0 
0 35 1 
n.c. 
57 7 Th-lymphocytes 
4 
PHA 
2 
61 2 
0 21 1 
n.c. 
27 1 Cytotoxic T cells 
4 
PHA 
2 
34 9 
0 13 1 
n.c. 
11 7 NK-cells 
4 
PHA 
2 
2 1 
0 17 1 
n.c. 
14 5 Monocytes 
4 
PHA 
2 
1 2 
0 56 1 
n.c. 
84 11 CD3+ 
4 
PHA 
2 
94 2 
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Figure 4-16. Percentage of each lymphocyte subset in freshly isolated PBMC compared to total cell number 
is given as mean value.  
 
Th-lymphocytes
NK-cellsMonocytes
B-lymphocytes
Cytotoxic
T-cells
 
Figure 4-17. Percentage of each cell subtype in isolated PBMC left untreated for 4 days compared to total 
cell number is given as mean value.  
 
Th-lymphocytes
Cytotoxic T-cells
NK-cells
Monocytes
 
Figure 4-18. Percentage of each cell fraction in isolated PBMC stimulated with 2 µg/ml PHA for 4 days 
compared to total cell number is given as mean value.  
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4.4.4 Effect of PHA and ethanol on IL-12 receptor density on PBMC 
To answer the question whether low levels of IFN γ production seen in ethanol-treated cells is due 
to a lower density of IL-12 receptor on cell surface, the expression of IL-12 receptor subunits was 
evaluated by flow cytometry  
In PBMC isolated and stimulated with PHA for 6 days, 82 % of the cells were IL-12Rβ1+ 
compared with only 20 % in untreated cells. Similar results were seen for the IL-12Rβ2 subunit, 
where 63 % of the PHA-treated were IL-12Rβ2+ compared to 18 % in unactivated cells. 
Considering alcohol treatment of unactivated and PHA-stimulated PBMC (22 mM, 44 mM and 66 
mM) for 6 days in vitro, we found no significant change in the expression of IL-12-Rβ1 or IL-12Rβ2 
(Figure 4-19a, b and 4-20). 
 
a    b  
 
Figure 4-19. Flowcytometry results in representative cases. No change in IL-12 receptor density in PHA-
stimulated T cells treated with three different alcohol concentrations. PBMC isolated from leukocyte-enriched 
buffy coats were stimulated with PHA (2 µg/ml) and treated with 22 mM, 44 mM and 66 mM ethanol for 6 
days. The surface expression of a) IL-12-receptor subunit β1 and b) subunit β2 were assessed by FACS 
analysis. Appropriate isotype controls () were included for determination of non-specific binding. Neither 
unstimulated controls ( 0 ‰,  1 ‰, 3 ‰), nor PHA-activated cells ( 0 ‰,  1 ‰, 3 ‰) showed 
any difference in receptor density when treated with different ethanol concentrations. 
 
 
 
 
 
 
 
 
 
 
 
 
Isotype  
non-stim±ET0H  
PHA-stim±ET0H  
Isotype  
non-stim±ET0H  
PHA-stim±ET0H  
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Table 4-14. Expression of IL-12Rβ1 (a) and IL-12Rβ2 (b) by unstimulated and PHA-stimulated 
T cells isolated from cell-enriched whole blood from 6 healthy donors treated with two different ethanol 
concentrations. The percentage of cells expressing IL-12Rβ1 and IL-12Rβ2 cells were measured by flow 
cytometry. N: number of cases; SD: standard deviation; eF-test: (ANOVA: significance of ethanol 
concentration). 
a percentage of cells expressing IL-12Rβ1 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 6 31 10 
1 6 31 12 n.c. 
3 6 29 7.8 
0.9427 
0 6 81 2.8 
1 6 80 6.1 PHA 
3 6 80 3.9 
0.9456 
 
 
b percentage of cells expressing IL-12Rβ2 
 significance of ethanol concentration 
Stimulation 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
0 6 16 3.1 
1 6 17 3.7 n.c. 
3 6 18 4.1 
0.7370 
0 6 57 9.6 
1 5 66 2.6 PHA 
3 6 61 17 
0.4504 
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Figure 4-20. Expression of IL-12Rβ1 (a) and IL-12Rβ2 (b) by unstimulated and PHA-stimulated 
T cells isolated from cell-enriched whole blood from 6 healthy donors treated with two different ethanol 
concentrations. The percentage of cells expressing IL-12Rβ1 and IL-12Rβ2 cells were measured by flow 
cytometry. The horizontal line shows the mean values for each group. Cells show an increase in IL-12 
receptor density when treated with PHA compared to unstimulated cells. The addition of ethanol to the 
medium did not alter the percentage of IL-12Rβ1+ or IL-12Rβ2+ cells. 
 
0 mM        22 mM        66 mM        Ethanol     0 mM       22 mM        66 mM 
 
                    n.c.                                                                   PHA 
0 mM    22 mM 66 m thanol 0 mM  M        66 mM 
 
                    n.c.                                                                   PHA 
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4.5 Interferon γ production by NK-92 cells 
4.5.1 Effect of IL-12 on the Interferon γ production by NK-92 cells 
The ability of IL-12 to induce the production of Interferon γ in NK-92 cells and the kinetics of 
cytokine release was the focus of this experiment. 
The absolute mean concentrations of IFN-γ after 6, 8, 10, 12, 14, and 24 hours did not rise 
significantly above the initial value in cell supernatants of non-stimulated NK-92 cells. IL-12 
stimulation led to a significant increase of absolute mean values of IFN-γ concentration. IFN-γ 
production of NK-92 cells stimulated with IL-12 was significantly higher at 10, 12 and 24 hours 
compared to unstimulated cells (see Table 4-15 and Figure 4-21). 
Although cells were kept in starvation medium for 16 hours without IL-12, IL-2, FCS and HS, 
1093 pg/ml IFN-γ were detected as initial concentration. 
For further evaluation, absolute mean values were transformed into relative mean values by 
defining the absolute mean value of IFN-γ concentration at 14 hours in the supernatant of IL-12 
stimulated NK-92 cells as 100 %. In contrast to absolute mean values, incubation time had a 
significant effect on the relative mean values of IFN-γ in the supernatant of NK-92 cells stimulated 
with IL-12. The relative mean concentrations of IFN-γ were significantly higher at 10, 12 and 24 
hours compared to the initial value. As seen for absolute mean values, IL-12 stimulation also 
increased relative mean values of IFN-γ concentration in the supernatant of NK-92 cells. Post hoc 
test (Tukey’s HSD) indicated that relative mean IFN-γ concentration in the supernatant of NK-92 
cell stimulated with IL-12 was significantly higher at 10, 12, 14 and 24 hours, compared to those 
not stimulated with IL-12 (Table 4-15 and Figure 4-21).  
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Table 4-15. Effect of IL-12 on IFN-γ production by NK-92 cells. NK-92 cells were maintained in starvation 
medium without IL-12, IL-2, FCS, or HS for 16 hours. Cells were replated and the medium was 
supplemented with or without 75 ng/ml IL-12. Samples of the supernatants were collected within 24 hours 
and IFN-γ was determined via ELISA. Table a) absolute mean values; b) relative mean values (IL-12, 14 
hours = 100 %); N: number of cases; SD: standard deviation, SF-test (ANOVA, monofactorial: significance 
of IL-12 stimulation), post hoc test: Tukey’s Honest-Significant-Difference test; tF-test (ANOVA, 
monofactorial: effect of time), post hoc test: *D-test = Dunnett’s-test (6, 8, 10, 12, 14, 24 hours versus 0 h); 
n.c.: negative control; IL-12: cells stimulated with IL-12, Inc.: incubation.  
 
a absolute IFN-γ concentration [pg/ml] 
n.c. IL-12 
significance of IL-12 
stimulation 
Inc 
[h] 
N 
mean SD Mean  SD tF-test sF-test #p(Tukey) 
0 10 1093 426 1093 426 - 
6 10 1074 478 2861 2482 0.125 
8 10 990 654 2763 1935 0.133 
10 10 1042 446 3151 1788 0.023 
12 10 1095 399 3243 1884 0.018 
14 10 1068 444 2855 1099 0.124 
24 10 1043 534 3253 2119 
0.119 <0.001 
0.013 
 
b relative IFN-γ concentration [%] 
n.c. IL-12 
significance of IL-12 
stimulation Inc 
[h] 
N 
mean SD Mean  SD tF-test 
*p(Dunnett 
vs 0 h) 
sF-test #p(Tukey) 
0 10 37 10 37 10 - - 
6 10 37 12 97 78 0.092 0.056 
8 10 32 20 91 62 0.155 0.070 
10 10 36 11 109 54 0.026 0.004 
12 10 38 9 111 56 0.022 0.004 
14 10 37 12 100 28 0.068 0.032 
24 10 37 16 117 69 
0.044 
0.012 
<0.001 
<0.001 
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Figure 4-21. Effect of IL-12 on IFN-γ production by NK-92 cells. Cells were maintained in starvation 
medium without IL-12, IL-2, FCS, or HS for 16 hours. Cells were replated and incubated in the presence or 
absence of 75 ng/ml IL-12. Samples of the supernatants were collected within 24 hours and IFN-γ was 
determined via ELISA. Top: absolute mean values; Bottom: relative mean values ± SEM (IL-12, 14 hours = 
100 %); SF-test (ANOVA, monofactorial: significance of IL-12-stimulation), post hoc test: #Tukey’s Honest-
Significant-Difference test; tF-test (ANOVA, monofactorial: effect of time), post hoc test: *D-test = 
Dunnett’s-test (6, 8, 10, 12, 14, 24 hours versus 0 h); n.c.: negative control; IL-12: cells stimulated with IL-12, 
 */ # = p-value < 0.05; / ## = p-value < 0.01; ***/ ### = p-value < 0.001; n.c.: negative control; IL-12: cells 
stimulated with IL-12.  
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4.5.2 Effect of ethanol on IL-12-induced IFN-γ production by NK-92 cells 
In a next step, we sought to investigate whether ethanol treatment of NK cells is leading to results 
comparable to those seen in PHA-activated PBMC. 
The absolute mean value of IFN-γ level in the supernatants of IL-12 stimulated and with ethanol 
incubated cells decreased significantly within 24 hours with respect to each applied ethanol 
concentration, i.e. 1 ‰, 2 ‰ or 3 ‰ ethanol (Table 4-16, Figure 4-22).  
Regarding treatment with 1 ‰ ethanol, IFN-γ concentration in cell supernatants of IL-12-
stimulated NK-92 cells were significantly lower at 6 and 14 hours of incubation compared to initial 
values. For 2 ‰ and 3 ‰ treatment absolute mean values of IFN-γ level were significantly 
suppressed at each time point of sample drawing compared to concentrations at incubation start. 
Comparing absolute mean values of IFN-γ concentration in the supernatants of IL-12 stimulated 
NK-92 cells with those of IL-12 stimulated and ethanol-treated cells, the addition of ethanol  
(1 ‰, 2 ‰ or 3 ‰) had a significant effect on IFN-γ levels. IL-12-induced IFN-γ production of 
exclusively IL-12 stimulated NK-92 cells was significantly higher compared to the absolute mean 
value of IFN-γ level in the supernatant of NK-92 cells incubated with IL-12 and either with 1 ‰,  
2 ‰, or 3 ‰ ethanol after 6, 8, 10, 12, 14, and 24 hours.  
For further evaluation, absolute mean values of IFN-γ levels were transformed into relative mean 
values. The absolute mean value at 14 hours of IL-12 stimulated cells was set to 100 %. The IFN-γ 
production decreased in a highly significant manner, when incubating NK-92 cells with ethanol. 
The relative mean values of IFN-γ level in the supernatant were significantly lower at each time 
point of sample drawing and for all applied ethanol concentrations (Table 4-16 and Figure 4-22). 
Additionally IFN-γ concentrations in ethanol-containing preparations were below the 
concentration in cell supernatants of non-stimulated cells. 
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Table 4-16. Effect of ethanol on IL-12-induced IFN-γ production by NK-92 cells: NK-92 cells were 
maintained in starvation medium for 16 hours. Cells were replated and the medium was supplemented with 
75 ng/ml IL-12 and in part with 1, 2, or 3 ‰ ethanol. Samples of the supernatants were collected and IFN-γ 
was measured by ELISA. Table a) absolute mean values ± SD, Table b) relative mean values ± SD (IL-12, 14 
hours, without ethanol = 100 %); tF-test (ANOVA, monofactorial): effect of incubation time (24 hours), post 
hoc test: *D-test= Dunnett’s-test (6, 8, 10, 12, 14, 24 hours versus 0 h); N: number of experiments; SD: 
standard deviation, Inc: incubation. All concentrations of IFN-γ in the presence of any ethanol concentration 
were significantly lower (p<0.001). 
a absolute IFN-γ concentration [pg/ml] 
IL-12 IL-12 1 ‰ IL-12 2 ‰ IL-12 3 ‰ 
IFN-γ 
effect 
of 
time 
IFN-γ effect of time IFN-γ effect of time IFN-γ effect of time Inc 
[h] 
N 
mean SD 
tF-
test 
mean SD 
tF-
test 
#D-
test 
mean SD tF-test 
#D-
test 
mean SD tF-test 
#D-
test 
0 10 1093 426 1093 426 - 1093 426 - 1093 426 - 
6 10 2861 2482 344 358 0.008 87 48 <0.001 59 35 <0.001 
8 10 2763 1935 560 378 0.096 2611 334 <0.001 91 36 <0.001 
10 10 3151 1788 514 568 0.060 99 39 <0.001 73 25 <0.001 
12 10 3243 1884 695 675 0.313 109 52 <0.001 152 136 <0.001 
14 10 2855 1099 454 450 0.031 147 84 <0.001 112 62 <0.001 
24 10 3253 2119 
0.119 
633 598 
0.048 
0.190 348 455 
<0.001 
<0.001 323 436 
<0.001 
<0.001 
 
b relative IFN-γ concentration [%] 
IL-12 IL-12 1 ‰ IL-12 2 ‰ IL-12 3 ‰ 
IFN-γ effect of time IFN-γ effect of time IFN-γ effect of time IFN-γ effect of time Inc 
[h] 
N 
mean SD 
tF-
test 
#D-
test 
mean SD 
tF-
test 
#D-
test 
mean SD tF-test 
#D-
test 
mean SD tF-test 
#D-
test 
0 10 37 10 - 37 10 - 37 10 - 37 10 - 
6 10 97 78 0.092 11 11 <0.001 3 1 <0.001 2 1 <0.001 
8 10 91 62 0.155 20 11 0.022 122 18 <0.001 3 1 <0.001 
10 10 109 54 0.026 15 15 0.003 3 1 <0.001 3 1 <0.001 
12 10 111 56 0.022 21 17 0.035 4 1 <0.001 6 6 <0.001 
14 10 100 28 0.068 14 13 0.002 5 2 <0.001 4 1 <0.001 
24 10 117 69 
0.044 
0.012 20 15 
0.002 
0.026 11 14 
<0.001 
<0.001 11 14 
<0.001 
<0.001 
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Figure 4-22. Effect of ethanol on IL-12-induced IFN-γ production by NK-92 cells. NK-92 cells were 
maintained in starvation medium without IL-12, IL-2, FCS or HS for 16 hours. Cells were replated and the 
medium was partly supplemented with 75 ng/ml IL-12 and with 1, 2, or 3 ‰ ethanol. Samples of the 
supernatants were collected and IFN-γ was determined via ELISA. Top: absolute mean values; Bottom: 
relative mean values (IL-12, 14h, without ethanol = 100 %) ± SEM; post hoc tests: #Dunnett’s-test (IL-12 
versus IL-12 + 1, 2 or 3 ‰); # = p-value < 0.05; ## = p-value < 0.01; ### =  p-value < 0.001; n.c.: negative 
control; IL-12: cells stimulated with IL-12; IL-12 + 1, 2 or 3 ‰: cells incubated with  
IL-12 and either 1, 2, or 3 ‰ ethanol. 
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4.6 Effect of  ethanol incubation on cell viability 
To determine the reduced ability of IL-12 to stimulate IFN-γ production under ethanol was due to 
changes in cytokine production or post-translational modulation and to exclude that ethanol in the 
concentrations applied had an effect on NK-92 cell survival we assessed a cell viability test using 
SYTOX Green in combination with Triton X-100. 
On average, 59 % of the cells were still viable after 24 hours of incubation with starvation medium 
(= RPMI medium without additives) without ethanol. Regarding incubation with 1 ‰ ethanol,  
65 % of the cells were still viable after 24 hours, regarding incubation with 2 ‰ ethanol 
60 % of the cells were still viable and regarding incubation with 3 ‰ ethanol 62 % of the cells were 
still viable. Statistical evaluation did not indicate significant differences with respect to cell viability 
among incubations without ethanol and incubations with 1, 2, or 3 ‰ ethanol. 
The results on cell viability upon ethanol treatment are given in Table 4-17. 
Table 4-17. Effect on ethanol incubation on cell viability. Cells were plated and incubated in RPMI medium 
(without FCS, HS, IL-2) and without or either with 1, 2, or 3 ‰ ethanol for 24 hours. Results are given as 
mean values with SD of percent cells viable; eF-test (ANOVA) monofactorial, significance of ethanol  
 mean viable cells [%] 
significance of ethanol 
ethanol N mean SD 
eF-test 
0 20 59 17 
1 20 65 11 
2 20 60 14 
3 20 62 14 
0.456 
 
These results lead us to the conclusion that low IFN-γ levels seen in cell supernatants of NK-92 
cells treated with ethanol concentrations between 1, 2 and 3 ‰ are not due to a non-specific 
cytotoxic effects causing an increase in cell death.  
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4.7 IL-12-induced activation of  transcription factors in 
NK-92 cells 
4.7.1 Kinetics of IL-12-induced STAT4 phosphorylation 
In previous experiments, it was shown that alcohol treatment had an inhibitory effect on IFN-γ 
production. As IL-12 is a potent inducer of IFN-γ production in NK-92 cells and STAT4 is the 
prominent signal transducer in IL-12 activation we studied the kinetics of STAT4 phosphorylation 
upon IL-12 stimulation using western blot analysis to establish an experimental setting for 
maximum STAT4 activation. 
 
 
    n.c.         30 min          60 min         120 min           180 min 
 
 
Figure 4-23. Activation kinetic of STAT4. NK-92 cells were incubated in the absence or presence of IL-12 
(70 ng/ml) for the times indicated. Whole-cell extracts were prepared at the indicated time points. Extracts 
were resolved by SDS–PAGE, and then blotted with anti-phospho-STAT4 (upper panel). The filter was then 
stripped and reprobed with monoclonal anti-STAT4 to demonstrate equal loading (lower panel). Results are 
representative of three experiments. 
 
Figure 4-23 shows the result of western blot analysis of STAT4 phosphorylation. Activated STAT4 
is not detectable in untreated cells. IL-12 stimulation in contrast leads to STAT4 phosphorylation 
already traceable within 30 min of cytokine treatment. The highest level of activation is seen within 
120 min of incubation. This time point was used for further experiments investigating the effect of 
ethanol incubation. 
 
 
 
 
 
Total STAT4 
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4.7.2 Effect of ethanol on IL-12-induced STAT4 phosphorylation 
We showed that ethanol treatment at physiological concentrations leads to a dramatic decrease of 
IFN-γ expression in NK-92 cells. Aim of our research was to find out whether this is caused by 
suppression of STAT4 activation (the main transcription factor for IFN-γ induction). 
Using whole cell lysates of ethanol-treated cells, we investigated the modulation of IL-12-induced 
STAT4 activation by acute alcohol treatment.  
 
 
         n.c. 
 
Figure 4-24. Western blot analysis of IL-12-induced STAT4 phosphorylation in NK-92 cells. NK-92 cells 
were plated and incubated with starvation medium in the absence (n.c.) or presence of 75 ng/ml IL-12 and  
3 different ethanol concentrations. Samples of the cell lysate were used for western blotting. The antibody 
used was against phospho-STAT4. Blots were reprobed with the antibody for GAPDH to demonstrate equal 
loading. The membrane shown is representative for five independent experiments done. 
 
 
As shown in previous experiments (4.7.1) IL-12-induced a strong activation of STAT4 2 hours 
upon stimulation. Alcohol used at physiologically relevant doses did not inhibit STAT4 
phosphorylation as seen in Figure 4-24.  
Cells did not response to ethanol incubation with a downregulation of IL-12-induced STAT4 
activation as seen on protein level. Hence, low Interferon γ expression in alcohol-treated cells is not 
due to a significant reduction in STAT4 phosphorylation. 
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4.7.3 Effect of ethanol on STAT4 translocation 
Considering the significant modulator potential of ethanol on the expression of IFN-γ gene that 
contains a STAT4 responsive element, we hypothesized that, though STAT4 activation through IL-
12 stimulation is unchanged in ethanol-treated cells, the inhibition of translocation of transcription 
factors to the nucleus could explain changes in cytokine expression. Therefore, the effect of acute 
ethanol treatment was tested on the nuclear translocation of STAT4 dimers after IL-12 stimulation 
in NK-92 cells. Cells were stimulated with 75 ng/ml IL-12 for 2 hours in combination with three 
different ethanol concentrations. Nuclear extracts were prepared and tested for phospho-STAT4 
levels by Western blot technique as described in Methods. NK-92 cell stimulated with IL-12 served 
as positive control for STAT4 translocation. 
Figure 4-25 illustrates that 2 hours upon stimulation a substantial amount of phospho-STAT4 is 
translocated to the nucleus but the addition of ethanol does not lead to a change in translocation 
activity.  
 
 
  Histon 1 
n.c. 
 
Figure 4-25. Phospho-STAT4 analysis of IL-12-induced nuclear translocation in NK-92 cells. NK-92 cells 
were plated and incubated with starvation medium in the absence (n.c.) or presence of 75 ng/ml IL-12 and  
3 different ethanol concentrations. Samples of the nuclear extracts were used for western blotting. The 
antibody used was against phospho-STAT4. Blots were reprobed with the antibody for Histon 1 to 
demonstrate equal loading. The result shown is representative for five independent experiments performed. 
 
 
 
 
 
 
Histone 1 
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4.7.4 IL-12-induced IFN-γ production by NK-92 cells is not mediated by 
AP-1 
The may interact with other transcription factors previous to binding to the IFN-γ promoter to 
enhance its activation. This hypothesis is based on the recent observation that STAT4 interacts with 
c-Jun, a component of AP-1, to activate transcription (Malmgaard et al., 2004). Therefore, we 
examined whether c-Jun is detectable in NK-92 cells and whether IL-12 stimulation is leading to an 
increase in c-Jun Phosphorylation.  
Samples of the cell lysate and nuclear extract were tested. Samples of IL-12 stimulated and 
unstimulated cells were loaded onto the gel. As illustrated in Figure 4-26 AP-1 was not activated 
upon IL-12 stimulation. There was no band (indicating the position of phospho-c-jun) upon 
stimulation neither with nor without IL-12. This held true for the nuclear extracts as well as for the 
cell lysates. In NK-92 cells, IL-12-induced IFN-γ production is not mediated by AP-1.  
 
 
a) 
 
 
b) 
 
 
 
 
c) 
 
d) 
 
  
Figure 4-26. Phospho-c-Jun analysis of IL-12-induced activation of AP-1 in NK-92 cells. NK-92 cells were 
plated and incubated with starvation medium in the absence (n.c.) or presence of 75 ng/ml IL-12. Samples of 
the cell lysate and nuclear extract were used for western blotting. The antibody used was against phospho-c-
Jun. Blots were reprobed with the antibody for GAPDH to demonstrate equal loading. Panel a) cell lysate 
samples of three independent experiments, Panel b) reblot of panel a, Panel c) nuclear extract of four 
independent experiments, Panel d) reblot of panel c for the presence of Histone 1. The arrow indicates the 
position of phospho-c-Jun. 
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4.8 IL-12-induced IFN-γ mRNA expression in NK-92 cells 
4.8.1 Kinetics of IL-12-induced IFN-γ mRNA expression in NK-92 cells 
Since changes in STAT4 phosphorylation and translocation are not responsible for ethanol-induced 
modulation of IFN-γ production the mechanisms behind alcohol-mediated downregulation of 
IFN-γ remains unrevealed. In the following experiments, we assessed the modulation of IFN-γ 
production at the mRNA and protein level.  
To study the kinetics of IL-12-induced mRNA-expression, NK-92 cells were starved for 4 hours, 
replated and stimulated with 75 ng/ml IL-12 for up to 72 hours. In Table 4-18, the result of mRNA 
quantification using real-time PCR as described in Material and Methods are shown. The number of 
IFN-γ mRNA copies is related to those of 18S rRNA resulting in a relative copy number for each 
experiment done.  
Table 4-18. Effect of IL-12 on relative IFN-γ mRNA expression in NK-92 cells. NK-92 cells were 
maintained in starvation medium without IL-12, IL-2, FCS or HS for 4 hours. Cells were replated and the 
medium was partly supplemented with 75 ng/ml IL-12. Samples of the supernatants were collected within 72 
hours and IFN-γ mRNA expression was determined using real-time PCR. Relative number of copies [IFN-
γ/18S rRNA); N: number of cases; SD: standard deviation, SF-test (ANOVA, monofactorial: significance of 
IL-12-stimulation), post hoc test: Tukey’s-test; tF-test (ANOVA, monofactorial): effect of time (72 hours), 
post hoc test: *D-test = Dunnett’s-test (0, 2, 4, 6, 8, 18, 24, 32, 48 and 72 hours vs.  0 h); n.c.: negative 
control; IL-12: cells stimulated with IL-12.  
 relative number of IFN-γ mRNA copies [IFN-γ/18S rRNA] 
n.c. IL-12 
significance of IL-12 
stimulation 
Inc 
[h] 
N 
mean SD Mean SD *Dunnett sF-test ♦Tukey’s-test 
0 8 0.037 0.022 0.037 0.022   
2 4 0.063 0.044 0.129 0.028 0.004 0.047 
4 8 0.021 0.012 0.085 0.036 0.134 <0.001 
6 4 0.058 0.035 0.175 0.057 <0.001 0.013 
8 7 0.017 0.016 0.088 0.048 0.094 0.002 
18 7 0.027 0.030 0.058 0.048 0.930 0.172 
24 4 0.016 0.015 0.056 0.056 0.994 0.227 
32 3 0.007 0.007 0.051 0.027 0.999 0.041 
48 4 0.018 0.025 0.025 0.023 1.000 0.718 
72 3 0.003 0.004 0.016 0.024 0.983 
<0.001 
0.405 
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Between 2 and 8 hours, IL-12 stimulation led to a significant increase in relative IFN-γ mRNA. 
mRNA level at 2 and 6 hours did rise significantly above initial value. Cells not treated with IL-12 
expressed a far smaller amount of mRNA.  
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Figure 4-27. Effect of IL-12 stimulation on relative IFN-γ mRNA expression in NK-92 cells. Cells were 
maintained in starvation medium without IL-2, FCS or HS for 4 hours. Cells were replated and incubated in 
the presence or absence of 75 ng/ml IL-12. Samples were collected within 72 hours and IFN-γ mRNA 
expression was determined using real-time PCR. The results are given as relative copy number [IFN-γ/18S 
rRNA] ± SEM; post hoc test: *Dunnett’s-test (monofactorial, significance of incubation time: 0, 4, 8, 18, 24, 
32 48 and 72 h vs.  0 h); ♦Tukey’s test (multifactorial, significance of IL-12 stimulation, IL-12 versus n.c.); */♦ 
= p-value < 0.05; **/♦♦ = p-value < 0.01; ***/♦♦♦ = p-value < 0.001; n.c.: negative control; IL-12: cells 
stimulated with IL-12.  
 
If we compare the relative copy number (IFN-γ/18S rRNA) at each incubation time point IL-12 
stimulation led to a significant increase of mRNA expression at 2, 6 and 32 hours. At 4 hours of 
incubation, the IFN-γ mRNA expression is highly significant elevated. At six hours of stimulation, 
the mRNA concentration reaches a peak, with levels 3-fold higher compared to unstimulated cells. 
This time point was picked for investigation of ethanol-mediated changes in mRNA expression of 
NK-92 cells. 
The mentioned results on the effect of IL-12 stimulation on IFN-γ mRNA expression of NK-92 
cells are given in Figure 4-27. 
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4.8.2 Effect of ethanol on IL-12-induced IFN-γ mRNA expression 
in NK-92 cells 
To investigate the intracellular mechanism of ethanol-driven downregulation of IFN-γ production 
by NK-92 cells, we examined whether ethanol (22 mM, 44 mM and 66 mM) could suppress 
expression of IFN-γ mRNA expression after IL-12 stimulation in 4 hour-starved NK cells. First, 
RT-PCR was performed with total RNA extracts from cells stimulated and ethanol-treated for 6 
and 18 hours. IFN-γ mRNA transcripts were quantified in relative units compared to 18S rRNA 
transcripts for each culture condition. As expected, IL-12 enhanced IFN-γ mRNA expression 6 
hours after incubation start, which is consistent with previous experiments. Surprisingly, however, 
ethanol did not lower expression of IFN-γ mRNA.  
Thus, these results imply that suppression of IFN-γ production by NK-92 cells exposed to ethanol 
is not attributable to decreased IFN-γ gene transcription. The results are shown in Table 4-19 and 
Figure 4-28. 
To examine long-term effects of ethanol on the IFN-γ -mRNA-expression RT-PCR was performed 
with total RNA extracts from cells stimulated and ethanol-treated for 18 hours. IFN-γ mRNA 
transcripts were quantified in relative units compared to 18S rRNA transcripts for each culture 
condition. In NK-92 incubated for 18 hours with IL-12 and ethanol no significant effect of IL-12 
stimulation occurred between negative control and positive control (p = 0.535). Additionally 
ethanol incubation caused no change in IFN-γ expression (see Table 4-20). 
Table 4-19. Effect of ethanol on IL-12-induced IFN-γ mRNA expression by NK-92 cells (6 hours). NK-92 
cells were maintained in starvation medium without IL-2, FCS or HS for 4 hours. Cells were replated and the 
medium was supplemented with or without 75 ng/ml IL-12 and without or with 1, 2, or 3 ‰ ethanol. 
Samples were collected 6 hours after incubation start and relative IFN-γ mRNA copy number was 
determined via real-time PCR. Results are given as relative number of IFN-γ mRNA copies [IFN-γ/18S 
rRNA] ± SD; eF-test ANOVA, (monofactorial, significance of ethanol incubation); post hoc test: *Tukey’s 
test (IL-12 versus IL-12 + 1, 2 or 3 ‰, and n.c.)  
 relative number of IFN-γ mRNA copies [IFN-γ/18S rRNA] 
 significance of ethanol concentration 
ethanol 
concentration 
[‰] 
N mean SD 
eF-
test 
p 
(Tukey’s) 
vs.  0 ‰ 
p 
(Tukey’s) 
vs.  1 ‰ 
p 
(Tukey’s) 
vs.  2 ‰ 
p 
(Tukey’s) 
vs.  3 ‰ 
n.c. 4 0.058 0.035  0.038 0.168 0.306 0.133 
0 4 0.175 0.057  0.863 0.673 0.914 
1 4 0.145 0.058   0.983 0.999 
2 4 0.131 0.027    0.959 
3 4 0.150 0.068 
0.719 
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Table 4-20. Effect of ethanol on IL-12-induced IFN-γ mRNA expression by NK-92 cells (18 hours). NK-92 
cells were maintained in starvation medium without IL-2, FCS or HS for 4 hours. Cells were replated and the 
medium was supplemented partly with 75 ng/ml IL-12 and with 1, 2, or 3 ‰ ethanol. Samples were collected 
after 18 h and relative IFN-γ mRNA copy numbers were determined via real-time PCR. Results are given as 
relative numbers of IFN-γ mRNA copies [IFN-γ/18S rRNA] ± SD; eF-test ANOVA, (monofactorial, 
significance of ethanol incubation); post hoc test: *Tukey’s test (IL-12 versus IL-12 + 1, 2 or 3 ‰, and n.c.)  
 relative number of IFN-γ mRNA copies [IFN-γ/18S rRNA] 
 significance of ethanol concentration 
ethanol 
concentration 
[‰] 
N mean SD eF-test 
n.c. 7 0.027 0.030 
0 7 0.058 0.048 
1 3 0.039 0.040 
2 4 0.050 0.043 
3 4 0.076 0.075 
0.535 
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Figure 4-28. Effect of ethanol on IL-12-induced IFN-γ mRNA expression by NK-92 cells (6 hours). NK-92 
cells were maintained in starvation medium without IL-12, IL-2, FCS or HS for 4 hours. Cells were replated 
and the medium was partly supplemented with 75 ng/ml IL-12 and with 1, 2 or 3 ‰ ethanol. Samples were 
collected after 6 h and relative IFN-γ mRNA copy numbers were determined via real-time PCR. Results are 
given as relative numbers of IFN-γ mRNA copies [IFN-γ/18S rRNA] ± SEM eF-test ANOVA, 
(monofactorial, significance of ethanol incubation); post hoc test: *Tukey’s test (IL-12 versus IL-12 + 1, 2 or 
3 ‰, and n.c.) 
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4.9 Intracellular IFN-γ concentration of  NK-92 cells  
4.9.1 Effect of IL-12 on intracellular IFN-γ concentration of NK-92 cells 
Since there were no changes on mRNA-level of ethanol-treated NK-92 cells, we sought to 
determine intracellular IFN-γ concentrations in order to investigate whether the low protein 
concentrations in cell supernatant of alcohol-incubated cells were due to intracellular accumulation 
causing an ethanol-induced decrease of IFN-γ secretion into incubation medium. 
In a first step, the intracellular changes of IFN-γ concentration upon IL-12 activation were 
determined.  
Table 4-21. Effect of IL-12 on intracellular IFN-γ concentration of NK-92 cells. NK-92 cells were 
maintained in starvation medium for 16 hours. Cells were replated and incubated in the absence or presence 
of 75 ng/ml IL-12 for 24 hours. Cell lysates were used for measurement of IFN-γ levels via ELISA and 
related to the total protein content. a) absolute mean values; b) relative mean values (IL-12, 14 hours = 100 
%); N: number of cases; SD: standard deviation, Inc.: incubation; SF-test (ANOVA, bifactorial): significance 
of IL-12 stimulation, tF-test (ANOVA, monofactorial): effect of time (24 hours), n.c.: negative control; IL-12: 
cells stimulated with IL-12.  
a IFN-γ  mean [pg/mg protein] 
n.c. IL-12 significance of IL-12 stimulation Inc 
[h] 
N 
mean SD mean SD tF-test sF-test 
0 10 195 223 195 223 
6 10 165 184 277 354 
8 10 183 120 356 443 
10 10 151 76 319 273 
12 10 180 73 410 322 
14 10 194 95 395 274 
24 10 301 206 495 457 
0.573 0.864 
 
b IFN-γ mean [%] 
n.c. IL-12 significance of IL-12 stimulation 
Inc N 
mean SD mean SD tF-test sF-test 
0 10 52 36 52 36 
6 10 42 31 65 55 
8 10 57 28 98 79 
10 10 47 28 90 54 
12 10 66 46 99 22 
14 10 63 29 100 24 
24 10 87 47 113 75 
0.147 0.796 
 
 
 
  
4  RESULTS  1 29   
Incubation time had no significant effect on mean values of intracellular IFN-γ level, neither with 
respect to the absolute, nor to the relative data (absolute mean value of intracellular IFN-γ level at 
14 hours upon IL-12 stimulation set to 100 %). Intracellular IFN-γ levels remained nearly constant 
within the incubation time. Bifactorial ANOVA (incubation time/IL-12 stimulation) indicated a 
significant effect of IL-12 stimulation neither on the absolute nor on the relative mean values of 
intracellular IFN-γ concentration. Table 4-21 and Figure 4-29 comprises the relative and absolute 
mean values of intracellular IFN-γ level of IL-12 stimulated and unstimulated NK-92 cells, as well 
as of statistical analysis as mentioned above. 
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Figure 4-29. Effect of IL-12 on intracellular IFN-γ concentration of NK-92 cells. NK-92 cells were 
maintained in starvation medium for 16 hours. Cells were replated and incubated in the absence or presence 
of 75 ng/ml IL-12 for 24 hours. Cell lysates were used for measurement of IFN-γ levels via ELISA and 
related to the protein content. Top: Results are given as absolute mean values Bottom: Relative mean values 
± SEM; N: number of cases; SF-test (ANOVA, multifactorial: significance of IL-12 stimulation, tF-test 
(ANOVA, monofactorial: effect of time), n.c.: negative control; IL-12: cells stimulated with IL-12.  
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4.9.2 Effect of ethanol on intracellular IFN-γ concentration of IL-12 
stimulated NK-92 cells  
Next, we investigated whether the ethanol-driven suppression of IFN-γ production from NK-92 
cells was due to inhibition of IFN-γ secretion.  
Incubation time had no significant effect on the absolute mean values of intracellular IFN-γ level of 
NK-92 cells incubated in the presence of IL-12 and either with 1, 2 or 3‰ ethanol (4.9.1).  
No differences were indicated comparing absolute mean values of intracellular IFN-γ level of NK-
92 cells upon IL-12 stimulation with those upon combined incubation with IL-12 and 1, 2, or 3 ‰ 
ethanol (Table 4-22, Figure 4-30). We therefore conclude that ethanol did not affect the 
intracellular IFN-γ concentration.  
When evaluating data relatively (absolute mean value of intracellular IFN-γ concentration at 14 
hours of IL-12 stimulated NK-92 cells set to 100 %), incubation time had no significant effect on 
the relative mean values of intracellular IFN-γ concentration of NK-92 cells incubated in the 
presence of IL-12 and 1 ‰ ethanol. Regarding the combined incubation of NK-92 cells with IL-12 
and 2 or 3 ‰ ethanol, incubation time had a significant effect on the relative mean values of 
intracellular IFN-γ level. With respect to incubation with 2‰ ethanol, the relative mean values of 
intracellular IFN-γ level were significantly higher at 12 and 24 hours compared to the initial value. 
With respect to 3‰ ethanol, the relative mean values of intracellular IFN-γ level at 14 and 24 hours 
were significantly higher than the initial value. 
Nevertheless, no significant differences were found comparing the relative mean values of 
intracellular IFN-γ level of exclusively IL-12 stimulated NK-92 cells, with those of the ethanol-
treated cells throughout total incubation time of 24 hours.  
Results on the effect of ethanol on intracellular IFN-γ concentration of IL-12 stimulated NK-92 
cells are given in Table 4-22 and are diagrammed in Figure 4-30. 
Based on these measurements, it appeared that the ethanol-induced suppression of IFN-γ 
production was not mediated through interference with IFN-γ secretion. Cells stimulated with  
IL-12 exclusively or with additional ethanol treatment did not react with significant changes of 
intracellular IFN-γ protein content. We therefore conclude that NK-92 cells keep a constant pool 
of cytokine; higher mRNA expression leading to higher protein biosynthesis is correlated with 
higher IFN-γ secretion. 
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Table 4-22. Effect of ethanol on intracellular IFN-γ concentration of IL-12 stimulated NK-92 cells. NK-92 
cells were maintained in starvation medium without IL-12, IL-2, FCS or HS for 16 hours. Cells were replated 
and incubated with medium supplemented with or without 75ng/ml IL-12 and with or without 1, 2, or 3 ‰ 
ethanol within 24 hours. Samples of the cell lysate were collected and IFN-γ was determined via ELISA and 
related to the protein content. Table a) absolute mean values; Table b) relative mean values (IL-12, 14 hours 
= 100 %); N: number of cases; SD: standard deviation; tF-test (ANOVA, monofactorial) effect of time, post 
hoc test: *D-test= Dunnett’s-test (6, 8, 10, 12, 14, 24 hours versus 0 h); eF-test (ANOVA, monofactorial) 
significance of ethanol treatment (IL-12 versus IL-12 + 1, 2, or 3 ‰); IL-12: cells stimulated with IL-12; IL-
12 + 1, 2 or 3 ‰: cells incubated with IL-12 and either 1, 2, or 3 ‰ ethanol. 
a absolute IFN-γ concentration [pg/ml] 
IL-12 1 ‰ IL-12 2 ‰ IL-12 3 ‰ 
IFN-γ 
effect of 
time 
IFN-γ 
effect of 
time 
IFN-γ 
effect of 
time 
significance 
of ethanol 
Inc 
[h] 
N 
mean SD tF-test mean SD tF-test mean SD tF-test eF-test 
0 10 195 223 195 223 195 223 1.000 
6 10 344 460 266 337 340 490 0.961 
8 10 376 462 166 107 387 500 0.674 
10 10 421 321 418 428 504 490 0.768 
12 10 487 447 560 425 580 513 0.812 
14 10 493 421 503 531 599 544 0.801 
24 10 543 469 
0.559 
703 628 
0.059 
551 468 
0.434 
0.817 
 
b relative IFN-γ concentration [pg/ml] 
IL-12 1 ‰ IL-12 2 ‰ IL-12 3 ‰ 
IFN-γ 
effect 
of 
time 
IFN-γ effect of time IFN-γ 
effect of 
time 
significance 
of ethanol Inc 
[h] 
N 
mean SD 
tF-
test 
mean SD tF-test 
*D-
test 
mean SD 
tF-
test 
*D-
test 
eF-test 
0 10 52 36 52 36 - 52 36  1.000 
6 10 88 79 59 51 1.000 70 80 0.988 0.793 
8 10 93 75 56 21 1.000 91 81 0.731 0.603 
10 10 109 34 98 44 0.458 112 47 0.329 0.692 
12 10 116 47 142 49 0.022 138 55 0.070 0.140 
14 10 114 36 127 75 0.078 145 70 0.043 0.337 
24 10 146 109 
0.078 
176 131 
<0.001 
0.001 181 133 
0.006 
0.002 0.529 
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Figure 4-30. Effect of ethanol on intracellular IFN-γ concentration of IL-12 stimulated NK-92 cells. NK-92 
cells were maintained in starvation medium without IL-12, IL-2, FCS or HS for 16 hours. Cells were replated 
and the medium was supplemented with or without 75 ng/ml IL-12 and with or without 1, 2, or 3 ‰ ethanol 
for 24 hours. Samples of the cell lysate were used for measurement of IFN-γ via ELISA. IFN-γ levels were 
related to the protein content. Results are given as relative mean values ± SEM (IL-12, 14 hours = 100 %), 
ANOVA (monofactorial, significance of incubation time), post hoc test: *Dunnett’s-test (6, 8, 10, 12, 14, 24 
hours versus 0 h) * = p-value < 0.05; **= p-value < 0.01; *** = p-value < 0.001; n.c.: negative control; IL-12: 
cells stimulated with IL-12; IL-12 + 1, 2 or 3 ‰: cells incubated with IL-12 and either 1, 2, or 3‰ ethanol. 
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4.10 Detectability of  IFN-γ in the presence ethanol-treated 
NK-92 cells or their cell-free supernatant 
Since no significant difference occurred in mRNA expression and intracellular accumulation of 
IFN-γ, we asked whether ethanol treatment is leading to a more rapid degradation of IFN-γ once 
released from NK-92 cells instead of a lower production by the cells themselves. To address this 
question, cells were kept in starvation medium containing 2.5 % FCS for four hours at a density of 
2.5 × 106 cell/ml. At the end of starvation phase, cells were spinned down and resuspended in new 
medium containing 2.5 % FCS. Cells and cell culture supernatant were replated in 24 well plates. To 
examine the detectability of IFN-γ, recombinant human IFN-γ was supplemented to the cell-free 
supernatant at a concentration of 2 ng/ml and samples were taken at 0, 10 and 70 min upon IFN-γ 
addition. 
Table 4-23. Effect of ethanol on the detectability of IFN-γ in presence of the cell-free supernatant of NK 92 
cells. Absolute data. NK-92 cells were maintained in starvation medium for 4 hours. Cells were pretreated 
with different ethanol concentrations (1, 2, or 3 ‰), spinned down and cell culture supernatant was replated 
in 24 well plates and supplemented with 2 ng/ml human recombinant IFN-γ. Samples of the supernatants 
were collected and IFN-γ was determined via ELISA. Table a) absolute mean values ± SD; Table b) eF-test 
(ANOVA, monofactorial): significance of ethanol, post hoc test: #Tukey’s-test (0 versus 1, 2, or 3 ‰). 
a absolute IFN-γ concentration [pg/ml] 
0 ‰ 1 ‰ 2 ‰ 3 ‰ Inc 
[min] 
N 
mean SD mean SD mean SD mean SD 
10 8 1512 458 175 89 49 16 47 16 
70 8 1537 452 327 216 66 25 56 15 
 
b  
significance of ethanol concentration 
Inc 
[min] eF-test 
#Tukey’s test: 
p.c. vs. 1 ‰ 
#Tukey’s test: 
p.c. vs. 2 ‰ 
#Tukey’s test: 
p.c. vs. 3 ‰ 
10 <0.001 <0.001 <0.001 <0.001 
70 <0.001 <0.001 <0.001 <0.001 
 
The preincubation of NK-92 cells with 1, 2 or 3 ‰ ethanol had a highly significant effect on the 
detectability of IFN-γ in the cell-free supernatant at 10 and 70 min compared to the supernatant of 
cells without ethanol treatment (see Table 4-23 and Figure 4-31). 
To reevaluate the results, absolute data were transformed into relative data. The absolute IFN-γ 
concentration at 0 minutes was set to 100 % (see Table 4-24 and Figure 4-32).  
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Table 4-24. Effect of ethanol on the detectability of IFN-γ in presence of the cell-free supernatant of NK 92 
cells. Relative data. NK-92 cells were maintained in starvation medium for 4 hours. Cells were treated with 
different ethanol concentrations, spinned down and cell culture supernatant was replated in 24 well plates and 
supplemented with 2 ng/ml human recombinant IFN-γ (0 min = 100 %). Samples of the supernatants were 
collected and IFN-γ was determined via ELISA. Table a) relative mean values ± SD; Table b) eF-test 
(ANOVA, monofactorial): significance of ethanol, post hoc test: #Tukey’s test (p.c. versus 1, 2, or 3 ‰). 
a relative IFN-γ concentration [pg/ml] 
IL-12 0 ‰ IL-12 1 ‰ IL-12 2 ‰ IL-12 3 ‰ Inc 
[min] 
N 
mean SD mean SD mean SD mean SD 
10 8 76.3 24.9 8.28 3.13 2.6 1.18 2.52 1.31 
70 8 79.1 31.4 14.6 7.14 3.31 1.07 9.55 19.4 
 
b  
significance of ethanol concentration 
Inc 
[min] eF-test 
#Tukey’s test: 
p.c. vs. 1 ‰ 
#Tukey’s test: 
p.c. vs. 2 ‰ 
#Tukey’s test: 
p.c. vs. 3 ‰ 
10 <0.001 <0.001 <0.001 <0.001 
70 <0.001 <0.001 <0.001 <0.001 
 
As seen in absolute data, relative data emphasize the rapid changes in the concentration of IFN-γ in 
cell supernatant of ethanol-treated NK-92 cells compared to the concentration of IFN-γ in the 
supernatant of untreated NK-92 cells. The results in Table 4-23 and Figure 4-31 document that the 
loss of IFN-γ in cell-free supernatant of ethanol-treated NK-92 cells already appeared 10 min after 
addition of human recombinant IFN-γ. Suggesting, that ethanol-treated cells release a substance 
that is able either to bind or to degrade IFN-γ. The same holds true at 70 min, where the 
concentration of IFN-γ tended to be slightly higher compared to the 10-min-values (Table 4-23). 
This effect is not seen in incubation experiments where ethanol-treated cells were separated from 
their supernatant and resuspended in new cell culture medium. The results of these experiments are 
shown in Table 4-25 as absolute and in Table 4-26 as relative data and depicted in Figure 4-31 and 
4-32. 
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Table 4-25. Effect of ethanol on the detectability of IFN-γ in presence of NK 92 cells. Absolute data. NK-
92 cells were maintained in starvation medium for 4 hours. Cells were treated with different ethanol 
concentrations, spinned down, resuspended in new medium and replated in 24 well plates and supplemented 
with 2 ng/ml human recombinant IFN-γ. Samples of the supernatants were collected and IFN-γ was 
determined via ELISA. Table a) absolute mean values ± SD; Table b) eF-test (ANOVA, monofactorial): 
significance of ethanol, post hoc test: #Tukey’s test (p.c. versus 1, 2, or 3 ‰). 
a absolute IFN-γ concentration [pg/ml] 
0 ‰ 1 ‰ 2 ‰ 3 ‰ Inc 
[h] 
N 
mean SD mean SD mean SD mean SD 
10 8 1524 782 1528 746 1557 696 1607 478 
70 8 1617 838 1735 806 1633 781 1830 523 
 
b  
significance of ethanol 
Inc [h] 
eF-test 
#Tukey’s test: 
p.c. vs. 1 ‰ 
#Tukey’s test: 
p.c. vs. 2 ‰ 
#Tukey’s test: 
p.c. vs. 3 ‰ 
10 0.999 1 1 0.9999 
70 0.935 0.9999 1 0.9988 
 
Table 4-26. Effect of ethanol on the detectability of IFN-γ in presence of NK 92 cells. Relative data. NK-92 
cells were maintained in starvation medium for 4 hours. Cells were treated with different ethanol 
concentrations, spinned down and cell were replated in 24 well plates and supplemented with 2 ng/ml human 
recombinant IFN-γ (0 min = 100 %). Samples of the supernatants were collected and IFN-γ was determined 
via ELISA. Table a) relative mean values ± SD; Table b) eF-test (ANOVA, monofactorial): significance of 
ethanol, post hoc test: #Tukey’s test (p.c. versus 1, 2, or 3 ‰). 
a relative IFN-γ concentration [%] 
0 ‰ 1 ‰ 2 ‰ 3 ‰ Inc 
[min] 
N 
mean SD mean SD mean SD mean SD 
10 8 78.6 45 78.1 42.2 79 37.7 82.6 32.5 
70 8 81.7 43.3 87.3 40.4 82.0 38.6 92.8 30.5 
 
b  
significance of ethanol 
Inc 
[min] eF-test 
#Tukey’s test: 
p.c. vs. 1 ‰ 
#Tukey’s test: 
p.c. vs. 2 ‰ 
#Tukey’s test: 
p.c. vs. 3 ‰ 
10 0.996 0.999 0.999 0.997 
70 0.930 0.991 0.999 0.939 
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In comparison to the results seen in cell-free supernatant, the concentration of IFN-γ remained 
stable when added to ethanol-treated NK-92 cells, separated from their incubation medium and 
resuspended in new cell culture medium. The fact that ethanol-treated cells are not the reason for 
the loss of IFN-γ, negate a mechanism by which the once released IFN-γ is re-uptaken by NK-92 
cell as a consequence of ethanol preincubation.  
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Figure 4-31. Comparison of the ethanol-mediated detectability of IFN-γ in presence of the cell-free 
supernatant (top) or ethanol-treated NK-92 cells (bottom). After 4 hours of starvation, cells were treated with 
different ethanol concentrations, spinned down and cell culture supernatant was separated from NK-92 cells. 
Both cell supernatant and resuspended cells were replated and supplemented with 2 ng/ml human 
recombinant IFN-γ. Samples of the supernatants were collected and IFN-γ was determined via ELISA. 
Absolute mean values ± SEM; eF-test (ANOVA, monofactorial): significance of ethanol, post hoc test: 
#Tukey’s test (p.c. versus 1, 2, or 3 ‰), ### = p-value < 0.001  
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Figure 4-32. Comparison of the ethanol-mediated detectability of IFN-γ in presence of the cell-free 
supernatant of NK 92 cells (top) or ethanol-treated NK-92 cells (bottom). NK-92 cells were maintained in 
starvation medium for 4 hours. Cells were treated with different ethanol concentrations, spinned down and 
cell culture supernatant was separated from NK-92 cells. Both cell supernatant and resuspended cells were 
replated in 24 well plates and supplemented with 2 ng/ml human recombinant IFN-γ. Samples of the 
supernatants were collected and IFN-γ was determined via ELISA. Relative mean values ± SEM; eF-test 
(ANOVA, monofactorial): significance of ethanol, post hoc test: #Tukey’s test (p.c. versus 1, 2, or 3 ‰), ### 
= p< 0.001. 
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4.11 Ethanol-induced secretion of  soluble IFN-γ receptor 
The result of the former experiment suggests a mechanism, in which once released IFN-γ is either 
bound or degraded by an unknown soluble protein that is secreted by ethanol-treated NK-92 cells. 
The fact that soluble cytokine receptors are a possible way to regulate cytokine signaling, we 
hypothesized that this also may be the case in ethanol-treated NK-92 cells.  
In the following, we used two different approaches to investigate the change of soluble cytokine 
receptors in the supernatant of NK-92 cells incubated with different ethanol concentrations. 
First, we used IFN-γ receptor antibody to prevent binding of IFN-γ protein by the soluble 
receptor. Second, we used a commercially available ELISA kit to measure IFN-γ receptor 1 
concentration in NK-92 cell supernatants. 
 
4.11.1 Effect of IFN-γ receptor antibody on the ethanol-mediated change 
of IFN-γ concentration in NK-92 cell supernatant 
The addition of IFN-γ receptor antibody was used to investigate if the ethanol incubation of  
NK-92 cells leads to an increase in soluble cytokine receptor, which is able specifically to bind  
IFN-γ released from NK-92 cells. 
To address this question, cells were kept in starvation medium containing 2.5 % FCS for four hours 
at a density of 2.5 × 106 cell/ml. At the end of starvation phase, cells were treated with 3 different 
ethanol concentrations for 10 min, cells were spinned down and cell culture supernatant was 
replated in 24-well plates. In a next step, IFN-γ receptor antibody was added at a concentration of  
2 ng/ml and incubated for 1 h to allow receptor/antibody binding. To examine whether the 
addition of IFN-γ receptor antibody changed the amount of IFN-γ detectable in cell culture 
supernatant of ethanol-treated NK-92 cells, recombinant human IFN-γ was supplemented at a 
concentration of 2 ng/ml and samples were taken at 10 min upon IFN-γ addition. 
The addition of IFN-γ receptor 1 antibody had no effect on the concentration of IFN-γ in cell-
supernatants of ethanol-pretreated NK-92 cells. IFN-γ detectability in supernatants of NK-92 cells 
that underwent a pretreatment with ethanol at concentrations of 44 mM remained low (~12 %) 
compared to supernatants of untreated NK-92 in the presence or absence of the IFN-γ receptor 
antibody  (see Table 4-27 and Figure 4-33). 
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Table 4-27. Effect of IFN-γ R1 ab addition on the detectability of IFN-γ in cell supernatants of ethanol-
treated NK 92 cells. NK-92 cells were maintained in starvation medium for 4 hours. Cells were treated with 
different ethanol concentrations, spinned down and cell culture supernatant was replated in 24 well plates,  
2 ng/ml IFN-γ R1 ab was added. Incubation lasted 1 h, followed by a supplementation with 2 ng/ml human 
recombinant IFN-γ. Samples of the supernatants were collected and IFN-γ was determined via ELISA. 
Absolute mean values ± SD; eF-test (ANOVA, monofactorial): significance of ethanol, post hoc test: #T-test 
= #Tukey’s test (0 versus 2 ‰) abF-test (ANOVA, monofactorial): significance of antibody incubation. 
 absolute IFN-γ concentration [pg/ml] 
 0 ‰  2 ‰ 
significance of 
ethanol 
significance of 
antibody incubation N ab 
mean SD mean SD eF-test #T-test abF-test 
15 – 633 380 74 33 <0.001 
9 + 861 253 112 77 
<0.001 
<0.001 
0.116 
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Figure 4-33. Effect of IFN-γ R1 ab addition on the detectability of IFN-γ in cell supernatants of ethanol-
treated NK 92 cells. NK-92 cells were maintained in starvation medium for 4 hours. Cells were treated with 
different ethanol concentrations, spinned down and cell culture supernatant was replated in 24 well plates, 
2 ng/ml IFN-γ R1 ab was added. Incubation lasted 1 h, followed by a supplementation with 2 ng/ml human 
recombinant IFN-γ. Samples of the supernatants were collected and IFN-γ was determined via ELISA. 
Absolute mean values ± SEM. 
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4.11.2 Effect of ethanol on the IFN-γ receptor 1 concentration in NK-92 
cell supernatant 
Since the question remained whether the affinity of IFN-γ to the soluble receptor was higher then 
that of soluble receptor/receptor antibody complexes, the second approach to measure IFN-γ 
receptor concentrations in cell supernatants of ethanol-treated NK-92 cells was a direct method, 
using a commercial available ELISA kit for the IFN-γR1 chain. 
To investigate the effect of ethanol on the concentration of IFN-γ receptor subunit R1 
concentration in cell supernatants, NK-92 cells were kept in starvation medium containing 2.5 % 
FCS for four hours at a density of 2.5 × 106 cell/ml. At the end of starvation phase, cells were 
treated with 3 different ethanol concentrations for 10 min, cells were spinned down and cell culture 
supernatant was collected for ELISA assay. 
Table 4-28. Effect of ethanol on the IFN-γ receptor antibody concentration in NK-92 cell supernatant.  
NK-92 cells were maintained in starvation medium for 4 hours. Cells were treated with different ethanol 
concentrations, spinned down, samples of the supernatants were collected, and IFN-γR1 concentration was 
determined via ELISA. Absolute mean values ± SD; eF-test (ANOVA, monofactorial): significance of 
ethanol 
 absolute IFN-γ R1 concentration [pg/ml] 
 significance of ethanol concentration 
ethanol 
concentration [‰] 
N mean SD eF-test 
0 4 40 35 
1 4 85 65 
2 4 115 57 
3 4 99 52 
0.279 
  
Direct measurement of IFN-γ receptor 1 concentration in cell supernatants of ethanol-treated NK-
92 cells in the presence of ethanol had no significant effect on the secretion of soluble IFN-γ 
receptor, though there is a tendency to higher receptor subunit 1 concentrations in cell supernatants 
of NK cells incubated with 3 different ethanol concentrations (Table 4-28 and Figure 4-34).  
The results on the IFN-γR1 concentration in the supernatant of NK-92 cells reflect the data of 
experiments done with IFN-γ receptor antibody (see Table 4-27 and Figure 4-33). 
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Figure 4-34. Effect of ethanol on the IFN-γ receptor antibody concentration in NK-92 cell supernatant. 
NK-92 cells were maintained in starvation medium for 4 hours. Cells were treated with different ethanol 
concentrations, spinned down, samples of the supernatants were collected and IFN-γR1 concentration was 
determined via ELISA. Absolute mean values ± SEM. 
 
In summary, the concentration of IFN-γR1 concentration was extremely low and the changes of 
IFN-γR1 cannot serve as an explanation for the fact that the supplementation with 2000 pg/ml 
human recombinant IFN-γ is practically not longer detectable anymore in the supernatants of 
ethanol-incubated cells. 
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4.12 Effect of  a protease inhibitor cocktail on the ethanol-
mediated change of  IFN-γ concentration in NK-92 cell 
supernatant 
Instead of binding to a specific protein, IFN-γ loss in supernatants of ethanol-treated NK-92 cells 
could be due to extracellular proteolysis. Another posttranslational mechanism by which once 
released cytokines are modulated. Since human mononuclear cells express an array of serine and 
metal dependent proteinases that are under complex developmental control and are also highly 
regulated by physiologic and pharmacologic stimuli, we hypothesized whether an increase in IFN-γ 
extracellular degradation by proteolytic enzymes is a result of ethanol incubation. If so, inhibition of 
proteases, followed by IFN-γ addition to cell supernatants of ethanol-treated NK-92 cells should 
abolish the dramatic decrease of IFN-γ concentration seen in preparations containing ethanol. 
To confirm this hypothesis, cells were kept in starvation medium for four hours. At the end of 
starvation phase, cells were treated with 3 different ethanol concentrations for 10 min and cell 
culture supernatants were replated in 24-well plates. In a next step, a protease inhibitor cocktail was 
added. To examine whether the addition of a mixture of inhibitors of proteolytic degradation 
changed the amount of IFN-γ detectable in cell culture supernatant of ethanol-treated NK-92 cells, 
recombinant human IFN-γ was supplemented at a concentration of 2 ng/ml. Samples were probed 
of IFN-γ after 10 min of incubation. 
Table 4-29. Effect of a commercially available protease inhibitor cocktail on the IFN-γ concentration in cells 
supernatants of ethanol-incubated NK-92 cells, supplemented with 2 ng/ml human recombinant IFN-γ. Cells 
were starved for 4 hours, treated with ethanol, spinned down, protease inhibitor cocktail was added, samples 
of the supernatants were collected and IFN-γ concentration was determined via ELISA. Absolute mean 
values ± SD; InhF-test (ANOVA) effect of protease inhibitor cocktail; post hoc test hoc test: #t-test (effect of 
inhibitor cocktail for each ethanol concentration) ### = p< 0.001. 
 absolute IFN-γ concentration (pg/ml) 
 effect of protease inhibitor cocktail 
ethanol 
[‰] 
N Inhibitor mean SD InhF-test #t-test (Student) 
8 – 1806 181 
0 
8 + 1841 99 
1.000 
8 – 1618 225 
1 
8 + 1748 115 
0.868 
8 – 399 273 
2 
8 + 1846 241 
<0.001 
8 – 149 32 
3 
8 + 1889 224 
<0.001 
<0.001 
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The addition of protease inhibitor cocktail inhibited the ethanol-induced decrease of IFN-γ 
concentration compared to preparations without inhibitor when cells were treated with 2 and 3 ‰ 
(Table 4-29 and Figure 4-35). We therefore assume that ethanol incubation is leading to a rapid 
release of proteases by NK-92 cells. 
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Figure 4-35. Effect of a commercially available protease-inhibitor cocktail on the IFN-γ concentration in 
cells supernatants of ethanol-pretreated NK-92 cells, supplemented with 2 ng/ml human recombinant IFN-γ. 
Absolute mean values ± SEM; InhF-test (ANOVA, monofactorial): significance of the addition of a 
commercially available protease inhibitor cocktail; post hoc test: #Tukey’s test (effect of inhibitor for each 
ethanol concentration) ### = p< 0.001. 
  ###   ### 
 5 Discussion 
 
5.1 Different cells as a model to investigate IFN-γ 
expression 
5.1.1 Isolated human Peripheral Blood Mononuclear Cells (PBMC) 
The model system of activated PBMCs has been well established in clinical immunology for several 
decades and allows standardization of T cell activation and T cell–macrophage interaction. It is 
certainly more informative than using cell lines alone and more relevant for in vivo testing. Our 
approach has already been used for testing ethanol effects for more than 5 years with very 
reproducible results even among cytokine assays of blood from different donors. PBMC 
preparations provide insight into signaling cascades, especially those initiated by T cells. Moreover, 
this strategy monitors the net effect of various pro- and antiinflammatory cascades initiated during 
stimulated immune response in vitro and provides data on the influence of tested compounds on the 
whole cascade of events (Winkler et al., 2006).  
The Th1-type cytokine Interferon-γ was predominantly affected by ethanol and besides that is an 
important proinflammatory mediator, which is pivotal in inflammation and highly relevant in the 
pathogenesis of alcohol-induced processes. Additionally, seven other cytokines were determined to 
study alcohol-mediated effects.  
Accordingly, we investigated human peripheral blood mononuclear cells (PBMC) freshly isolated 
from whole blood of healthy donors and stimulated them with a mitogen (PHA) or LPS. We found 
a concentration of 2 µg PHA or 1 µg LPS per ml was optimal for cell activation, proliferation 
and/or cytokine production. The concentrations of IFN-γ, TNF-α TGF-β, IL-2, IL-10, IL-12 IL-
18 and IP-10, secreted by PHA-activated or LPS-challenged PBMC from healthy individuals were 
determined and compared with those treated with different ethanol concentrations. 
However, it has to be taken into consideration that cytokine production by immunocompetent cells 
investigated by using multistep procedures to isolate blood cells, may lead to uncontrolled cell 
activation, a change in the ratio between lymphocytes and monocytes, and deprive cells of exposure 
to essential cellular and molecular components present in whole blood. In whole blood, natural 
cell–cell interactions are preserved but also circulating stimulatory and inhibitory mediators, such as 
soluble receptors, are present at their physiological concentrations (Godoy-Ramirez et al., 2004).  
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5.1.2 NK-92 cells in culture 
Cytotoxicity mediated by NK cells has been hypothesized to play an important role in host’s 
defense. Human NK cells are an immunophenotypically distinguishable subset of lymphocytes that 
exhibits a striking capacity to destroy tumor cells and virally infected cells. This cytotoxic activity 
does not require prior sensitization and is not restricted by MHC antigens. The development and 
functional activity of NK cells are regulated by many cytokines, including IL-2, a cytokine initially 
identified as T cell growth factor. IL-2 stimulates the proliferation of both T cells and NK cells. 
However, in NK cells, IL-2 has the additional effect of augmenting cytotoxic function, similar to 
the effect of IL-12. On the other hand, NK cells are a major source of Interferon γ, whose 
importance as an immunmodulatory cytokine has already been described (Ahmad et al., 2005). 
Both, enriching the NK cell fractions without comprising their biological activity and obtaining 
pure NK cells without contaminating T cells or other immune-response effector cells, limit studies 
of the mechanisms whereby NK cells exert their tumoricidal effects and maintain their cytokine 
production. To avoid these problems, many investigators have used established NK-derived cell 
lines to explore the biological mechanisms of cytotoxicity and IFN-γ expression. 
The NK-92 cell line is a established human NK cell clone, originally derived from a human non-
Hodgkin’s lymphoma with the morphology of large granular lymphocytes and a CD56+CD3–
CD16– immunophenotype. As a rhIL2-dependent cell line, NK-92 cells retain the characteristics of 
activated human NK cells (Yan et al., 2006). 
The NK-92 cell line was used as a model within the current study because of its similarity to 
primary human NK cells with respect to changes in IFN-γ production in response to IL-2 and  
IL-12 (Hodge et al., 2002).  
The proliferation of NK-92 cells depends on IL-2, and NK-92 cells express the cell surface marker 
CD56 bright indicating the subpopulation of natural killer cells that are specialized in the production 
of cytokines such as IFN-γ (Cooper et al., 2001).  
Since NK-92 cells are IL-2 dependent, cells were maintained in α-modification of Eagle’s Medium 
supplemented with 12.5 % fetal calf serum, 12.5 % horse serum and 10 ng/ml IL-2. Cell viability 
tests indicated that NK-92 cells depleted of IL-2 die within 72 hours. The addition of 1 ng/ml IL-2 
already leads to proliferation of NK-92 cells, which is dose dependent and reaches its maximum at 
50 U/ml. In contrast to IL-2, other cytokines such as IL-12, IFN-γ IL-4 and IL-6 exerted no effect 
on cell proliferation (Gong et al., 1994). 
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5.2 Stimulation of  lymphocytes 
5.2.1 Human T cell activation with phytohemagglutinin 
Lymphocyte proliferation in response to mitogens such as phytohemagglutinin (PHA), 
concanavalin A, pokeweed, and/or specific antigens has been the method of choice for in vitro 
diagnosis of cell-mediated immune function. Phytohemagglutinin, the lectin extract from red kidney 
bean (Phaseolus vulgaris), contains potent cell agglutinating and mitogenic activities (Tyrsted et al., 
1977). PHA includes a family of five isolectins of two different types, designated leukocyte reactive 
(L) and erythrocyte reactive (E). Type L has high affinity for lymphocyte surface receptors and is 
responsible for the mitogenic properties of the isolectins. PHA is a commonly used high quality 
tool for the stimulation of cell proliferation in lymphocyte cultures and functional analysis of  
T lymphocytes. PHA is not processed by proteases like other antigens, but binds to T cell receptors 
and MHC-II-molecules, acting as a superantigen (Löffler and Petrides, 2003). 
This interaction initiates a cascade of biochemical events in the T cell that results in growth and 
proliferation. This occurs primarily through an increase in IL-2 secretion by the T cell and an 
increase in IL-2 receptors on the T cell surface. IL-2 is a potent inducer of T cell growth, which, in 
T cell activation, acts in an autocrine fashion to promote the growth, proliferation and 
differentiation of the T cell recently stimulated by antigen. Activated Th cells then continue to 
become effector cells whose role is proliferation and cytokine production (Augustine et al., 2007).  
In our study, PHA confirmed its capability as a potent activator of T cell function seen in a strong 
induction of cytokine production (TNF-alpha, IL-2 IL-12, IP-10 and IFN-γ) and proliferation in 
comparison to untreated cells that showed negligible cytokine production and proliferation within 4 
days of cell cultivation.  
Fluorocytometric analysis also demonstrated the change in cell composition in consequence of 
PHA-activation. PHA-stimulation is causing selective proliferation of certain cell types. Four days 
of activation led to a fraction of CD3+/CD56− cells of more than 90 %. Monocytes instead 
decreased probably due to adherence. These findings are in agreement with other studies (Gollob et 
al., 2000, Toyoda et al., 2004) where PHA-activation of freshly isolated PBMC led to more than  
95 % CD3+/CD56−. This activation and differentiation of cells causes an increase in IL-12Rβ1 and 
IL-12Rβ2 expression on the T cell surface. Thus, our findings are in agreement with studies 
showing that IL-12 responsiveness, including IFN-γ secretion, is PHA-dependent (Gollob et al., 
2000). The coherence between IFN-γ production and IL-12Rβ expression supports previous 
studies showing that IL-12 increases the IFN-γ expression only in preactivated (PHA-stimulated)  
T cells (Janefjord and Jenmalm, 2001), whereas non-activated T cells are poor responders for IL-12. 
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5.2.2 Induction of cytokine production in human T lymphocytes by 
lipopolysaccharide (LPS)  
Lipopolysaccharide (LPS) is the main constituent of the outer leaflet of Gram-negative bacteria 
(Rietschel and Brade, 1992). LPS consists of a saccharide part and a lipid part, termed lipid A. The 
hydrophobic lipid A portion has been identified as the endotoxic principle of LPS ( Galanos et al., 
1985). LPS released into the blood stream, as observed during severe Gram-negative bacterial 
infections or caused by translocation of enterobacteria from the gut, leads to various 
pathophysiological reactions such as fever, leucopenia, tachycardia, tachypnoe, hypotension, 
disseminated intravascular coagulation, and multi-organ failure (Rietschel et al., 1994). Many 
different cell types have been documented to be reactive to LPS, e.g. monocytes/macrophages, 
vascular cells, polymorphonuclear cells, and even B lymphocytes.  
Additionally, LPS is a potent inducer of human T lymphocyte proliferation and cytokine 
production. The activation of T lymphocytes by LPS requires direct cell-to-cell contact with viable 
accessory monocytes. This interaction was found to be MHC-unrestricted, but strongly dependent 
on costimulatory signals provided by B7/CD28 interactions. The frequency of responding  
T lymphocytes is less than 1:1000 (Ulmer et al., 2000). 
Stimulation of T lymphocytes by a classical protein antigen requires accessory cells presenting 
antigen-derived peptides as well as providing costimulatory signals. Purified T lymphocytes could 
not be stimulated by LPS neither to proliferate nor to produce cytokines. The response of T 
lymphocytes to LPS, however, could be restored by the addition of monocytes. Macrophages and 
dendritic cells, matured from blood monocytes in vitro, were found to be less active in providing 
accessory cell activity than monocytes, whereas B lymphocytes exhibited no accessory cell activity 
(Mattern et al. 1998).  
In our study, stimulation of freshly isolated Peripheral Blood Mononuclear Cells with 1 µg/ml LPS 
led to a highly significant induction of monokine production as seen in TNF-α release. IFN-γ 
production was also increased significantly by LPS compared to unstimulated cells, supporting the 
ability of LPS to induce typical T cell-related cytokines, but IFN-γ concentration was still 30-times 
lower than in supernatants of PHA-stimulated PBMC. 
The ability of T cells to responded to LPS was already provided by the findings that human MNC, 
stimulated with LPS, not only expressed mRNA for the monokines such as IL-1, IL-6 and tumor 
necrosis factor-alpha (TNF-α), but also mRNA for the Th1-cytokines interferon-gamma (IFN-γ) 
and IL-2 (Ulmer et al. 2000).  
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We were also able to detect a highly significant increase of the Th2-cytokine IL-10 in consequence 
of LPS challenge, which is not surprising since TNF-α, is the most important trigger of IL-10 
release. The concentration of IL-18 protein secreted into the culture supernatants was close to the 
detection limit. 
In contrast to other studies, cell proliferation was not observed during LPS stimulation (data not 
shown). This could be due to the isolation method leading to a depletion of CD34+ hematopoietic 
stem cells that are required for the stimulation of human T lymphocytes by LPS. Since the 
depletion of CD34+ cells from MNC resulted in an almost total loss of the LPS-induced DNA 
synthesis (Ulmer et al., 2000). 
In conclusion, the activation of T lymphocytes by LPS represents a unique mechanism of  
T lymphocyte activation differing from that induced by classical mitogens, superantigens or 
antigens reflected in a different cytokine pattern and in the absence of cell proliferation.  
 
5.2.3 Enhancement of NK-92 cell activity by Interleukin 12 
NK cells play a pivotal role in protecting the body against infectious agents and cancers. Thus, 
cytokine-induced variations in activation in NK cells may have profound effects on NK cell biology 
and immune response. Cytokine treatment of NK cells results in alterations in multiple cellular 
responses that include cytotoxicity, cytokine production, proliferation, and chemotaxis. 
IFN-γ, a product of NK and T cells, is a key cytokine contributing to innate and adaptive 
immunity. IFN-γ production is induced via direct cell–cell contacts with APC and IFN-γ-producing 
cells or by cytokines. During microbial infections, macrophage-derived IL-12 enhances IFN-gamma 
production and Th1 response.  
In NK cells, IL-12 induces proliferation and cytolytic activity as well. IL-12 transmits signals by 
binding to a receptor complex composed of two subunits, leading to the formation of a high 
affinity receptor and subsequent signaling. IL-12 receptor subunits do not possess intrinsic kinase 
activity but rather function by associating with the members of the Janus family of kinases (JAK).  
Phosphorylation of JAK2 and TYK 2 induces the phosphorylation of other transcription factors 
such as STAT4. The translocation of transcription factors to the nucleus then leads to gene 
regulation (Sudarshan et al., 1999). STAT4 and AP-1 both participate in the regulation of IFN-γ 
gene expression, consequently, we focused our investigations on these two transcription factors 
although the IFN-γ gene is known to include consensus sequences for other transcription factors as 
well(other STATs, NFAT) (Aramburu et al., 1995). 
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IL-12-induced activation of STAT4. To investigate the kinetics of STAT4 phosphorylation and nucleic 
translocation, NK-92 cells were stimulated with IL-12 and incubation was stopped at different time 
points, cell lysates were prepared and underwent a Western-Blot analysis using specific phospho-
STAT4-Ab. In this study we have shown that STAT4 is phosphorylated in response to IL-12 
stimulation. The addition of 75 ng/ml IL-12 led to a significant increase in STAT4 activation, 
compared to untreated cells, where no phosphorylated STAT4 was detectable. The IL-12-induced 
phosphorylation peaks at 120 min. Following IL-12 stimulation for more then two hours results in 
the down-regulation of phosphorylated STAT4 for which a mechanism of proteosomal degradation 
has been suggested (Wang et al., 2000).  
It has been reported earlier that STAT4 is activated in response to IL-12 in activated NK and 
T cells as well as NK-92 cells. The kinetics of tyrosine phosphorylation and activation of STAT4 in 
these studies was similar to our findings. STAT4 phosphorylation was already detected at 30 min, 
was maximal at 2 hours and remained elevated up to 6 hours (Matikainen et al., 2001).  
The observation that IL-12 is able to activate STAT4 30 min upon stimulation suggests that the 
cytokine receptors and transcription factors are already present in cells without the requirement of 
ongoing protein synthesis and can directly activate the IFN-γ gene (Matikainen et al., 2001). 
The results reported here further demonstrate that IL-12 induces transient STAT4 presence in the 
nucleus. 
IL-12-induced IFN-γ production is not mediated by AP-1. Within the current work, we investigated 
whether the transcription factor AP-1 is also involved in NK-92 cell activation, leading to IFN-γ 
production. Consistent with other studies conducted either with T cells or native NK cells AP-1 is 
not activated in IL-12 stimulated NK-92 cells. Nakahira et al. (2002) already showed that upon  
IL-18, but not upon IL-12 stimulation accumulation of phosphorylated c-Jun occurred in the 
nucleus of a mouse T cell clone. Additionally, IL-18 confirmed its ability to promote IFN-γ 
expression via AP-1 in human primary CD4+ T cells. This was not observed by IL-12 alone 
(Barbulescu et al., 1998). 
The same holds true for IL-2 stimulated IFN-γ production where only IL-2 induced IFN-γ gene 
activation is mediated by AP-1. Consequently, AP-1 transcriptional activity and increased binding to 
its response element was only present in IL-2 stimulated cells (Azzoni et al., 1996). 
c-Jun is phosphorylated by c-Jun N terminal kinase (JNK), a kinase that is not activated following 
IL-12 stimulation. This may explain why IL-12 fails to induce IFN-γ gene expression via AP-1, 
whereas other cytokines such as IL-18 exhibit JNK activation capability. Although c-Jun was found 
to accumulate in the nucleus upon IL-12 stimulation, without prior phosphorylation by JNK, AP-1 
binding to the promoter region of IFN-γ remained very low (Sugimoto et al., 2003). 
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IL-12-induced alterations in IFN-γ gene expression. Control of IFN-γ gene expression is complex and 
involves both transcriptional and posttranscriptional regulation. The complexity of this regulation is 
common among many early-response genes that encode proteins for transcriptional modulators, 
structural proteins, and cytokines (Hodge et al., 2002). 
In NK cells the IFN-γ promoter is primed for transcriptional activation, as reflected by constitutive 
demethylation of the locus and acetylation of histone H3. The short-life of transcripts prevents 
synthesis of higher protein amounts in the absence of appropriate stimuli. These conditions make 
the cell exquisitely poised for rapid and efficient induction of IFN-γ biosynthesis in response to 
signals that activate transcription (Mavropoulos et al., 2005). 
The fact that NK cells are able to react rapidly in the presence of transcription-activating proteins is 
reflected in the results measured, when mRNA expression of IFN-γ was quantified using RT-PCR. 
Already 2 hours of IL-12 stimulation led to a significant increase of IFN-γ mRNA compared to 
initial level and unstimulated control. This increase can still be detected 8 hours upon IL-12 
activation. Interestingly, long-time incubation for more than 48 hours caused a decrease in mRNA 
expression below initial values. 
With our results we demonstrate IL-12 impacts the transcriptional activity of the IFN-γ gene and 
the amount of IFN-γ mRNA produced. 
IL-12 has no effect on intracellular IFN-γ concentrations. IL-12 stimulation did not significantly affect the 
intracellular concentration of IFN-γ in NK-92 cells. During 24 hours of incubation and IL-12 
stimulation, intracellular concentration remained constant, suggesting that NK-92 cells maintain an 
intracellular pool of IFN-γ at an average of 350 pg per mg cellular protein. Above this level, NK-92 
cells continuously secrete IFN-γ. 
IL-12 induced IFN-γ production by NK-92 cells. The results mentioned so far accent the importance of 
IL-12 in NK cell activation, where STAT4 activation followed by induction of mRNA expression 
finally leads to IFN-γ production. This increase in protein expression is secreted into cell culture 
supernatant, when reaching more than 350 pg per mg cellular protein, since intracellular 
accumulation was not observed.  
This significant increase in IFN-γ production induced within current work is in agreement with 
several previous findings (Kalina et al., 2000, Hodge et al., 2002). To compare the absolute amount 
of IFN-γ produced in different studies, one must take into consideration, that different cell 
numbers and IL-12 concentrations were applied. In our case, cells produced 1144 pg IFN-γ per 106 
cells. The cell density was 2.5 × 106 per ml, the applied IL-12 concentration was 75 ng/ml. Hodge 
and colleagues used NK-92 cells at a concentration of 1 x 106/ml and stimulated them with 10 
U/ml IL-12 for 24 h. In this case, cells produced up to 5000 pg/ml IFN-γ.  
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This was confirmed in several other studies where IL-12 induced IFN-γ production in NK cells 
freshly purified from PBMCs (Chan et al., 1991, Aste-Amezaga et al., 1994, Wang et al., 2000, 
Matikainen et al., 2001). Using human NK3.3 cells Ye et al. (1995), showed a significant increase in 
IFN-γ production upon IL-12 stimulation. Additionally, mouse splenocytes were also capable of 
IL-12 induced IFN-γ production (Thierfelder et al., 1996, Lawless et al., 2000). 
It is important to mention, that though cells were depleted of IL-2 and cultivated in serum-free 
medium for 16 hours previous to IL-12 stimulation produced IFN-γ. This is probably due to IL-2, 
which is essential for NK-92 cell survival (Gong et al., 1994) but is also able to induce IFN-γ 
production (Ye et al., 1995, Liebermann and Hunter 2002, Hodge et al., 2002); Concluding that the 
initial IFN-γ levels produced during ‘starvation phase’ were still a result of prior IL-2 
supplementation. 
The kinetics of IL-12-induced IFN-γ production showed an increase within the first 6 hours where 
cells responded more stronger to IL-12 than in the later phase of incubation. In the delayed phase 
of IL-12, exposure IFN-γ levels remained static. This supports the findings by Watford et al. (2004) 
where prolonged exposure also resulted in a stagnation of IFN-γ concentrations. 
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5.3 Ethanol-induced changes in cell activation and 
cytokine pattern seen in activated PBMC and NK-92 
cells 
5.3.1 Ethanol in cell culture: maintenance of constant ethanol 
concentrations 
In order to investigate the effect of ethanol exposure, it was important to keep constant alcohol 
concentrations in the cell culture medium during the whole time of incubation. To avoid 
evaporation, cells were maintained in ethanol-containing medium of a specified concentration 
inside of plastic boxes with additional open beakers containing an aqueous solution of the 
corresponding ethanol concentrations, in this case 1, 2 or 3 ‰.  
This model was used in our laboratory for years to guarantee constant conditions concerning 
ethanol incubation during periods lasting for several days without substantiate decrease in ethanol 
concentration due to evaporation. It was first described by Rodrigues and colleagues in 1992 where 
cells culture dishes were kept in ‘alcohol vapor chambers’ on the one hand or were placed directly 
in the incubator. On the other hand, in the ‘open system’ 90 % of the initial concentration of  
100 mM evaporated within 24 h. In the ‘closed system’ with ethanol-containing dishes, the ethanol 
concentrations in cell culture medium remained constant. They further showed that the number of 
dishes including ethanol solutions had no effect. Changes in pH-values were not observed 
(Rodrigues et al., 1992). 
Even more important is the fact that cultivating cells in ethanol-free media inside sealed plastic 
boxes did not change their viability, growth rate and protein or phospholipid composition 
compared to cultures grown outside the boxes. This model was even improved using a special ‘Bio-
foil’ in the lid of each box allowing a constant exchange of O2 and CO2 without any passage of 
ethanol. With this ‘improved alcohol vapor chambers’, tests concerning ethanol evaporation were 
performed by Gesierich in 2002. Cell culture media containing 1 and 2 ‰ ethanol were incubated 
for more than 4 days, ethanol concentrations were tested using an enzymatic method at 16, 32, 48, 
72 and 96 hours upon incubation start. The change in alcohol concentration over incubation period 
was below 0.03 ‰ and therefore negligible low. 
Regarding experiments done within this study, it was suggested that ethanol concentrations 
remained stable during incubation time. In long-term incubation, ethanol-containing beakers were 
changed every 24 hours to avoid loss in alcohol concentration. We therefore affirm that all 
experiments done in ‘alcohol vapor chambers’ were conducted with constant ethanol 
concentrations in culture media and that all effects observed were due to the applied concentration. 
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5.3.2 Influence of ethanol on Peripheral Blood Mononuclear Cells 
Effect of ethanol on PHA-induced IFN-γ production. In this work, the effect of acute ethanol 
administration on PHA-stimulated IFN-γ production was evaluated using freshly isolated 
Peripheral Blood Mononuclear Cells. In our model we used ethanol levels, which may be on the 
one hand representative for acute, moderate alcohol intake (1 ‰) and, on the other hand, are seen 
in binge drinking and chronic abuse in humans (3 ‰). 
In the current study PHA-stimulated IFN-γ production was already reduced in a significant manner 
upon the addition of 1 ‰ Ethanol to the cell culture medium. This decrease in IFN-γ expression 
was even more predominant, when 3 ‰ of ethanol were applied. IFN-γ concentration in cell 
culture medium was reduced to 5 % compared to ethanol-free stimulation after 72 hours of 
incubation.  
Ethanol consumption has adverse effects on the host’s ability to combat infectious pathogens. 
Numerous clinical reports have identified alcoholism as a comorbidity with pulmonary infections 
(Friedman et al., 1998). Additionally ethanol-associated defects in the ability to clear invading 
microbes have been described in the experimental setting for bacterial pathogens, mycobacteria, 
Listeria and others (Nelson et al., 1990).  
Similar experiments were conducted by Wagner et al., in 1992 where isolated human peripheral 
blood mononuclear cells were isolated and treated with ethanol. In this case, cells were incubated 
with ethanol concentrations ranging between 0 and 100 mM for 72 hours, after removement of 
ethanol-containing medium cells were stimulated with Con A and PHA for additional 24 hours. 
As seen in our results, ethanol induced a statistically significant inhibition of Interferon γ secretion. 
The effect was also dose-dependent and already demonstrable at very low ethanol concentration 
(6.25 mM). At 50 mM, ethanol-induced reduction ranged from 72 % to almost 90 % (depending on 
individuals tested). With these findings, Wagner et al., demonstrated for the first time that ethanol 
inhibits the mitogen-induced IFN-γ secretion by human peripheral blood mononuclear 
lymphocytes of healthy donors in vitro. 
Our results are in agreement with Wagner’s study. We have also shown that PBMCs isolated from 
healthy donors were strongly affected by ethanol treatment concerning IFN-γ production and our 
findings suggest that this down-regulation of IFN-γ expression may be an important element to 
many immune alterations seen in alcohol abuse.  
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Does ethanol influence the production of other cytokines? In addition to IFN-γ, the effect of ethanol on 
seven other cytokines was investigated. The question was, whether changes seen in ethanol-treated 
Peripheral Blood Mononuclear Cells were exclusively concerning IFN-γ expression or if other 
cytokines were affected by alcohol as well, and if so, to which extend addressing hereby the 
exclusive interaction between ethanol and IFN-γ production. 
PHA- as well as LPS-stimulated TNF-α production by PBMC was suppressed in a highly significant 
manner when cells were treated with 3 ‰ ethanol for 12 hours (38 % for PHA-stimulation, 55 % 
for LPS-stimulation). Remarkably is the fact that the addition of 1 ‰ ethanol to the cell culture 
medium led to a TNF-α release that tended to be higher but the level of significance was >0.05. 
Other researchers that focused on acute exposure also observed an ethanol-induced suppression of 
TNF-α production in stimulated immunocompetent cells. Using LPS-stimulated isolated human 
monocytes Bikash et al. (1993) and Szabo et al. (1996) obtained a TNF-α suppression that was dose-
dependent (in contrast to our results) and this effect was already seen in monocytes incubated in 
medium containing 25 mM (1.1 ‰) ethanol-containing medium.  
This suppression of TNF-α expression by acute ethanol exposure can be explained by the 
interference of ethanol with different intracellular signaling molecules.  
Mitogen-activated protein kinases (MAPK) have been demonstrated to play a role in mediating 
intracellular signal transduction and regulating cytokine production by mononuclear cells in 
response to a variety of extracellular stimuli. In particular, p38 plays a role in the LPS (endotoxin)-
induced inflammatory response (Nick et al. 1996). 
LPS-induced TNF-α production was inhibited in a similar pattern by pretreatment with either 
ethanol or SB202190 (1 µM), a specific inhibitor of p38 kinase. Western blot analysis, using a dual 
phospho-specific p38 mitogen-activated protein kinase Ab, demonstrated that ethanol pretreatment 
inhibited LPS-induced p38 activation (Arbrabi et al. 1999). 
NF-κB, a pivotal transcription factor regulated by various stresses of bacterial or viral stimuli, 
serves as the central mediator of innate immune responses. The NF-κB transcription factor consists 
of two subunits of either homodimers or heterodimers of RelA/p65, c-Rel, and p50.  
The complexes are present in cytoplasma and prevented from activation by a class of proteins 
referred to as inhibitors of NF-κB or IκB proteins. Upon stimulation, the IκB proteins are 
phosphorylated by the IκB kinases (IKK) IKKα, IKKβ, and IKKγ ubiquitinated, and degraded 
thereby releasing the NF-κB complex for nuclear translocation (Hacker et al. 2006). 
Using human peripheral blood monocytes and Chinese hamster ovary cells transfected with CD14, 
Mandrekar et al. 2007 showed that acute alcohol treatment in vitro exerts NF-κB inhibition by 
disrupting phosphorylation of p65. Immunoprecipitation of p65 and IκBα revealed that acute 
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alcohol exposure for 1 h decreased NF-κB-IκBα complexes in the cytoplasm. Phosphorylation of 
p65 at Ser536 is mediated by IκB kinase (IKK)β and is required for NF-κB-dependent cellular 
responses. Furthermore, nuclear expression of IKKα increased after alcohol treatment, which may 
contribute to inhibition of NF-κB (Szabo et al. 1999). 
Some researchers have also shown a significant posttranscriptional and posttranslational component 
of acute alcohol-mediated TNF-α suppression in both rodent and primate macrophages (Zhao et al. 
2003). One possible posttranslational effect of acute ethanol results in decreased processing of 
TNF-α by TNF-α-converting enzyme (TACE), a member of the disintegrin and metalloproteinase 
(ADAM) family of proteins (Zhang et al. 2003). 
Using transfected murine fibroblasts, acute alcohol resulted in a dose-dependent suppression of 
TACE-mediated processing of TNF-α. Additionally, acute ethanol suppresses processing and 
secretion of TNF-α by altering membrane compartmentalization of the enzyme and substrate 
(Zhao et al. 2003).  
TNF-α is also thought to play a particularly critical role in the pathogenesis of ALD. Production of 
TNF-α is one of the earliest responses of the liver to injury. Circulating TNF-α is increased in the 
blood of alcoholics and in animals chronically exposed to ethanol. In addition to increasing LPS 
exposure, chronic ethanol also increases sensitivity to LPS. Moreover, it was shown that LPS-
stimulated TNF-α secretion is increased in Kupffer cells isolated from rats fed ethanol in their diet 
for 4 weeks compared to pair-fed controls (Kishore et al. 2005). 
In this case chronic ethanol feeding disrupts specific LPS-stimulated signal transduction pathways 
which regulate both TNF-α transcription and mRNA stability.  
Chronic ethanol has also complex effects on the regulation of LPS-stimulated TNF-α mRNA 
transcription; the transcriptional activity of NF-κB was dramatically decreased, but this was 
compensated by increased Egr-1 activity (Kishore et al., 2002). Therefore LPS-stimulated TNF-α 
mRNA accumulation in Kupffer cells isolated from rats chronically exposed to ethanol is due to a 
stabilization of TNF-α mRNA. These data suggest that regulation of TNF-α mRNA stability 
mediates increased TNF-α production during ethanol consumption and thus contributes to the 
progression of inflammation during alcoholic liver disease (Kishore et al., 2002). 
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In our model system of isolated human PBMC, IL-2 was only induced in cells treated with PHA at 
a concentration of 2 µg/ml. The addition of ethanol to cell culture medium of PHA activated cells 
had no effect on IL-2 concentration measured. This is in agreement with other studies, where 
ethanol did not affect IL-2 expression itself but suppressed mRNA expression of a variety of IL-2-
induced genes and the activity of transcription factors (Zhou et al., 2003). 
Previous studies clearly show that ethanol consumption decreases innate cytolytic activity of NK 
cells as well as IL-2 stimulated NK cytolytic activity and lymphokine-activated killer cell activity 
(Gallucci et al., 1995, 1996; Meadows et al., 1993). It is also known that this inhibition of NK 
cytolytic activity is associated with decreased protein expression of perforin, granzyme A, and 
granzyme B in response to IL-2 stimulation (Collier 2000). 
Ethanol has shown to modulate significantly the production not only of proinflammatory cytokines 
such as TNF-α but also the expression of antiinflammatory mediators such as TGF-β or IL-10 
(Szabo, 1996). In addition, monocyte-derived TGF-β and IL-10 are both potent inhibitors of T cell 
proliferation (Wahl et al. 1992). Ethanol has shown to induce TGF-β and IL-10 in Kupffer cells and 
monocytes (Szabo et al. 1992). This change in expression of antiinflammatory cytokine production 
can potentially attenuate host defense in both inflammatory and immune responses. 
The use of blood monocytes, treated with a physiologically relevant dose of alcohol (25 mM) 
resulted in a significantly decreased production of TGF-β and IL-10, and further augmented 
bacterial (both LPS and SEB) stimulation-induced production of both cytokines (Szabo et al. 1996). 
These results are not supported by our findings, where neither LPS nor PHA had any effect on 
TGF-β production and the addition of ethanol to cell culture medium did not change TGF-β 
production in a significant manner. Even more interestingly, in contrast isolated human monocytes, 
IL-10 production in isolated human PBMC treated with ethanol concentrations of 22 to 66 mM led 
to a significant and dose-dependent decrease when cells were additionally stimulated with LPS. 
Interleukin-12 is an important effector cytokine for defense of the host against a multitude of 
invading organisms, including intracellular bacterial pathogens. Enhancement of NK cell and T 
lymphocyte activity by IL-12 is responsible for augmentation of defenses against these pathogens. 
IFN-γ then plays a key role in the orchestration Th1 lymphocyte cell-mediated immunity directed 
against intracellular pathogens. Thus, IL-12 exerts its immunostimulatory effects in most parts by 
activating IFN-γ production (Watford et al., 2004).  
Since IL-12 is a potent inducer of IFN-γ production one could ask whether ethanol-mediated IL-12 
expression is causing low IFN-γ concentrations. A question we also took into consideration, 
especially since Mason et al. (2000) showed that ethanol suppressed IL-12 expression in LPS-
challenged mice and Interleukin 12 therapy restored cell-mediated immunity in ethanol consuming 
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mice (Peterson et al., 1998). But besides the measurement of IFN-γ levels, we also tested cell culture 
supernatants of ethanol-treated cells for IL-12 concentration. Surprisingly ethanol-treated PHA-
activated PBMCs showed an increase in IL-12 expression compared to untreated cells. This is the 
reason why low IFN-γ production was not due to low stimulation by IL-12.  
IL-18, like IL-12, was discovered initially to be a factor that drives the T cell toward T helper 1 cell 
subtype and thus was referred as ‘IFN-γ-inducing factor’ (Okamura et al. 1998) and since IL-18 has 
been shown to enhance IL-12-depedendent IFN-γ production, it appears that IL-18 promotes cell-
mediated immunity and thus is essential to host defences against a variety of infections. However, 
like many other proinflammatory cytokines, IL-18 possesses broad immunomodulatory properties 
(Leung et al. 2001).  
In the present study we tested cell culture supernatants for IL-18 to investigate if IL-18 − as IFN-γ-
inducing factor − was suppressed in a similar way than IFN-γ expression itself. But in our model 
using isolated human PBMC IL-18 expression was not induced in PHA or LPS-stimulated cells. 
Hence it is unlikely that IL-18 is responsible for the IFN-γ-suppressing effect of ethanol. 
IP-10 was initially identified as an abundantly induced mRNA in U937 cells upon IFN-γ 
stimulation, and its expression is predominantly induced by IFN-γ in endothelial cells, monocytes, 
fibroblasts, astrocytes, keratinocytes, and neutrophils. IP-10 chemoattracts activated T cells and NK 
cells, but not resting T cells, B cells, or neutrophils (Faber et al. 1997). IP-10 expression has been 
found in various clinical conditions such as psoriasis, tuberculoid leprosy, sarcoidosis, and viral 
meningitis. All of these diseases are associated with an increased expression of IFN-γ (Th1-type 
diseases), which may induce IP-10 expression in involved tissues (Mosmann et al. 1996). 
As expected, high IFN-γ expression measured in PBMC treated with PHA is associated with high 
IP-10 levels in cell culture supernatant of those cells, whereas lower IFN-γ expression in LPS-
stimulated cells is reflected by lower IP-10 expression. However, a significant reduction in IP-10 
expression after ethanol treatment as seen for IFN-γ was not observed. 
Is T cell proliferation affected by ethanol? Many of the immunosuppressive effects of acute alcohol 
treatment have been linked to decreased production of proinflammatory cytokines. On the other 
hand, a decline in cell number and viability was also observed in some in vivo studies (Nagy et al., 
1994). To find out whether ethanol concentrations administered in this study are responsible for 
lower cytokine release or if this is simply due to an impaired PHA-driven proliferation, we 
determined cell proliferation and viability.  
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The addition of ethanol to cell culture medium of isolated and PHA-activated cells had no 
significant effect on cell proliferation over 9 days of incubation.  
These results are in contrast to other studies, where ethanol was applied in vivo to healthy volunteers 
and peripheral blood mononuclear cells were isolated from blood samples taken before alcohol 
consumption, 4 hours and 18 hours after alcohol intake. The allostimulatory capacity of blood 
monocytes was determined by [3H]thymidine incorporation into purified naïve allogeneic T cells in 
a mixed lymphocyte reaction (MLR) (Mandrekar et al., 2004). 
Compared with T cell proliferation in MLR prior to alcohol use, T cell proliferation was reduced in 
the presence of stimulator cells obtained from the same individual. These results suggest that the 
reduced alloantigen-induced T cell proliferation is due to suppressed accessory cell function rather 
than T cell dysfunction after acute ethanol intake (Mandrekar et al., 2004). A report by Peterson et 
al., (1998) identified reduced accessory cell-derived IL-12 levels as a potential mechanism for 
diminished antigen-specific T cell proliferation after chronic alcohol feeding. 
Results obtained in the same study with PBMCs stimulated with PHA isolated before and 18 hours 
after alcohol intake support the findings of the current study. In contrast to reduced antigen-
induced T cell proliferation, T cell proliferation after direct mitogen stimulation remained 
unchanged after alcohol intake. Considering that, PHA-induced T cell proliferation is not 
dependent on costimulatory signals from accessory cell. The current results support the hypothesis 
that acute alcohol intake rather affects accessory cell function than proliferation of lymphocytes per 
se (Szabo et al., 2001).  
T cell proliferation response in MLR was also decreased in mice after chronic alcohol feeding 
(Chang and Norman, 1999). In those experiments, allospecific MLR of the responder cells from 
alcohol-consuming mice was reduced but there was no suppression of the cytotoxic T lymphocytes 
in the alcohol consuming mice, suggesting involvement of MHC class II rather than MHC class I 
events (Chang and Norman, 1999). 
After acute alcohol intake in humans, there was no significant defect in T cell proliferation when 
cells were obtained from the alcohol-consuming volunteers, suggesting that acute and chronic 
alcohol treatment may have different effects on T lymphocytes (Szabo et al., 2001). 
In the current work, there was no ethanol-modulated proliferation verifiable, suggesting that the 
suppression of proinflammatory cytokines such as IFN-γ is due to suppression of molecular 
mechanisms regulating cytokine production instead of diminished cell numbers caused by acute 
ethanol treatment. 
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Fluorocytometric analysis of IL-12 receptor subunits. IL-12-driven Interferon γ production requires signals 
provided through interleukin 12 receptors. It has been proposed that the magnitude of the immune 
response in T-lymphocytes may be directly correlated to the cell surface expression of IL-12 
receptor subunits (Trinchieri et al., 2003). The biologic activities of IL-12 are mediated through a 
specific, high affinity IL-12R composed of an IL-12Rbeta1/IL-12Rbeta2 heterodimer, with the IL-
12Rbeta2 chain involved in signaling via STAT4. For that reason, we investigated IL-12R 
expression in human PHA-activated PBMC when treated with ethanol. 
To date, two subunits of the IL-12R, IL-12Rβ1 and IL-12Rβ2, have been identified and cloned. 
When individually expressed in COS-7 cells, human IL-12Rβ1 and β2 each bind IL-12 with low 
affinity, while coexpression of both IL-12Rβ1 and β2 results in both low and high affinity IL-12 
binding and responsiveness. Splenocytes from IL-12Rβ1-deficient mice fail to display IL-12-
induced enhancement of NK lytic activity, suggesting that IL-12Rβ1 is an essential component for 
IL-12 responsiveness in vitro and vivo (Zhang et al., 2003). 
From previous studies, it has been become increasingly evident that IL-12 is a key regulator of 
IFN-γ. The ability of IL-12 to stimulate Th1 responses requires the expression of the IL-12R on T 
cells. However, both receptor chains are differently regulated. The IL-12Rβ1 is constitutively 
expressed on T cells; in contrast, the IL-12Rβ2 is selectively expressed on Th1 but not on Th2 cells 
(Kim et al., 2001). 
In the current study, PHA-activation led to an increase in IL-12Rβ1 and IL-12Rβ1 expression on T 
cell surface; suggesting that PHA-stimulation leads to an induction of Th1 cytokine pattern.  
The importance of sufficient IL-12 R expression with respect to host resistance against pathogens 
is highlighted since IL-12Rβ1 deficiency is the most common genetic aetiology of Mendelian 
susceptibility to mycobacterial disease. The known mutations in the IL12Rβ1 gene are recessive and 
are associated with the abolition of the response to both IL-12 and IL-23. Patients with IL-12Rβ1 
deficiency classically experience clinical disease caused by Bacille Calmette-Guerin (BCG), 
environmental mycobacteria, and non-typhoid Salmonella species (Rosenzweig and Holland, 2004). 
As a result of defective IL-12R signaling, IFN-γ is underproduced by T cells and natural killer cells. 
For that reason, we asked whether the same held true in alcohol-treated cells. Underproduction of  
IFN-γ in the presence of sufficient IL-12 concentrations may be caused by changes in IL-12 
receptor expression on activated T cells. 
The fluorocytometric analysis of PHA-activated T cells did not support this hypothesis of ethanol-
mediated changes in IL-12R subunit expression. The addition of 1 and 3 ‰ ethanol to cell culture 
media did not affect IL-12 receptor expression of both subunits at all. 
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5.3.3 Ethanol-induced suppression of IFN-γ expression in NK-92 cells 
NK cells play a pivotal role in protecting the body against infectious agents and cancers. Thus, 
alcohol-induced variations in IFN-γ production may have profound effects on NK cell biology and 
immune response. In this study, we have examined global changes in IFN-γ expression in response 
to IL-12 alone and in combination with different ethanol concentrations. 
As demonstrated within the current study, ethanol treatment in vitro resulted in a significant 
decrease of IL-12-induced IFN-γ production by NK-92 cells, just in the same manner as in PBMC.  
Other in vitro studies on the effects of ethanol on cytokine production are the continuation of the 
observed effects of ethanol on circulating cytokine levels in vivo (Deaciuc 1997). 
In vivo studies in alcohol abusers and in patients with alcohol-induced liver disease are often hard to 
interpretate since possible comorbidities and malnutrition as well as vitamin deficiency among 
alcohol abusers may at least in part contribute to immune alterations seen in alcohol-consuming 
patients (Windle et al., 1993). 
Although these observations cannot be directly related to the ethanol intake, the correlation of 
findings in vivo is supported by animal and cell models (Wagner et al., 1992, Chen et al., 1993, Laso et 
al., 1997, Deaciuc, 1997, Waltenbaugh et al., 1998, Szabo et al., 2001, Starkenburg et al., 2001, Dokur 
et al., 2003). 
The ethanol-mediated changes seen in NK-92 cells are in agreement with several other studies, 
where different models were used with respect to cell type and applied ethanol concentration as 
well as different cell stimuli. 
A comparable model was used by Wagner et al., (1992) where freshly isolated PBMC were treated 
with ethanol concentration ranging between 0 and 100 mM in vitro. Cells produced significant less  
IFN-γ either unstimulated or mitogen-activated. This was even seen at as low ethanol 
concentrations as 6.25 mM. 
Ethanol-treatment of isolated mouse splenocytes also resulted in downregulation of IFN-γ 
production. Splenocytes from healthy mice were challenged with LPS or Con A for 24 hours and 
additionally incubated with ethanol ranging from 0.1–1.0 % (v/v). The production of IFN-γ in this 
model was found to be reduced in a dose-dependent manner (Chen et al., 1993). 
Other studies focused on in vivo exposure to ethanol, followed by cell isolation, direct cytokine 
measurement or prior in vitro stimulation. 
Isolated PBMC of healthy volunteers stimulated with PHA showed a reduced IFN-γ production 
upon in vivo alcohol consumption in an acute and moderate manner (Szabo 1998). The same result 
was obtained when rats were treated with ethanol in vivo and isolated splenocytes were activated 
thereafter with Con A in vitro (Dokur et al., 2003). 
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Furthermore, mice chronically fed a liquid diet with 5 % ethanol for 11 weeks showed a decrease in 
splenocyte IFN-γ production in the presence of Con A (Wang et al., 1994). 
In contrast, splenocytes obtained from mice ethanol-fed for 5 months did not express a significant 
change in IFN-γ production when stimulated with LPS or Con A. They produced as much IFN-γ 
as their non-alcohol-fed littermates (Chen et al., 1993). 
The comparison of different models to investigate ethanol-mediated changes in IFN-γ is always 
difficult to do and, in some cases, may lead to inconsistent results. It was already mentioned that 
ethanol-abuse in humans is correlated with malnutrition and different stages of alcoholic liver 
disease, making it impossible to distinguish the effect of ethanol alone, but still reflects the actual 
case in humans depending on alcohol. Animal models of in vivo exposure may be advantageous due 
to the control of nutrient intake, and are superior to cell models cause of existing organ and cell–
cell interactions. 
Cell isolation either from humans or animals is still a time-consuming method and may cause 
alterations of cells properties as well may cause non-specific stimulation. It is even questionable 
whether the changes induced by in vivo consumption are still persistent upon cell isolation and in 
vitro stimulation. 
A reason we favored the current model were isolated cells or cell lines were challenged 
simultaneously with ethanol at different concentration and potent inductors of IFN-γ expression. 
The resulting effects thereby can be directly related to acute ethanol treatment. 
It was even more important, that pretreatment with ethanol followed by ethanol-free PHA 
stimulation had no effect on IFN-γ production (data not shown). The effect of ethanol-induced 
IFN-γ suppression is therefore only present in coincubation experiments. 
Another quite important fact only occurred, when NK-92 cells were incubated with IL-12 and 
ethanol for a short period of time. First results obtained from isolated PBMCs only reflected long-
term incubation for more then 24 hours. This was quite normal since PHA-activation did not lead 
to rapid and sufficient short-term IFN-γ production within minutes or hours. In contrast, IL-12 
stimulation of NK-92 cells induced high amounts of IFN-γ already upon 6 hours of incubation. At 
first, we did not focus on this incubation time point, but it was quite astonishing, that in short-time 
incubation IFN-γ concentration in the cell culture medium of ethanol-treated cells was even below 
values of unstimulated cells without ethanol treatment. It seemed that in this case already produced 
IFN-γ virtually disappeared and was no longer detectable in cell culture supernatant. This results at 
first unattended, later changed our focus from intracellular signaling pathways to posttranscriptional 
mechanism such as the formation/release of a specific binding proteins or extracellular 
degradation. 
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5.3.4 Cell viability 
Is ethanol-induced suppression of IFN-γ expression due to changes in cell viability? Cell viability was assessed to 
exclude non-specific toxic effects of the ethanol concentrations applied in our cell culture model. 
The viability of NK-92 cells was 59 % in control cultures without ethanol addition, compared to  
65 % under treatment with 1 ‰ ethanol, 60 % under 2 ‰ and 62 % when 3 ‰ ethanol were 
applied. We therefore conclude that in all cases ethanol had no significant effect on cell viability. 
This is in agreement with several other studies where isolated PBMC were not affected by ethanol 
concentrations ranging between 0–100 mM for 72 hours (Wagner et al., 1992). Spleen cells treated 
with 0.1–1.0 % ethanol also showed no change in cell viability (Chen et al., 1993).  
Wagner and colleagues tested concentrations up to 100 mM and Chen and colleagues used 
concentration reaching 220 mM and are therefore not considered as concentrations seen in alcohol 
consuming humans. But even those high concentrations did not affect cell viability. 
The total number of viable cells in our study was lower compared to the studies by Wagner and 
Chen (95 %) though applied ethanol concentrations in those studies were comparable and even 
higher than those we used ranging between 0 and 66 mM. 
This fact can be explained by different culturing conditions. To avoid any additional effect of IL-2, 
NK-92 cells were maintained in a ‘starvation medium’ prior to incubation experiment. Since NK-92 
cells depend on IL-2, the number of viable cells upon incubation was lower in general, regardless 
whether cells were treated with or without ethanol. NK-92 cells are not able to survive for more 
than 72 hours upon IL-2 depletion (Gong et al., 1994). 
In summary, we assume that ethanol in concentrations applied here does not influence cell viability 
of NK-92 cells and even more important alcohol-suppressed IFN-γ production is not caused by 
lower cell numbers in experiments where ethanol was implemented. A non-specific toxic effect of 
ethanol on NK-92 cells can therefore be excluded. 
 
 
5.3.5 Physiological relevance of applied ethanol concentrations 
The previous chapter already dealt with the different alcohol concentrations applied in studies 
focusing on in vitro effects of ethanol in human, animal and cell models; a reason to address the 
consequences of physiological relevant alcohol blood concentrations. 
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Many studies (Diamond, 1990) have established that in humans, the evident behavioural changes 
associated with increases in blood alcohol concentrations are as follows: altered mood, impaired 
attention (6 to 20 mM); impaired cognition and coordination, and sedation (20–40 mM); 
intoxication, ataxia (40 to 65 mM); severe stupor, coma, death (65–110 mM). In addition, subjects 
can achieve what is referred to as acute tolerance, whereby they exhibit intoxication at a blood 
alcohol concentration of 40 mM. Heavy drinkers and alcoholics can achieve what is referred to as 
chronic tolerance whereby subjects can maintain blood alcohol concentrations of 30–120 mM 
ethanol and still appear sober. According to such studies, severe alcoholics can attain blood alcohol 
concentrations as high as 330 mM and still remain conscious and alert.  
Considering the alcohol concentrations mentioned above, the concentrations applied in this study 
ranging between 0 and 66 mM correspond to relevant blood alcohol levels occurring after acute, 
moderate alcohol consumption and even binge-drinking, defined within the field of epidemiology 
as drinking 5 or more drinks for men and 4 or more for women per occasion leading to blood 
alcohol concentrations of 3 ‰ and more. 66 mM in vitro correspond to 0.3 g/dl seen in alcoholics 
after acute alcohol consumption (Szabo 1997).  
Thus, our results are relevant for moderate as well as excessive ethanol intake by healthy subjects. 
Higher blood alcohol concentrations are only seen in chronic alcoholics in whom tolerance evolved 
over years of alcohol abuse. 
 
5.3.6 Ethanol effects on transcriptional activation of IFN-γ in NK-92 cell 
Are intracellular signaling molecules affected by ethanol? To study IL-12-induced STAT4 activation and 
phosphorylation, NK-92 cells were ‘starved’ for two hours and stimulated with 75 ng/ml IL-12 for 
another 2 hours. Additional cells were treated with ethanol concentrations of 22–66 mM. Western 
blot analysis showed no difference in IL-12-induced STAT4 phosphorylation whether cells were 
treated with ethanol of different concentrations or not. In contrast to IL-12 treated cells 
unstimulated NK-92 cells showed no STAT4 activation at all.  
To the best of our knowledge, no other study conducted so far focused on STAT4 activation in 
case of ethanol-induced modulation. However, Jak/STAT-signaling was already investigated and 
changes in the activation of other STAT molecules were already observed in other cell culture 
models. A reason we also hypothesized a mechanism of ethanol-mediated change in intracellular 
signaling molecules underlying the suppression of IFN-γ expression. 
Chen et al. (2003) studied the effect of ethanol on the Jak/STAT signaling in freshly isolated, 
cultured rat hepatocytes. Acute ethanol exposure inhibited IL-6-activated STAT3 in freshly isolated 
hepatocytes. Interleukin 6-induced activation of STAT3 is a critical step in liver regeneration. 
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Chronic ethanol consumption is known to increase the plasma concentration of IL-6, yet the ability 
of the liver to regenerate and regenerative induction of several IL-6 initiated events are impaired in 
chronic alcoholic liver disease. The inhibitory action of ethanol on the Jak/STAT signaling pathway 
therefore might be implicated in pathogenesis and progression of alcoholic liver disease (Chen et al., 
2001). 
Similar results were obtained by Nguyen et al., (2000). They studied mechanism underlying the 
ineffectiveness of Interferon treatment of viral hepatitis in alcoholics. They report that IFN-α/β 
and IFN-γ rapidly activate the Jak/STAT1 in freshly isolated rat hepatocytes. Treatment of 
hepatocytes with 25–100 mM ethanol for 30 min inhibited IFN-induced STAT1 activation and 
tyrosine phosphorylation. Pretreatment with non-selective tyrosine phosphatase and specific 
proteasome inhibitors did not reverse the inhibitory effect of ethanol, suggesting that phosphatases 
and the ubiquitin-proteasome are not involved in the suppressing action of ethanol (Nguyen et al., 
2000). 
Accumulating evidence suggests that activation of a variety of cytokines and their downstream 
signals are important in the development and progression of liver injury. TNF-α activation of the 
NF-κB signal, IFN-γ activation of STAT1 and IL-4 activation of STAT6 have all been shown to 
play crucial roles in the development of liver injury in Con A-induced hepatitis used as a model by 
Jaruga et al., in 2004. Results showed that in ethanol-fed mice, Con A activation of STAT1 and 
STAT3 signaling pathway was inhibited, whereas NF-κB, the expression of various chemokines 
and adhesion molecules controlled by NF-κB is enhanced in ethanol-fed mice, which may be an 
important mechanism contributing to the increase in susceptibility of ethanol-fed mice to T cell-
mediated hepatitis induced by Con A (Jaruga et al., 2004). 
Leptin acts via receptors that are homologous in sequence to class I cytokine receptors. These 
include receptors for IL-6, leukocyte inhibitory factor (LIF) and granulocyte colony stimulating 
factor (G-CSF). The leptin receptor is able to induce tyrosine phosphorylation through its 
association with Jak2. In the following leptin appears to activate STAT1, STAT3, STAT5 and 
STAT6. A reason the group of Degawa-Yamauchi examined the effects of ethanol on leptin-
induced STAT3 activation using human hepatoma cell lines. To determine the dose response of the 
inhibitory effects of ethanol on leptin-induced STAT3 phosphorylation, cells were incubated with  
0–100 mM ethanol for 30 min followed by leptin stimulation for 15 min. Inhibition of 50 % was 
already observed at a concentration of 0.1 mM and complete inhibition at 100 mM ethanol, 
indicating a dose-dependent inhibition of STAT3 activation (Degawa-Yamauchi, 2002). 
Summarizing these studies, it is quite obvious that ethanol is able to interfere with intracellular 
signaling molecules such as STATs or NF-κB, but due to our study does not support the idea of 
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ethanol-mediated inhibition of STAT4 activation at physiologically relevant ethanol concentrations. 
Once activated by tyrosine phosphorylation, STAT4 forms a homodimer, translocates to the 
nucleus, binds to specific DNA sequence and activates the transcription of the IFN-γ gene. To 
evaluate whether phosphorylated STAT4 of ethanol-treated NK-92 cells is able to translocate into 
the nucleus, we performed Western blotting using nuclear extracts prepared from unstimulated or 
IL-12 stimulated NK-92 cells with additional ethanol treatment. Phosphorylated STAT4 increased 
in the nuclear extracts of IL-12 treated cells already 30 min upon stimulation and peaked at 2 hours 
(data not shown), whereas untreated cells showed no translocation of activated STAT4 into the 
nucleus. Additional effects of ethanol were not observed.  
The mechanism regulating STAT4 cytoplasmatic – nuclear import and export is critical for IFN-γ 
production. As was shown for STAT1, facilitated transport of STAT1 into the nucleus requires the 
presence of signal motifs that are recognized by specific soluble shuttling receptors of the 
importin/karyopherin family. The exact mechanism how cells import STAT4 molecules on 
cytokine induction as well as the regulation of the export from the nucleus, is still not fully 
understood (Toyoda et al., 2004). 
There are a few cases reported where impaired translocation of STAT4 is causing recurrent 
infections in humans, which seems to be based on genetic defects (Toyoda et al., 2004). Whether 
exogenous agents such as alcohol, certain medication or specific inhibitors are able to influence 
STAT4 translocation has not been studied so far. At least in our cell culture model using ethanol-
treated NK-92 cells, effects on the nucleic accumulation of STAT4 on IL-12 stimulation were not 
detectable. 
Another transcription factor important for IFN-γ production is described as being ethanol-
sensitive. This was shown in mice administered the TLR3 ligand poly(I:C), causing an immune 
response similar to those seen in some virus infections. Additionally, 6 g/kg ethanol was given as a 
32 % (v/v) ethanol-water solution. In this case, the amount of phosphorylated c-Jun (AP-1 
component) in the nucleus of peritoneal macrophages was increased. In the case of simultaneous in 
vivo exposure to ethanol, this increase was suppressed. This was associated with a suppressed 
induction of mRNA for IFN-γ by ethanol (Pruett et al., 2004). 
This effect was also observed in splenic NK cells from mice fed an ethanol containing diet. 
Enriched NK cells were stimulated ex vivo with IL-2. As seen previously, the ethanol-induced 
reduction of AP-1 binding activity paralleled reduced mRNA expression of AP-1 related genes 
(perforin, granzyme A and granzyme B) IFN-γ expression was not investigated in this study (Zhou 
and Meadows 2003). 
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Within the current work, it was intended to investigate the effect of ethanol on AP-1 mediated  
IFN-γ production. However, since no IL-12-induced AP-1 activation was involved in IFN-γ 
production in NK-92 cells, the investigation of the effect of ethanol on AP-1 transcriptional activity 
was not preceded. 
Effect of ethanol on IFN-γ mRNA expression. The fact that ethanol has no effect on some transcription 
factors crucial for IFN-γ gene activation is supported by results on the level of IFN-γ mRNA 
expression. As expected IL-12 treatment of NK-92 cells led to a significant increase in IFN-γ gene 
expression seen in the relative number of IFN-γ copies compared to 18S rRNA, additional 
incubation with 1, 2 and 3 ‰ ethanol  had no significant effect on mRNA expression compared to 
IL-12 stimulated NK-92 cells. In summary, activation of transcription factors correlated with 
mRNA expression and was not affected by ethanol in a significant manner. 
In contrast, Dokur et al. showed previously that ethanol administration suppresses NK cell cytolytic 
activity in male Fischer rats. This study analyzed the effects of ethanol on perforin, granzyme B, 
and the cytokine interferon (IFN)-γ, factors that modulate NK cell cytolytic activity, to understand 
the molecular mechanism involved in ethanol’s suppression of NK cell activity. 
Male Fischer rats were fed an ethanol-containing diet (8.7% v/v), whereas a control group was pair-
fed an isocaloric diet. After 2 weeks, spleen tissues were immediately removed and used for analysis 
of NK cell cytolytic activity, the release of perforin, granzyme B, and IFN-γ messenger RNA 
(mRNA) or protein levels. The mRNA levels of perforin, granzyme B, and IFN-γ were evaluated 
by quantitative real-time polymerase chain reaction. Results showed that ethanol reduced the NK 
cell cytolytic activity and decreased the mRNA expression of perforin, granzyme B, and IFN-γ in 
ethanol-fed animals when compared with pair-fed animals. Ethanol also significantly reduced the 
protein levels of perforin and IFN-γ and the enzyme activity of granzyme B in alcohol-fed animals 
as compared with pair-fed animals. These data suggest that chronic ethanol consumption may 
suppress ex vivo NK cell cytolytic activity in male Fischer rats by decreasing the production, activity, 
or both of granzyme B, perforin, and IFN-γ (Dokur et al., 2003). 
Arjona et al. (2004) already demonstrated in their previous work that ethanol treatment for 2 weeks 
did not affect the splenocyte number, total NK cell number, or percentage of NK cells within the 
spleen in male Fisher rats. However, in their latest study they provide data that suggest the ability of 
ethanol to disrupt the physiological circadian rhythms of granzyme B, perforin, and IFN-γ, 
specifically by hampering the occurrence of the peaks in their mRNA and protein levels. This 
represents a specific alteration of NK cell circadian regulation. Furthermore, they demonstrated 
that chronic ethanol consumption is able to suppress NK cell activity by directly disrupting the 
circadian rhythm of granzyme B, perforin, and IFN-γ mRNA expression (Arjona et al., 2004). 
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5.3.7 Posttranscriptional events influenced by ethanol 
Since ethanol did not modulate the activation of IL-12-induced transcription factors and had no 
effect on IFN-γ mRNA-expression, we focused on posttranscriptional events that might be 
influenced by ethanol. 
Is there an alcohol-induced intracellular accumulation of IFN-γ? IL-12 stimulation did not significantly affect 
the intracellular IFN-γ concentration of NK-92 cells. The intracellular concentration of IFN-γ 
remained stable for 24 hours of incubation. Suggesting that NK-92 cells maintain an intracellular 
pool of IFN-γ at an average of approximately 350 pg per mg cellular protein; above this 
concentration, NK-92 cells continuously secrete IFN-γ. 
This intracellular pool was not affect by ethanol. Thus, the ethanol-induced decrease in IL-12-
induced IFN-γ medium concentration in NK-92, cannot be explained by an intracellular 
accumulation of IFN-γ. Hence, the transport of IFN-γ out of the cells was not affected by ethanol. 
These findings are in agreement findings of other workgroups. Mice were fed with drinking water 
containing 20% (w/v) ethanol for 2 weeks. NK cells isolated and enriched from splenocytes of 
these mice were cultured in the presence of 20 pg/ml IL-2 for 24 hours. In vivo treatment with 
ethanol did not affect intracellular levels of IFN-γ (Galluci and Meadows 1996). By contrast, in 
chronic alcoholics cytoplasmatic IFN-γ levels of peripheral blood T cells were found to be 
increased (Laso et al., 1999). As already mentioned, in vivo ethanol treatment and subsequent cell 
isolation may be associated with alterations of cells that modulate the resulting cytokine 
concentration. Additionally, the effect of ethanol treatment may not persist during and after cell 
isolation (Deaciuc 1997). Moreover, ethanol abuse in humans is often associated with malnutrition 
and comorbidities, which can be an indeterminable component for interpreting modified cytokine 
production (Chen et al., 1993). Thus, it is impossible to distinguish effects of malnutrition and 
comorbidities from effects of ethanol alone in human alcohol abusers (Lin et al., 1998). In 
comparison to in vivo ethanol exposure, simultaneous in vitro incubation with ethanol, as it was used 
within the current work, may be advantageous, since the effects on IFN-γ can be directly related to 
the acute effect of ethanol (Chen et al., 1993). In contrast to the results within the present work, the 
Dokur et al.  showed that in vitro ethanol treatment resulted in decreased intracellular IFN-γ levels in 
rat splenocytes enriched for NK cells. Isolated splencocytes enriched for NK cells were cultured for 
24 hours prior to incubation with 100 mM ethanol for another 18 hours. Under these conditions, 
ethanol treatment decreased intracellular protein levels of IFN-γ (Dokur et al., 2005).  
The controversial results may be explained by the different cell models applied and the way of 
ethanol treatment (chronic vs. acute). However, with respect to the applied cell model within the 
current experiments, an intracellular accumulation of IFN-γ by ethanol can be excluded. 
  
5  DISCUSSION  1 69   
Is there an increased uptake of IFN-γ in ethanol-treated NK-92 cells? If the whole process of NK-92 
activation and IFN-γ expression is not affected by ethanol, there might be a mechanism where once 
released from NK-92 cells, IFN-γ is re-uptaken in NK-92 cells and degraded intracellularly.  
To address this question, we used a differential experimental setting than in the former trials. In this 
case, IFN-γ production was not generated by IL-12 stimulation, but cells were treated with ethanol 
in the first place to induce intracellular changes or the release of certain proteases or binding 
proteins, cells and cell culture supernatant were separated and afterward human recombinant IFN-γ 
was supplemented at a concentration of 2000 pg/ml (a concentration also reached when cells were 
stimulated to produce IFN-γ and were left ethanol-untreated). If ethanol would induce a more 
rapid uptake of IFN-γ into NK-92 cells, the supplemented IFN-γ concentration might be lower in 
ethanol-treated preparations compared to experiments where NK-92 cells were untreated. 
In detail, the ethanol-treatment of NK-92 cells did not change the concentration of IFN-γ 
supplemented cell culture medium. Within one hour of incubation, the amount of IFN-γ in cell 
supernatants remained stable. For this reason, we do not assume a mechanism in which ethanol-
treated cells are induced in IFN-γ uptake. Different results were obtained when cell culture 
supernatant of ethanol-treated cells were supplemented with 2 ng/ml human recombinant IFN-γ. 
In this case, the supernatant of previously ethanol-treated cells was capable of a fast degradation of 
recombinant human IFN-γ. 
Unknown protein that binds or degrades IFN-γ upon ethanol incubation: Since no significant difference 
occurred in mRNA expression and intracellular accumulation of IFN-γ, we asked whether ethanol-
treatment is leading to a more rapid degradation of IFN-γ once released from NK-92 cells instead 
of a lower production by the cells itself. The preincubation of NK-92 cells with 1, 2 or 3 ‰ ethanol 
had a highly significant effect on the concentration of IFN-γ in the cell-free supernatant at 10 and 
70 min compared to the supernatant of cells without ethanol treatment. The detectability of IFN-γ 
might have been negatively affected, by a decomposing factor, such as a protease, in the presence 
of ethanol. Additionally, IFN-γ might have been masked by a protein in the presence of ethanol. 
Hence, no longer it would be possible to detect IFN-γ by ELISA. This in vitro observation of the 
reduced detectability of IFN-γ in the presence of the cell-free supernatants of NK-92 cells 
preincubated with ethanol is first described within the current work and comparable results were 
not found in literature.  
We would like to point out that all the results obtained so far are consistent with this observation, 
since no change in transcriptional activation and mRNA-expression was observed and intracellular 
accumulation of IFN-γ upon ethanol-action was not demonstrated, even more important this 
mechanism might explain the ‘disappearance’ of IFN-γ in short-term incubation. 
170  5  DISCUSSION  
 
 
This results led us to the conclusion that NK-92 cells treated with different ethanol concentration 
release an unknown protein that is either able to bind or to disintegrate IFN-γ.  
To the best of our knowledge, we are the first being able to demonstrate that changes in IFN-γ 
levels observed upon ethanol treatment are due to extracellular modification. 
The soluble IFN-γ receptor. Soluble cytokine receptors, which either attenuate or promote cytokine 
signaling, are important regulators of inflammation and immunity. The key role of soluble cytokine 
receptors is to prevent excessive inflammatory responses is illustrated by the autosomal dominant, 
autoinflammatory, TNF receptor-associated periodic syndrome (TRAPS), which was initially 
identified in patients with mutations in the extracellular domain of the 55-kDa, type I TNFR 
(TNFRSF1A, TNFR1) that impaired receptor shedding (Levine, 2004).  
The IL-1 and IL-6 receptor systems are paradigms for soluble cytokine receptors that mediate 
antagonistic and agonistic effects. Both systems are complex and are regulated by multiple cell-
associated and soluble receptors, as well as receptor-associated proteins. 
In contrast to the antagonistic effect of sIL-1RII on IL-1 signaling, soluble IL-6 receptors are an 
important mechanism by which IL-6 signaling is amplified. Soluble IL-6 receptors can be generated 
by two distinct pathways: proteolytic cleavage that sheds the membrane-bound IL-6R ectodomain 
or alternative mRNA splicing, with resulting synthesis of an IL-6Rα that lacks the transmembrane 
domain. Soluble IL-6 receptors bind IL-6 with an affinity similar to the membrane IL-6R, thereby 
prolonging the IL-6 half-life and preventing IL-6 from starting cellular activation (Rose-John et al., 
2006). 
Proteolytic cleavage of cell surface receptors is typically catalyzed by zinc metalloproteases of the 
ADAM (a disintegrin and metalloprotease) family. ADAM17 or TNF-α-converting enzyme (TACE) 
is the prototypical receptor sheddase that was identified by its ability to cleave membrane-bound 
TNF to its soluble form (Levine, 2004). 
The discovery that soluble forms of cytokine receptors are involved in the endogenous regulation 
of cytokine activity has prompted substantial interest in their potential application as 
immunotherapeutic agents (Fernandez-Botran et al., 2002). 
Subcutaneous administration of increasing doses of IL-12 in cancer patients increased the 
expression of certain cytokine genes (e.g. IFN-γ) in peripheral blood mononuclear cells. However, a 
marked decline of IFN-γ was observed. In addition, a constant up-regulation of serum soluble IFN-
γ receptor levels was observed after each cycle of IL-12 treatment. The constant rise of soluble 
IFN-γ receptor during IL-12 therapy may therefore contribute to the inhibition of IFN-γ activity 
detected after repeated cycles of IL-12 (Haicheur 2000). 
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The ability of many soluble cytokine receptors to inhibit the binding and biological activity of their 
ligands makes them very specific cytokine antagonists. The question whether the release of soluble 
cytokine receptors is also induced by exogenous substances such as ethanol is yet to be elucidated. 
For that reason, we used two different approaches to study ethanol-mediated secretion of the IFN-
γ receptor. In a first attempt, we used the addition IFN-γ receptor specific antibody to block the 
binding of NK-92 cell-released IFN-γ binding to the soluble IFN-γ receptor to enable detection of 
free IFN-γ.  
A second attempt to study ethanol-mediated IFN-γ receptor release was to use a commercially 
available ELISA set designed to detect the IFN-γ receptor 1 concentration. Concentration of IFN-γ 
receptor subunit 1 in cell supernatants of ethanol-treated cells tended to be slightly higher in 
comparison to cell supernatants of untreated NK-92 cells. However, this increase was not 
significant and overall concentrations ranged from 40 to 100 pg/ml and were far to low to explain 
the ‘loss’ of almost 2000 pg/ml of supplemented human recombinant IFN-γ protein.  
In summary, we conclude that the release of soluble IFN-γ receptor is not responsible for changes 
in IFN-γ concentration in supernatants of NK-92 cells incubated with ethanol. 
Does ethanol induce extracellular proteolysis? The addition of a commercially available protease inhibitor 
cocktail had a highly significant effect on the change in IFN-γ concentration in cell supernatants of 
ethanol-treated cells. This fact leads one to suggest that ethanol-incubated NK-92 cells rapidly 
release proteases capable of degrading IFN-γ in a specific manner and that the addition of a 
mixture of different protease inhibitors blocked the proteolytic effect, hereby stopping the 
degradation of IFN-γ, leading to IFN-γ concentrations in ethanol-treated cell’s supernatants as high 
as supplemented. 
Proteinases are important regulators in antigen presentation and cytotoxic activity. The most 
important roles of proteinases in the immune system are found in apoptosis and major 
histocompatibility complex (MHC) class II-mediated antigen presentation. 
A variety of cysteine proteinases, serine proteinases, and aspartic proteinases as well as their 
inhibitors are involved in the regulation of apoptosis in neutrophils, monocytes, and dendritic cells, 
in selection of specific B and T lymphocytes, and in killing of target cells by cytotoxic T cells and 
natural killer cells. In antigen presentation, endocytosed antigens are digested into antigenic 
peptides by both aspartic and cysteine proteinases.  
Proteinase activity in these processes is highly regulated by balance between active proteinases and 
specific endogenous inhibitors such as cystatins, thyropins, and serpins. (van Eijk 2003).  
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The possible involvement of cell surface-associated proteolytic enzymes in human NK cell-
mediated cytotoxicity and the mechanism by which such enzymes exert their activity have already 
been studied. Of the membrane-associated enzymes, those engaged in cytotoxicity seem to be 
concealed from the external environment, as pretreatment of the effector cells with protease 
inhibitors such as trasylol and PMSF have no effect on the reaction. Immediately upon addition of 
the target cells and the initiation of cytotoxicity, the reaction becomes highly sensitive to inhibitors. 
The surface-associated elastase on the other hand maintains a constitutive mode of activity 
distinctive and unrelated to that of enzymes engaged in cytotoxicity. These findings suggest the 
existence proteases on the surface of the NK lymphocyte and of a mechanism where resting 
cytotoxic structures become activated as the receptor attaches to the target cell. Therefore binding 
to the target cell triggers the exposure of the proteolytic moiety, and initiates the lytic phase of the 
reaction (Lavie et al., 1985). 
Another group of protease expressed in immunocompetent cells are the matrix metalloproteinases. 
They are members of a family of at least 21 Zn2+-dependent endopeptidases, of which 16 are 
soluble, secreted enzymes, while the other 5 are membrane bound. The expression of most MMPs 
is highly regulated by several mechanisms: at mRNA level transcriptionally by cytokines, hormones, 
and growth factors, and at protein level by proteolytic activation of latent enzymes and inhibition of 
active enzymes by endogenous inhibitors. They play important roles in many normal biological 
processes such as wound healing, and angiogenesis as well as in pathological processes, including 
arthritis, emphysema, and cancer metastasis (Nagase et al. 1999). The main characteristic of MMPs 
is the degradation of the extracellular matrix of basement membranes, thus enabling cells to invade 
into tissues. MMPs are secreted as proenzymes and subsequently activated by proteolytic cleavage. 
MMP activity is regulated by the naturally occurring inhibitors such as α-macroglobulins and the 
tissue inhibitors of MMPs (TIMPs) (Parson et al. 1997). 
MMPs in immune cells serve numerous specialized immunologic functions in addition to 
extracellular matrix degradation (Goetzl et al. 1997). T lymphocytes have been shown to produce 
MMP-9 constitutively, whereas MMP-2 expression is induced by IL-2 and VCAM-1-dependent 
adhesion to endothelial cells. These MMPs contribute to the ability of T cells to migrate through 
model subendothelial basement membranes (Xia et al. 1996). Neutrophils have been shown to store 
MMP-8 and MMP-9 intracellularly in specific granules and to secrete these enzymes upon 
stimulation. Macrophages express MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, and MT1-MMP as 
well as MMP-12. These MMPs mediate secretion of Fas ligand and TNF-α by cleavage of their 
membrane-bound forms and generation of angiostatin from plasminogen by proteolytic cleavage 
(Patterson et al. 1997). 
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Natural killer cells are endowed with the ability to express spontaneous cytotoxicity against tumor 
cells or virus infected cells. Upon several biological responses such as virus infection and 
carcinogenesis, NK cells encompass movements directed against target cells. They should possess 
proteinases, which mediate their transmigration through the ECM component for their migration 
to the target cells (Ishida et al., 2004).  
In the animal model, it was already documented that rat IL-2-activated NK cells produce matrix 
metalloproteinase-2 (MMP-2) and MMP-9. Additionally it was shown that mouse NK cell-derived 
MMPs, include MT-MMPs, and also TIMPs. RT-PCR analysis from cDNA of mouse NK cells 
revealed mRNA for MMP-2, MMP-9, MMP-11, MMP-13, MT1-MMP, MT2-MMP, TIMP-1, and 
TIMP-2. MMP-2 and MMP-9 expression was confirmed by gelatin zymography (Kim et al. 2000). 
Moreover, Kim et al. (2000) report MT-MMPs are expressed by NK cells, i.e., large granular 
lymphocytes as determined by both RT-PCR and Western blots. Taken together, these findings 
suggest that NK cells may therefore use multiple MMPs in various cellular functions. 
Recent findings suggested that ethanol activates matrix metalloproteinases (MMPs) via protein 
tyrosine kinase (PTK) signaling. Chronic alcohol administration has been shown to activate MMP-2 
and -9 in in vitro and in vivo models (Aye et al., 2004; Lois et al., 1999); however, mechanisms leading 
to such effects remain undefined. Two in vivo studies examined the effect of ethanol on MMPs. Lois 
et al. demonstrated that ethanol exposure increases MMP-2 and MMP-9 activity but not their 
production in rat lungs. Similarly, ethanol consumption upregulates the enzymatic activity of MMP-
2 in rat aortas. Although these studies do not identify the source of MMP-2, they support the fact 
that MMP-2 is a target of ethanol.  
The underlying mechanism of ethanol-mediated IFN-γ expression is still unknown and will be topic 
of our future investigations. With our results demonstrating a possible proteolytic degradation 
activation of MMPs by ethanol will be in the centre of our further experiments. 
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5.4 Outlook 
With our results demonstrating a possible proteolytic degradation of IFN-γ as a consequence of 
ethanol treatment we provide for the first time evidence that alcohol induces the release of specific 
proteolytic enzymes that are able to disintegrate IFN-γ. Since ethanol is long known to modulate 
cytokine patterns in vivo the question remains whether this mechanism seen in cell culture model is 
also present in isolated PBMC as well as in vivo. 
Future research will be the application of more specific inhibitors makes it possible to further 
characterize the protease responsible for IFN-γ degradation. It would be even more interesting if 
other cytokines influenced by ethanol are also substrates of ethanol-induced proteolytic enzymes 
and if the addition of inhibitors in those cases might also lead to the compensation of ethanol-
modulated effects. 
Additionally, one has to take into consideration that even though the amount of IFN-γ detected in 
cell culture supernatant of ethanol-treated cells might be restored by the addition of protease 
inhibitors, the question remains whether biological activity of IFN-γ, leading to STAT1 
phosphorylation and expression of IFN-regulated genes is reestablished in effector cells, such as 
monocytes and activated T cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 Summary 
 
Expose to potential pathogens is followed by inflammation. This reaction of the immune system 
includes the production of cytokines, a group of multifunctional proteins that play a critical role in 
cellular communication and activation. Cytokines have been classified as being proinflammatory or 
anti-inflammatory depending on their effects on the immune system. However, cytokines regulate 
inflammation, cell death, and cell proliferation and migration as well as healing mechanisms.  
Alcohol is known to modulate the immune system in a complex manner. The effects of alcohol on 
immune responses vary with acute and chronic exposure as well as depending on the history of 
alcohol consumption and the blood level of alcohol. The presence or absence of alcohol can affect 
the cytokine cascade in complex ways.  
Chronic alcohol consumption increases TNF-α, IL-6 and reactive oxygen release from resident 
macrophages in liver that underlie early alcohol-induced liver disease. Additionally alcohol use alters 
immune defenses against infections and results in increased incidence of bacterial pneumonias, a 
higher rate of chronic hepatitis C infection, and increased susceptibility to HIV infection (Nelson 
and Kolls, 2002; Prakash et al., 1998; Wiley et al., 1998; Zhang et al., 1997). Alcohol-induced 
alterations in immune functions extend to both innate and adaptive immune responses. Previous 
studies demonstrated that alcohol exposure results in impaired adaptive immune responses and 
antigen-specific T cell activation.  
In the current study the immunmodulatory capability of an acute, moderate (1 ‰) to high amount 
(3 ‰) of alcohol was tested on isolated Peripheral Blood Mononuclear Cells production of several 
proinflammatory and antiinflammatory cytokines after incubation for 12 to 72 hours. 
We found that lipopolysaccharide (LPS)-induced as well as phytohemagglutinin (PHA)-stimulated 
TNF-α was significantly reduced when PBMC were incubated with high concentrations of ethanol 
(3 ‰) for 12 hours. The same was seen in IL-10 production of LPS-challenged PBMC, whereas  
IL-2 concentrations in cell culture supernatants of ethanol-treated (3 ‰) cells was significantly 
increased compared to standard incubation. This is also true for PHA-stimulated PBMC tested for 
IL-12 concentration. In contrast, differences in cells proliferation and viability were not observed.  
However, the most affected cytokine in our model system of isolated human PBMC treated with 
two different ethanol concentrations was IFN-γ. Its concentration decreased in a highly significant 
manner in PHA- as well as in LPS-stimulated PBMC when treated with 66 mM ethanol and in a 
significant manner in PHA-activated PBMC when treated with 22 mM ethanol. 
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The fact that ethanol negatively affects IFN-γ production is supported by several in vivo and in vitro 
studies by Wagner et al., 1992, Chen et al., 1993, Laso et al., 1997 Waltenbaugh et al., 1998, 
Starkenburg et al., 2001, Szabo et al., 2001, Dokur et al., 2003. 
The reduced IFN-γ level observed might be a key factor in explaining comprised immunity seen 
after chronic alcohol abuse, since together with IL-12, IFN-γ is crucial for the innate and adaptive 
immune response to viral and bacterial infection (Vicente-Gutierrez et al., 1991, Windle et al., 1993, 
Szabo 1997, Szabo et al., 1999). 
Since NK cells are acting in the early state of host defense against infection where they serve as 
main source of IFN-γ and since IL-12 is one of the most efficient inducers of IFN-γ gene 
expression, we studied ethanol effects on IFN-γ in IL-12 stimulated NK-92 cells. 
As seen in isolated human Peripheral Blood Mononuclear Cells IFN-γ production by IL-12 
stimulated NK-92 cells is significantly reduced in the presence of ethanol. However, this decrease 
did not correlate with decreased phosphorylation and nuclear translocation of STAT4, a central 
regulator of IFN-γ gene expression.  
These results indicated that acute alcohol treatment in vitro did not affect intracellular pathways 
leading to IFN-γ gene expression. These findings paralleled results indicating that the amount of 
mRNA for IFN-γ synthesis in NK-92 cells is not affected by the applied ethanol concentrations as 
well. Additionally it was shown within the current work, that the reduced IFN-γ production by 
NK-92 cells in the presence of ethanol might not be explained by an intracellular accumulation of 
the IFN-γ protein.  
The inhibitory action of ethanol on IFN-γ may rather be caused by posttranslational modification 
once IFN-γ is released by NK-92 cells, since the addition of recombinant human IFN-γ to the cell 
culture supernatants of ethanol-treated cells led to a decline in the amount of IFN-γ concentration. 
We therefore hypothesized that ethanol may cause the release of either an IFN-γ-binding or IFN-γ-
degrading protein. An increase in soluble IFN-γ receptor as a result of ethanol treatment was not 
observed. But the addition of mixture of 5 commercially available protease inhibitors counteracted 
the effect of ethanol treatment, giving us a first hint of IFN-γ-modulatory mechanism, where IFN-γ 
released by NK-92 cells may be disintegrated by a protease released as consequence of ethanol 
incubation.  
To our best knowledge we are the first to demonstrate a posttranslational modification of IFN-γ as 
a consequence of ethanol incubation.  
In summary, the present results support the inhibitory role of ethanol on IFN-γ, but are too 
preliminary to explain the underlying immunmodulatory effect. 
 
 7 Zusammenfassung 
 
Eine Entzündung ist die Folge einer Reaktion des Immunsystems auf potentielle Pathogene. Die 
Zytokine, die hierbei gebildet werden sind Proteine, die eine zentrale Rolle im Zusammenspiel und 
in der Aktivierung von immunkompetenten Zellen spielen. Die einzelnen Zytokine können in pro- 
und antiinflammatorisch wirksam eingeordnet werden. Insgesamt sind sie für die Regulation der 
Entzündung, die Proliferation und Migration, sowie am Heilungsprozess beteiligt. 
Die Bildung von Zytokinen und damit die Immunabwehr selbst kann durch exogene Faktoren, wie 
Alkohol beeinträchtigt werden. Der Einfluss von Alkohol auf die Immunabwehr unterscheidet sich 
je nach Menge des konsumierten Alkohols und des damit erreichten Blutalkoholspiegels, sowie 
nach der Dauer des chronischen Missbrauchs. Dabei führt Alkohol zu vielfältigen Veränderungen 
innerhalb der Zytokin-Kaskade: Chronischer Alkoholmissbrauch führt in der Leber zu einer 
vermehrten Freisetzung von TNF-α aus Kuppferzellen und damit zu einer Entzündungsreaktion, 
die schon in einem frühen Stadium der alkoholbedingten Lebererkrankung eine entscheidende 
Rolle spielt. Zusätzlich kommt es zu weiteren Veränderungen, die in einer erhöhten Inzidenz von 
bakteriellbedingten Pneumonien sowie in einer erhöhten Anfälligkeit gegenüber viralen Infektionen 
wie Hepatitis C und HIV zu sehen ist (Nelson and Kolls, 2002; Prakash et al., 1998; Wiley et al., 
1998; Zhang et al., 1997). Dabei sind diese Veränderungen sowohl bei Reaktionen des angeborenen, 
als auch des adaptiven Immunsystems von entscheidender Bedeutung. In früherer Studien konnte 
bereits eine deutliche Schwächung der adaptiven Immunantwort nachgewiesen werden, sowie eine 
deutlich geringere Aktivierung der Antigen-spezifischen T-Zellaktivierung.  
In der nun vorliegenden Arbeit wurden die immunmodulatorischen Eigenschaften von Alkohol l in 
Konzentrationen von 1 ‰ und 3 ‰ untersucht. Hierzu wurde die Fähigkeit isolierter humaner 
PBMC unter dem Einfluss von Ethanol pro- bzw. antiinflammtorische Zytokine zu produzieren 
untersucht. Dabei konnte ein deutlicher Rückgang der LPS- bzw. PHA-induzierten TNF-α-
Ausschüttung gemessen werden, wenn Alkoholkonzentrationen von 3 ‰ zur Inkubation eingesetzt 
wurde. Für IL-10 gilt das gleiche, während im Gegensatz dazu IL-2 in seiner Produktion erhöht 
war. Für PHA-stimulierte PBMC wurde diese Erhöhung auch für IL-12 nachgewiesen. Andere 
Zytokine wie TGF-β, IP-10 und IL-18 wurden in ihrer Produktion nicht verändert. Messungen der 
Proliferation und Vitalität der Zellen ergaben ebenfalls keine Veränderungen bei Alkoholzusatz.  
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In unserem Modellsystem wurde IFN-γ in seiner Ausschüttung am deutlichsten gehemmt.  
Hohe Alkoholkonzentrationen von 3 ‰ führten zu einem hochsignifikanten Rückgang auf ca. 4 % 
der IFN-γ Menge, wie sie unter alkoholfreien Bedingungen gemessen werden konnte. Für Alkohol-
Konzentrationen von 1 ‰ betrug dieser Rückgang ca. 30 %. 
Die Tatsache, dass Alkohol die IFN-γ Ausschüttung negativ beeinflusst wurde bereits in anderen in 
vitro und in vivo Studien (Wagner et al., 1992, Chen et al., 1993, Laso et al., 1997 Waltenbaugh et al., 
1998, Starkenburg et al., 2001, Szabo et al., 2001, Dokur et al., 2003) gezeigt. 
IFN-γ ist ein pleiotropes Zytokin, essentiell für die angeborene und adaptive Immunantwort auf 
virale und bakterielle Infektionen. Damit könnten die verminderten IFN-γ Spiegel, wie sie auch in 
Seren von Menschen mit Alkoholabusus gemessen werden ein Schlüssel für die Erklärung der 
‘Immunschwäche’ in dieser Patientengruppe sein. 
Bei der Erstreaktion des Immunsystems wird IFN-γ hauptsächlich von NK Zellen gebildet. Dabei 
ist IL-12 der effektivste Aktivator der IFN-γ Genexpression und damit entscheidend für eine 
angemessene Reaktion gegen eingedrungene Pathogene viraler oder bakterieller Genese. 
Wir konnten belegen, dass die IFN-γ Ausschüttung durch IL-12-stimulierte NK-92 Zellen durch 
Ethanol in gleicher Weise gehemmt wird, wie bereits für PBMC beschrieben. Diese Hemmung geht 
jedoch nicht mit einer Veränderung der STAT-4-Phosphorylierung, einem entscheidenden Schritt 
hin zur IFN-γ-Genexpression, einher. Parallel zu dieser Messung konnte auch keine Verminderung 
der IFN-γ-mRNA-Menge unter dem Einfluss von Ethanol nachgewiesen werden. Auch eine 
intrazelluläre Akkumulation kann nach unseren Ergebnissen ausgeschlossen werden. 
Damit ist die inhibierende Wirkung von Alkohol auf posttranslatorisch wirksame Mechanismen 
zurückzuführen. Dabei zeigte sich, dass ein unbekanntes Agens im Zellkulturüberstand von zuvor 
mit Ethanol behandelten Zellen die Fähigkeit besitzt extern zugesetztes humanes rekombinantes 
IFN-γ so zu modulieren, dass ein anschließender Nachweis im ELISA nur noch in geringen 
Mengen möglich war. Damit scheint Alkohol die NK-92 Zellen zur Ausschüttung eines IFN-γ 
bindenden oder IFN-γ abbauenden Moleküls zu stimulieren. Die Bindung an den löslichen IFN-γ-
Rezeptor kann nach den Ergebnissen unserer Untersuchungen ausgeschlossen werden. Durch den 
Einsatz einer kommerziell erhältlichen Mischung von 5 Protease-Inhibitoren konnte der 
ethanolbedingte Abbau von IFN-γ in den Zellkulturüberständen gehemmt werden und damit ein 
möglicher Wirkmechanismus aufgezeigt werden.  
Ingesamt unterstützen unsere Resultate eindeutig die inhibierende Wirkung von Ethanol auf IFN-γ. 
Die bisher vorliegenden Resultate und der fehlende Nachweis einer IFN-γ modulierenden Protease 
macht es jedoch noch nicht möglich, den Mechanismus dieser hemmenden Wirkung zu erklären.  
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